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ABSTRACT

Skeletal Muscle Growth of Beef Cattle: Cattle Breed Types and Anabolic Implants

by

Caleb C. Reichhardt, Doctor of Philosophy
Utah State University, 2022

Major Professor: Dr. Kara J. Thornton
Department: Animal, Dairy and Veterinary Sciences
There is a need to further improve beef cattle production in the U.S. to ensure that
enough food is available for the growing population in both an environmentally and
economically sustainable manner. Two potential methods to help further improve
environmental and economic sustainability of the beef industry are by using growth
promotants and through increasing heterosis within the herd through crossbreeding Bos
taurus and Bos indicus. The mechanisms of action anabolic implants operate through to
improve skeletal muscle growth have yet to be determined, and very little research has
been done investigating the relationship between anabolic implants and cattle breed
types. However, the heterosis effect of crossbreeding these two cattle breed types has
been found to improve economically important traits, such as average daily gain and
carcass quality. Therefore, we hypothesized that the hormones in anabolic implants
would operate through different molecular mechanisms from each other. Furthermore, we
hypothesized that anabolic implants would cause breed-dependent changes resulting in
improved growth in different cattle breed types related to the innate muscle metabolism
differences between the two breed types. To investigate this, three different feedlot trials
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were conducted. In trial one, Angus steers (Bos taurus) were implanted with different
hormones commonly used in anabolic implants. In trials two and three, Angus- and Santa
Gertrudis-influenced steers (Bos indicus) were implanted with various anabolic implants
and following different anabolic implant protocols. Feedlot performance, animal
behavior, carcass characteristics, and skeletal muscle biopsies were collected from the
longissimus thoracis following implanting. In all three trials, anabolic implants improved
(P < 0.05) feedlot performance and hot carcass weight. Additionally, it was found that
estradiol improved growth by increasing (P ≤ 0.09) mRNA transcript abundance of genes
associated with mitochondrial activity and nutrient partitioning. Meanwhile, trenbolone
acetate increased (P < 0.10) mRNA transcript abundance of genes related to skeletal
muscle growth. Furthermore, mRNA related to protein turnover was altered (P ≤ 0.07) in
a breed dependent manner following implantation. Steer temperament and feeding
behavior was also affected by anabolic implants, with Santa Gertrudis steers being more
(P < 0.04) temperamental following implantation than Angus steers. The results from
this research provide important information on the mechanism of action that anabolic
implants operate through to increase skeletal muscle. Additionally, this research
demonstrates the importance of matching anabolic implant protocols to cattle breed type
to maximize economic return for producers.
(294 pages)

v
PUBLIC ABSTRACT

Skeletal Muscle Growth of Beef Cattle: Cattle Breed Types and Anabolic Implants

Caleb C. Reichhardt

Two potential methods that can be used by the U.S. to help further improve
environmental and economic sustainability of the beef industry are through the use
anabolic implants, typically composed of the hormones estradiol and trenbolone acetate,
and by crossbreeding Bos taurus and Bos indicus cattle. How anabolic implants operate
to improve growth, and their resulting relationship with different cattle breed types have
yet to be determined. However, crossbreeding these cattle breed types has been found to
have a positive influence on economically important traits such as average daily gain and
carcass characteristics. Therefore, we hypothesized that the different hormones utilized in
anabolic implants will operate through different mechanisms from each other, while
causing changes in a breed dependent manner due to the innate physiological difference
between different cattle breed types. This research found that estradiol primarily
improved growth by altering nutrient partitioning in skeletal muscle of feedlot steers,
while trenbolone acetate increased mRNA abundance associated with skeletal muscle
growth. Furthermore, this research found that anabolic implants elicit changes in feeding
behavior, animal temperament, serum metabolites, feedlot performance, carcass
characteristics, and mRNA associated with protein turnover in a breed dependent manner.
Economic return always improved when feedlot steers were implanted, however the
extent of this return varied based off breed and implant protocol used. Therefore, the
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findings from this research suggest that anabolic implant protocols need to be optimized
to match cattle breed types to help further improve environmental and economic
sustainability of beef production in the U.S.
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CHAPTER I
INTRODUCTION AND REVIEW OF THE LITERATURE
The U.S. is a leader in beef cattle production, with the largest annual beef
production, the third largest cattle herd, and the largest fed cattle industry in the world
[1]. In the U.S., beef production is widely distributed and exists in all 50 states with an
array of climates, environmental conditions, management strategies, and cattle breed
types [2-5]. The cattle industry is very unique, as it is divided into distinct segments
including seedstock production, cow-calf production, stocker and backgrounding,
feedlot/finishing, and the packing segment (Figure 1.1) [6]. Currently, there is a need to
further improve beef cattle production in the U.S., while adapting to changes in the
physical environment to ensure that enough food is available for the growing population
in both an environmentally and economically sustainable manner. Two potential methods
to help further improve environmental and economic sustainability of the beef industry
are through the use of heterosis by crossbreeding Bos taurus and Bos indicus type cattle,
and through the use of growth promotants [7].
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Figure 1.1: A schematic of the U.S. beef cattle industry from [6].

Growth
Growth: Importance and Mechanisms
Growth is an increase in size of any or all body components [8]. In livestock production,
bone growth, skeletal muscle growth, and adipose growth are important as these body
components directly affect when animals are harvested, the resulting meat quality and
yield grades, when heifers are bred, and a multitude of other factors related to animal
production. In mammals, protein accretion and fat accretion occur simultaneously in
early life [9]. As animals reach their mature size, the rate of protein accretion becomes
negligible, while fat accumulation continues [9] (Figure 1.2). Meanwhile, growth of bone
determines the ultimate length of individual muscles, and is a major determinant of total
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muscle mass [9]. Skeletal muscle plays an important role in maintaining the skeleton,
changing posture or engaging in physical activities, providing protection against cold
temperatures through shivering, and deposition of protein in growing mammals [10].

Figure 1.2: Rate of growth from conception to maturity as it relates to the
nervous system, bone, muscle and adipose. Adapted from [9].
In beef cattle, skeletal muscle growth is of the utmost importance as it becomes meat,
which is the primary marketable end product of meat animal livestock production [11].
Skeletal muscle growth involves both protein synthesis and protein breakdown [12], with
growth occurring when net protein synthesis is greater than protein breakdown [8]. This
growth is promoted by the two main skeletal muscle growth pathways: the insulin like
growth factor-1 (IGF-1) pathway and the myostatin pathway [13, 14]. In mammals,
skeletal muscle growth can grow via hyperplasia and hypertrophy prenatally [9].
However, the primary mechanism for postnatal growth to occur is via hypertrophy of
existing muscle fibers as muscle fiber number is primarily fixed at birth [15, 16]. Satellite
cells (SC) are eventually required to provide additional nuclei to allow for this postnatal
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hypertrophy growth to occur as muscle fiber nuclei do not divide [15, 16]. A more
thorough understanding of postnatal skeletal muscle growth is necessary to be able to
produce more meat in an environmentally and economically sustainable way.
In mammals, there are two primary pathways that have been characterized relative
to post-natal skeletal muscle growth: the IGF-1 pathway, a positive regulator of skeletal
muscle growth, and the myostatin pathway, a negative regulator of skeletal muscle
growth [13, 14]. The balance between these two pathways and the cross talk that occurs
between them is extremely important to ensure the animals can achieve adequate skeletal
muscle growth. The IGF-1 pathway can activate both the mitogen-activated protein
kinase/extracellular sign-regulated kinase (MAPK/ERK) pathway and the
phosphoinositide 3-kinase-protein kinase B (PI3k-Akt) pathway [13]. Upon activation of
Akt, Akt will inhibit protein degradation by phosphorylating and repressing the
transcription factors of the forkhead box O (FoxO) family [14]. Simultaneously, Akt
stimulates mammalian target of rapamycin (mTOR), ultimately resulting in protein
synthesis [17]. mTOR serves as a central regulator of cell metabolism, growth, and
proliferation [17]. Additionally, mTOR positively controls protein synthesis through
various downstream effects [17]. Four major signals influence mTOR activity: growth
factors, energy status, oxygen, and amino acids [17]. In mammals, activation of the Akt
pathway has been found to result in increased skeletal muscle hypertrophy, with
constitutively active Akt resulting in hypertrophy of transfected muscle fibers [18]. It has
been shown that Akt will promote muscle hypertrophy and block protein degradation
simultaneously [13, 14, 18]. The FoxO factors that are repressed by Akt are involved in
protein degradation, ultimately regulating the ubiquitination ligases, atrogin-1 and muscle
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ring finger-1, which causes the degradation of myosin and other muscle proteins by the
proteasome [14]. Myostatin is produced within skeletal muscle and acts as a negative
regulator of muscle growth [13]. When myostatin is added to differentiated C2C12
myotubes, myotube size and protein synthesis are decreased [19], acting as a negative
regulator of skeletal muscle growth. An example in cattle is the Belgian Blue cattle breed,
which has a myostatin mutation rendering the gene inactive, leading to animals
possessing a phenotype with increased muscle fibers and increase muscular hypertrophy
[20]. From a skeletal muscle growth perspective this may seem positive, however animals
possessing this phenotype have decreased reproductive abilities and decreased carcass
quality [20], and is a prime example of demonstrating the importance of balancing both
positive and negative regulators of muscle growth.
Myogenic Precursor Cells and Prenatal Growth
Prenatally, muscle development in cattle begins at around three months of gestation
[21]. Prenatal growth occurs via hyperplasia and hypertrophy, however once an animal is
born, muscle fiber number is primarily fixed, and growth occurs almost exclusively
through hypertrophy. Myogenic precursor cells are necessary for pre-natal growth, as
they are necessary for muscle fiber formation [22]. In pre-natal myogenesis there are two
waves of myogenesis, primary and secondary [21]. Primary myogenesis is the formation
of type I fibers, while secondary myogenesis is the formation of type I and type II fibers
[23]. The main pathway which is thought to help regulate pre-natal skeletal muscle
growth is the Wnt pathway [24]. In the Wnt pathway, Wnt binds to Frizzled proteins,
which activates the Disheveled proteins. When the Disheveled proteins are activated,
they inhibit a complex of three proteins that leads to β-catenin-dependent signaling. Both
paired box transcription factor 3 (Pax3) and glioma-associated oncogene (Gli) are
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activated by β-catenin. Paired box transcription factor 3 is an important upstream
regulator of myogenic differentiation factor (MyoD), while Gli is important for Myogenic
regulatory factor 5 (Myf5). Both Pax3 and Gli are activated by β-catenin. If β-catenin is
blocked, the number of myocytes decreases, ultimately decreasing pre-natal growth [24].
Pre-natal skeletal muscle growth is extremely important as muscle fiber number is
generally fixed around birth in mammals [22].
Satellite Cells and Postnatal Growth
Satellite cells were discovered using electron microscopes studying the peripheral
region of the skeletal muscle fibers of frogs [25, 26]. They were found lying along the
basal lamina (Figure 1.3) in 1961 by Alexander Mauro and Sir Bernard Katz in two
separate, independent studies [25, 26]. Satellite cells provide the additional nuclei to
support postnatal skeletal muscle growth [15, 16, 27, 28]. As myofibers accrete protein,
they need additional DNA to support that growth.
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Figure 1.3: The electron micrograph of a mammalian satellite cell from Mauro’s
paper [26]. As described in the paper, “Transverse section of a skeletal muscle
fiber from the rat sartorius, furnished by courtesy of Dr. G. Palade. As in Fig.9,
the apposing plasma membranes of the satellite cell (sp) and the muscle cell (mp)
are seen at the inner border of the satellite cell. The basement membrane (bm) can
be seen extending over “gap” between the plasma membrane of the muscle cell
and the satellite cell.” [26].
Satellite cells provide the necessary DNA to support protein accretion and myofiber
growth [22]. Satellite cells are muscle precursor cells that proliferate, then differentiate
and fuse with existing muscle fibers to support hypertrophy [27]. Satellite cells are
normally found along the basal lamina in a dormant, or quiescent state [22]. Satellite cells
will become activated, at which point then they will begin proliferating [22]. However,
the exact stimulus which leads to SC activation has yet to be determined. Paired box
transcription factor 7 (Pax7) is used as a marker for SC. Satellite cell proliferation is
marked by an increase in cell number. Increasing the number of proliferating SC,
increases the potential for growth [28]. A portion of SC express Myf5, which promotes
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SC differentiation. The primary markers of differentiation in skeletal muscle, known as
myogenic regulatory factors, include increased expression of Myf5, MyoD, and
myogenin, and decreased expression of Pax7 [16, 29, 30] (Figure 1.4). The role of the
remaining proliferating SC is to maintain the SC pool. This group of SC does not express
Myf5, but only Pax7. Differentiation and phenotypic maturation are necessary for SC to
be able to properly fuse into myotubes [22].

Figure 1.4.: This figure depicts the progression of the satellite cell from
“Quiescence” to “Fusion” to Protein Synthesis/Degradation”. Underneath each
stage of the satellite cell, the myogenic regulatory factors that are expressed at
that stage are listed. Paired box transcription factor 3 (Pax3), paired box
transcription factor 7 (Pax7), Myogenic factor 5 (Myf5), Myogenic differentiation
factor (MyoD), and Myogenin (MyoG). Adapted from [31].
Fiber Types
Fiber type can influence growth and be a source of variation in meat quality of
animals. In cattle skeletal muscle the main fiber types are type I, type IIa, type IIb, and
type IIx [32, 33]. Type I fibers are slow oxidative fibers, which are smaller in diameter,
and utilize substrates aerobically [32, 33]. Type IIx fibers are fast glycolytic fibers, which
are larger in diameter than type I fibers and utilize substrates anaerobically [32, 33]. Type
IIa and IIb fibers are intermediate fibers and possess traits of both type I and type IIx
fibers, however type IIb and type IIx are very similar [32, 33]. As cattle age, a fiber type
transition is typically observed [32]. While the total number of fibers remains mostly
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unchanged, an increase in the number of type IIx fibers is observed [32, 34-36].
Furthermore, it is well accepted that type IIa fibers possess more satellite cells [37].
Ideally, in production animals, type IIa fibers are desired as it allows for an ideal balance
of the different fiber type properties allowing for an increase in tenderness and improving
fresh meat quality [38], but still allows for growth to occur.
Bos indicus Influenced Cattle
Cattle Breed Types in the U.S.
In the U.S., there are currently more than 80 breeds of cattle [6], with there being
two main cattle breed types, Bos indicus and Bos taurus, which are physiologically
different from one another [39, 40]. Bos indicus cattle tend to be better adapted to higher
temperatures, nutritional stress [41], and are more disease resistant than Bos taurus [42],
while consuming less water [41, 43]. However, in the U.S., taurine breeds, including the
Angus (AN) and Hereford breeds, are typically favored by producers as they are known
to have improved carcass characteristics and temperaments [44]. When utilizing Bos
indicus genetics, producers have concerns related to growth, carcass characteristics, and
animal temperament [44, 45]. However, these negative traits can be minimized by
crossbreeding Bos taurus with Bos indicus influenced cattle [46]. The Santa Gertrudis
(SG) breed is an example of this cross and is a composite breed composed of 5/8
Shorthorn (a Bos taurus breed) and 3/8 Brahman (a Bos indicus breed) [47]. Currently,
the U.S. cow herd is only about 8% Bos indicus, with reports suggesting that to optimize
heterosis of the U.S. cattle industry 12-15% of commercial cows should be Bos indicus
influenced [48]. However, before Bos indicus influenced animals can be more readily
integrated into production systems, there is a need to examine the relationship between
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Bos indicus and Bos taurus hybrids and how they perform in more temperate settings
[49].
Santa Gertrudis History
The SG was one of the first composite breeds of cattle developed in the Americas in
the 1920s [47]. The breed was developed on the King Ranch in Texas to maximize cattle
production in the harsh, dry, and hot climate [50]. The King Ranch initially ran Texas
Longhorns, however the ranch eventually brought in Shorthorns and Herefords to
improve carcass characteristics and growth. Eventually, this resulted in the ranch running
a purebred Shorthorn and a purebred Hereford herd. However, the Texas ranch is
extremely dry, with very harsh and trying range conditions [50]. These trying conditions
for the ranch resulted in heavy stock losses. In time, the decision was made to introduce
Brahman genetics into the Shorthorn herd to improve heat tolerance and pest resistance,
while still maintaining the growth characteristics of the Shorthorns [50]. A half-blood
Shorthorn Brahman bull was purchased to be used on the Shorthorns. The offspring of
this bull performed so well, that the following year 52 more bulls were purchased
containing anywhere from ¾ to 7/8 Brahman blood. A planned breeding program was then
put into place to create the optimal animal for these conditions. A bull named Monkey
was eventually born from these efforts. Monkey was the ranch’s ideal specimen and sire,
and he became the founder of the new breed called the Santa Gertrudis named after the
Santa Gertrudis Land Grant from where the ranch was located (Figure 1.5) [50]. A
system of line breeding was eventually used, and now every animal containing SG blood
can trace their ancestry to the founding bull Monkey [50]. Today, as a result of this
breeding program, the SG breed is approximately 5/8 Shorthorn and 3/8 Brahman [47].
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Figure 1.5: A photograph of the son of the Santa Gertrudis foundation bull
“Monkey”, from [51].
Growth and Feedlot Performance of Bos indicus Influenced Cattle
Bos taurus and Bos indicus cattle breeds are known to be physiologically and
phenotypically different from one another [39]. Research completed in heifers has found
that as the percentage of Bos indicus increases, whither height increases [52].
Additionally, skeletal muscle metabolism is known to be different between the two cattle
breed types [45]. Research demonstrates that ¾ Bos taurus ¼ Bos indicus influenced
animals have a higher percentage of type IIa fibers and fewer type IIx fibers relative to
Bos taurus animals [45]. This altered fiber type proportion indicates an improvement in
growth potential in Bos indicus crossbred animals. In Arkansas, when AN x SG crossbred
steers are compared to straightbred AN calves, the crossbred calves have greater preweaning average daily gain (ADG) demonstrating the importance of heterosis [53].
Additionally, in the feedlot in Georgia it has been found that straightbred AN steers gain
less than SG x AN cross steers [54]. Furthermore, a marker of lean tissue anabolism is
serum urea nitrogen (SUN), as it is inversely correlated with N retention [55]. In a study
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comparing N retention between Hereford and Brahman steers, it was found that Brahman
steers also had greater N retention [56]. Taken together, these findings suggest that Bos
indicus influenced cattle may have a greater potential for lean tissue anabolism.
Furthermore, dry matter intake is an important part of the feedlot stage, as feed costs
account for over 70% of production costs in production livestock [57]. A study
comparing Brahmans and Herefords found that Brahman cattle consumed 12% less feed
than the Herefords [58]. Another study investigating feed intake between grazing SG and
grazing AN cattle, found that intake was not typically different between the two breeds
[59]. These findings suggest that future research is warranted in respect to the
relationship between cattle breed type and performance in the feedlot when steers are
raised in a temperate climate.
Cattle Behavior
For cattle producers, temperament is extremely important as more temperamental
cattle can increase the risk of injury to both the cattle and the producer [60], while
leading to decreased growth rates, ADG, and carcass quality [61]. Evaluating
temperament in cattle can be assessed by chute scores, exit velocity, cortisol [44], and as
of more recently, rectal temperature [62]. It is well accepted that Bos indicus cattle have a
more excitable temperament when compared to Bos taurus cattle [44]. When evaluating
the temperament of heifers, it has been found that Brahman x AN cross heifers have
greater exit velocities than straightbred AN heifers, and Brahman sired heifers have
greater chute scores than non-Brahman sired heifers [63]. Additionally, research has
shown that cattle of both breed types become adapted to human handling and become less
temperamental as time goes on [44]. Additionally, feeding behavior has been shown to be
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linked to feedlot performance [64, 65]. In Red Angus heifers, the duration of feed bouts
and ADG were intimately linked, with longer feed bouts correlating with increased ADG
[65]. Other research in grazing heifers has found that cattle breed type can influence
feeding behavior, with AN heifers having shorter and fewer grazing periods than AN x
Brahman heifers [41]. Therefore, it is important to understand this intimate relationship
between feeding behavior and performance as it relates to cattle breed types, and the
resulting impact on animal performance and economic viability.
Meat Quality of Bos indicus Influenced Cattle
Meat quality refers to a range of attributes of meat [66], specifically the important
qualitative characteristics of meat, including tenderness, flavor, juiciness, and color [67].
These quality characteristics can be influenced by both pre-and post mortem changes and
management strategies including genetics, growth promotants, age, as well as postmortem pH decline and an array of other factors [67]. Additionally, the grid system is
typically used to determine payments to producers in the United States [68]. A combined
high quality grade and low yield grade is optimal for producers paid on the grid system
[68]. Increased marbling increases quality grade, while increased subcutaneous fat
undesirably increases yield grade [69]. A concern when introducing Bos indicus
influenced genetics into the beef herd is the resulting effects on quality score, carcass
traits, and palatability characteristics compared to the typical Bos taurus animal [45]. In
the U.S., beef producers are typically paid on the grid system, resulting in yield grade and
quality grade being extremely important [68]. Typically, there is less fat on Bos indicus
influenced carcasses compared to those of only Bos taurus influence [70]. Furthermore,
when compared to AN and Bos indicus crossbred animals, Bos indicus cattle produce
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carcasses with smaller ribeye areas, and their ribeye steaks are tougher than AN ribeye
steaks as measured by Warner Bratzler Shear force (WBSF) and trained sensory panelists
[71-73]. However, it was found that heterosis improved hot carcass weight, dressing
percentage, ribeye area, and fat over the ribeye. Results from this study found that
animals with up to 50% Brahman had limited negative impacts on meat quality, while
maximizing yield due to heterosis [71].
Tenderness contributes to overall meat quality, and is often described as one of the
more important factors influencing overall acceptance of cooked beef [74]. Tenderness
refers to how tough the meat is. Tenderness is primarily dependent on two things:
myofibrillar structure and conjunctive tissue [67]. Calpain-1 and calpastatin have been
found to be useful indicators of tenderness [75]. The calpain-1 locus provides a protease
that breaks down myofibrillar protein post-mortem, and the calpastatin locus produces an
inhibitor of the calpain-1 protease [75]. Elevated calpastatin is associated with decreases
tenderness because of the inhibition of calpain-1 [75]. In Brahman steers, it has been
found that as the percentage of Brahman increases, the degree of calpain-1 autolysis
decreases [76]. Being able to crossbreed Bos indicus with Bos taurus is a great tool to be
able to improve both meat quality and carcass characteristics to help mitigate the
concerns associated with meat quality when utilizing Bos indicus cattle.
Anabolic Implants
Anabolic implants (IMP) are consistently used to improve the environmental and
economic sustainability of the beef industry via increasing the efficiency and growth rate
of beef cattle [77-79], and have been found to be one of the best tools available to beef
producers. Implants increase economically important traits such as average daily gain,
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feed intake and efficiency, carcass weight and ribeye area [77], ultimately leading to
increased economic return to producers. Depending on cattle prices and anabolic implant
protocol used, economic returns for producers can be anywhere from $15 to $163 per
head [77, 80].
Economic sustainability is not the only improvement when using IMP, but
environmental sustainability also improves as there is a positive correlation between
improved production and environmental sustainability [7]. The carbon footprint of cattle
that receive an IMP is lower than cattle that do not receive an IMP or that are grass-fed,
as fewer animals and less land, water, and fossil fuels are needed to produce a set amount
of beef [81]. Current research suggests that IMP decrease land usage by 7.8% to 9.1% [7,
82], water usage by 5.5% [83] and greenhouse gas emissions by 5.1% to 8.9% within the
beef industry [7, 82]. Overall, IMP help to create a more environmentally sustainable
end-product [83].
Despite both the environmental and economic benefits of IMP, over 50% of
consumers consider exogenous hormones used in beef production a serious issue [84, 85].
If IMP were to be removed from use, it would decrease both the environmental and
economic sustainability of the industry [7]. Furthermore, the exact physiological and
molecular mechanisms these IMP operate through to increase growth of cattle have yet to
be fully characterized [28, 86-89]. If the mechanisms of action can be determined, it may
be possible to develop consumer accepted strategies to increase economic and
environmental sustainability of beef production.
Implants and Cattle Performance
History of Implants
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In the U.S. there are currently over 40 commercially available IMP approved by the
Food and Drug Administration (FDA). These IMP are approved for all stages of cattle
production: from suckling calves to finishing beef cattle, with different anabolic implants
having different hormonal payout periods [78]. Due to this, over 90% of cattle on feed
receive an anabolic implant at some point during production, with 80% receiving two or
more [90]. Anabolic implants are administered as pellets in the middle third section of the
ear under the skin as a fail-safe, as the ear is rarely consumed.
Anabolic implants have routinely been used in the U.S. since the late 1950’s [55].
The first study examining the use of IMP was conducted in 1947, examining the effects
of the estrogen, diethylstilbestrol, in Hereford heifers [91, 92]. Diethylstilbestrol was then
approved by the FDA in 1957 to be used commercially in beef cattle production [92].
Diethylstilbestrol was routinely used in beef production, until 1972, when it was removed
from use by the FDA over concerns in regard to human health [92]. Now, IMP are
typically classified as estrogenic (typically containing E2); androgenic (typically
containing the synthetic testosterone analogue trenbolone acetate ;TBA), or as combined
(being composed of both estrogenic and androgenic hormones) [55]. Trenbolone acetate
is a synthetic androgen that is non aromatic, meaning it is not aromatized to estradiol
within the body, is more potent, and has higher affinity for the androgen receptor than
testosterone [93]. The hormones currently utilized in beef cattle production have
routinely been proven safe by the FDA [55], however the FDA is currently reviewing reimplanting protocols.
Live Animal Performance
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One of the benefits of using IMP in production is the increase in live animal
performance. It has been found that IMP increase ADG by 18%, feed efficiency by 6%,
and feed intake by 6% [77]. Present-day research demonstrates that these economically
viable traits are influenced by the IMP protocol that producers use [94] with different
IMP protocols increasing DMI by 5% to 12% [94]. Table 1.1 highlights the improved
performance observed in implanted cattle (Table 1.1). It is important to note that when
producers use IMP, performance can vary greatly from one operation to another [95].
This variation in response to IMP can come from the animals being in different stages of
production, as well as the animal’s nutritional status, and the different types of implants
that were used [95].
Table 1.1. Benefits of Implanting Cattle
Trait
I or D*
Performance
Average Daily Gain
I
18%
Feed Intake
I
6%
Feed Efficiency
I
6%
Carcass Weight
I
5%
Ribeye Area
I
4%
Economic Return
I
$15-$163**
Environmental
Greenhouse Gas Emissions
D
5.1-8.9%
Water Usage
D
5.5%
Land Usage
D
7.8%-9.1%
*Increase or Decrease.
**Varies depending on the year.
Adapted from Duckett and Pratt, 2014 [77] and Capper
and Hayes, 2012 [7].

Emerging research is suggesting that cattle type, including weight [96], breed type
[97], sex [98] and dairy cattle verse beef cattle [99], may play a role in how cattle
respond to IMP. When comparing the effectiveness of heavy vs light weight crossbred
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calves at time of implanting, the heavy weight calves have increased ADG and DMI
[100]. This is likely due to the increase in DMI that the heavier steers had [96].
Furthermore, it has recently been demonstrated that breed impacts how animals respond
to IMP [97]. In a study utilizing grazing steers of different breeds (AN, Hereford,
Holstein and Overo Colorado) it was found that Hereford steers had a much lower live
weight gain when implanted when compared to implanted AN and Overo Colorado steers
[97]. Additionally, heifers make up roughly 28-30% of the beef consumed in the U.S. [6].
When heifers are implanted with an IMP containing 14 mg E2 benzoate and 100 mg TBA
and compared to steers receiving the same IMP, the hot carcass weight of steers is
increased by 45 kg when compared to the non-implanted steers in their cohorts. In heifers
that are implanted, it was found that hot carcass weight improved by 5 kg when compared
to their non-implanted control counterparts [98]. This could be in part due to the role that
sex plays in skeletal muscle growth [101]. Meanwhile, dairy calves make up 16% of
U.S. beef production [102]. However, IMP protocols that optimize feeding performance
and carcass performance for these dairy calves have yet to be fully optimized [103].
Dairy and beef breeds are physiological and conformationally different from one another,
making extrapolating data from beef to dairy cattle breeds difficult [103]. Holstein
animals are in feedlots longer than traditional beef animals [99], therefore it is imperative
to optimize production of these cattle to make them more environmentally and
economically profitable. Overall, it appears necessary to match the animal’s
physiological state with an anabolic IMP protocol, demonstrating that there is not a one
size fits all anabolic IMP protocol that should be used.
Serum Metabolites and Markers of Growth in Implanted Cattle
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The early research studying possible mechanisms by which anabolic implants
increased skeletal muscle growth investigated IGF-1 [104, 105]. This early research
found that when crossbred steers were implanted with 120 mg TBA and 24 mg E2,
mRNA abundance of IGF-1 was 69% higher in the livers of implanted steers when
compared to control steers 38 d post-implanting [106]. When this research investigated
mRNA abundance in muscle, the authors found that implanted steers had 50% greater
mRNA abundance of IGF-1 than control steers in the longissimus, however insulin-like
growth factor binding protein-3 (IGFBP3), insulin like growth factor binding protein-5,
hepatocyte growth factor, and myostatin mRNA abundance were not altered in the
muscle of implanted steers 40 d post-implantation [106]. However, circulating serum
IGF-1 and IGFBP3 increased by 30-40% in implanted crossbred steers when compared to
the control crossbred steers by d 38 post-implanting [106]. This has been consistently
demonstrated in the literature with circulating IGF-1 being higher on d 6, 14, and 21 after
steers were implanted with 120 mg TBA and 24 mg E2 when compared to control steers
[107], and again with circulating IGF-1 increasing over a 21 d period in implanted steers
[108]. Abundance of IGF-1 has also been consistently demonstrated to be increased by
implanting, with steers having 40% higher transcript abundance in the longissimus
lumborum 40 d post implanting when compared to control steers [105]. Furthermore,
IGF-1 receptor (IGF-1R) and IGF-1 mRNA abundance increase on d 111 and d 55 postimplanting, respectively, as well [109]. These results suggest that one possible
mechanism through which IMP stimulate growth is through increasing local production
of IGF-1 in skeletal muscle, possibly leading to an increase in circulating IGF-1
concentrations [105]. Since then, research has examined cortisol [110], oxytocin [111],

20
and nitrogen retention [94] as possible additional paths that IMP increase skeletal muscle
growth in cattle showcasing the diverse physiological mechanisms that IMP effect.
When Brahman steers are implanted with 200 mg TBA and 20 mg E2, an increase
in circulating plasma oxytocin is observed [111]. This study found a 50-fold increase in
circulating oxytocin in implanted steers 80 d post-implant when compared to control
steers. In skeletal muscle biopsies that were taken from these steers, the mRNA precursor
of oxytocin was 21-fold higher in the longissimus of implanted steers compared to
control steers [111]. Oxytocin is a nonapeptide hormone that appears to have dampening
effects on the stress response [112]. This is intriguing as IMP are known to increase
protein accretion in steers [110], and one possible explanation for this increase in protein
accretion has been that IMP decrease circulating cortisol [110]. This decrease in
circulating cortisol leads to an increase in protein accretion and a decrease in protein
catabolism [113]. Research has consistently demonstrated that when cattle receive IMP,
circulating cortisol concentrations are decreased when compared to non-implanted
controls within the first 40 d following implanting [110, 113, 114].
Implanting has been shown to decrease SUN, indicating an increase in N retention
[109], however the type of IMP and number of IMP an animal receives influences the
extent to which SUN is decreased [94]. When steers receive multiple IMP, plasma urea
nitrogen decreases on d 70 post-implant [115], while a milder IMP protocol doesn’t
demonstrate a decrease in SUN until d 213 [94].
Implants and Trace Minerals
As understanding of IMP and growth improves, it appears that IMP may increase
trace mineral requirements to support skeletal muscle growth [115]. When lambs are

21
implanted with zeranol, a synthetic estrogen, they tend to retain greater amounts of Zinc
(Zn), and lose less Copper (Cu) and Manganese (Mn) [116]. Zinc has been found to
support growth in a number of ways, including being critical in the function of IGF-1
[117]. In cattle, research is beginning to surface demonstrating that IMP alter zinc
metabolism, with steers implanted with a Component TE-200 (200 mg TBA 20 mg E2)
implant having decreased serum and liver Zn levels [118]. In another study, Zn and Mn
were supplemented in three amounts: (1) none added, (2) national recommendations, and
(3) industry levels of trace mineral supplementation [115]. Within each treatment group,
half of the steers received an IMP, and half of the steers did not. This research found that
supplementing trace minerals to implanted cattle improved ADG by over 50% when
compared to non-implanted steers not receiving trace mineral supplementation. In the
economic analysis of the study, the researchers found that only cattle receiving the IMP
and trace mineral supplementation were profitable [115]. However, current
understandings of trace minerals and IMP is extremely limited, and under studied. More
studies are needed to examine the interaction between trace minerals and IMP.
Implants and Fiber Type
When steers are administered an IMP containing 120 mg TBA and 24 mg E2, no
differences in the three myosin heavy chains have been reported on d 0 and day 28 after
implanting in the longissimus [119]. However, when fiber type was determined by
immunohistochemistry in the longissimus lumborum, it was found that at harvest, heifers
implanted with 200 mg TBA and 20 mg E2 had altered fiber types when compared to
controls [120, 121]. These IMP did not impact the proportion of fibers, but rather they
impacted the size, with IMP increasing the cross sectional area of type I and IIx fibers
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[120]. A second study utilizing crossbred beef heifers and the same IMP (200 mg TBA
and 20 mg E2) found that muscles from implanted animals had an increase in the
percentage of type I fibers, and a decrease in the percentage of type IIX fibers after
harvest [121]. This study also observed an increased cross sectional area of type I and
type IIx fibers [121]. No changes were observed in type IIa fibers in either study [120,
121]. When fiber diameter is examined post-harvest in steers that have received an IMP
containing 24 mg E2 and 120 mg TBA, an increase in fiber size is observed [122].
Although this increase in fiber size is ideal in terms of growth, it may negatively affect
tenderness and could lead to an increase in WBSF values.
Carcass and Meat Quality
One of the major concerns that producers have when utilizing IMP, is the resulting
effect on quality grade [123], despite the well documented increases that IMP have on
improving hot carcass weight and ribeye area [124]. Quality grade is a component of the
grid system in which producers are primarily paid from [68], with marbling score being
the primary determinant of quality grade [68]. Research has shown that a single
estrogenic implant reduced marbling by 3.75% when compared to non-implanted controls
[79], while a TBA-IMP reduced marbling as well when compared to control animals
[94]. This has been repeatedly confirmed with cattle receiving 14 mg E2 benzoate and
100 mg TBA having decreased marbling compared to non-implanted cattle [98]. When
Holstein steers are implanted with a coated combined E2 TBA-IMP, a 15% decrease in
carcasses grading USDA choice or better is observed [125]. Research has also found that
as the number of IMP an animal receives increases, marbling decreases [126]. Marbling
contributes to juiciness, flavor, and tenderness of beef [127], with tenderness often being
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described as one of the more important factors influencing overall acceptance of cooked
beef [74]. Consumers ranked steaks from steers that had never received an IMP juicier
than steaks from steers that were implanted from various IMP protocols [126]. Purge loss
represents the water holding capacity of meat, and is important for fresh meat quality
[128], however the interactions between IMP and purge loss have been inconsistent. Both
studies examining purge loss utilized black-hided heifers receiving an IMP containing
200 mg TBA and 20 mg E2. The first study found that steaks from the heifers receiving
the IMP had greater purge loss compared to control heifers, but when cooked, moisture
retention issues were not observed [120]. This study also found that steaks from heifers
receiving IMP had a greater pH 21 d after ageing than control heifers [120]. The second
study, again using the same IMP and in heifers, found that purge loss and pH were not
altered by the IMP [121].
A method to measure tenderness, is through the use of WBSF [129] with less tender
meat having a higher WBSF value. Steaks from cattle which have received an IMP,
consistently have a higher WBSF value than control steers and heifers [98, 120, 121,
126]. One possible explanation for this increase in WBSF score is that IMP increase fiber
diameter [120, 121], as previously mentioned. Collagen can also influence tenderness
[130], however research has shown that IMP do not impact total and insoluble collagen in
heifers [120, 121]. Thus, collagen most likely does not play a role in the increase in
WBSF score that is observed in implanted cattle. When consumers evaluate tenderness,
they also rate steaks from non-implanted steers as being more tender than steaks from
implanted steers [126]. This study also found that as the number of IMP that an animal
receives increases, consumer satisfaction decreases, however 60-74% of all consumers

24
were satisfied with steaks from steers receiving various IMP protocols [126]. Taken
together, IMP do not appear to have a negative influence on fresh meat quality when
managed correctly.
Estradiol, Trenbolone Acetate, and Bovine Satellite Cells
Estradiol, Trenbolone Acetate, and Proliferating Bovine Satellite Cells
Steers implanted with a combined E2-TBA implant have been found to have an
increased number of proliferating SC [107]. After discovering that steers implanted with
a combined E2-TBA IMP had an increase number of proliferating SC [107], researchers
soon began investigating the relationship between steroidal hormones and SC in vitro.
The earliest studies measured proliferation rates of bovine SC via measuring [H3]
thymidine incorporation. Initial research examined the effects of 1 nM E2 or 1 nM TBA
on bovine SC proliferation. Neither increased proliferation rates, however when 10 nM
E2 or 10 nM TBA was used to treat the cells, bovine SC proliferation was approximately
1.5 times greater than control treated cultures [131]. In these proliferating bovine SC
cultures, mRNA abundance of the androgen and estrogen receptors was measured. In E2treated proliferating bovine SC, there was a 2.3 fold increase in mRNA abundance of the
estrogen receptor compared to control cultures [131]. In TBA-treated proliferating bovine
SC cultures, mRNA abundance of the androgen receptor increased by 1.5 fold [131].
Steers implanted with IMP containing 120 mg TBA and 24 mg E2 are known to have
increased circulating IGF-1. In SC, abundance of IGF-1 mRNA was 3.5 times higher in
E2 treated cultures than compared to control cultures, while TBA increased abundance by
1.7 times compared to control cultures [131]. Myostatin, which is involved in one of the
main muscle growth pathways, was also investigated in this early study. The authors
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found that mRNA abundance of myostatin was not altered by either TBA or E2 treatment
[131], suggesting that E2 and TBA mediated proliferation of bovine SC involved the
IGF-1 pathway and not the myostatin pathway.
After demonstrating that mRNA abundance of the androgen and estrogen receptors
were increased by steroid hormones [131, 132], the research group studying this decided
to examine the importance of these receptors in proliferating bovine SC. First, the authors
investigated mRNA abundance of IGF-1R in proliferating bovine SC treated with either
E2 or TBA, and they found that mRNA abundance of IGF-1R was not altered by the
steroidal hormones [132]. Then, the authors used ICI 182 780 to suppress the ability of
E2 to bind to the estrogen receptor, and Flutamide to inhibit the binding of TBA to the
androgen receptor. When the ability of the estrogen receptor to bind E2 was suppressed,
E2-stimulated proliferation of bovine SC was suppressed [132], and Flutamide
suppressed TBA stimulated proliferation of bovine SC [132]. Lastly, due to the increase
in IGF-1 mRNA abundance that was found in earlier studies, the authors used JB1 to
inhibit binding of IGF-1 to the IGF-1R. Despite no increase in mRNA abundance of IGF1R being observed when the receptor was inhibited, neither E2 nor TBA altered
proliferation rates of bovine SC [132]. These results indicate that the estrogen receptor
and IGF-1R are necessary for E2-stimulated proliferation of bovine SC, and that the
androgen receptor and IGF-1R are necessary in TBA-stimulated increases in bovine SC
proliferation.
The next study investigated the role of the G protein-coupled receptor 43, now
referred to as G protein-coupled estrogen receptor 1 (GPER-1) on E2- and TBA-mediated
effects as they relate to bovine SC proliferation. When the activity of GPER-1 is inhibited
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in E2 treated bovine SC and all GPCR are knocked down in TBA treated bovine SC, E2and TBA-mediated proliferation of bovine SC is completely suppressed [133, 134]. This
suggests a very likely role for GPER-1 in E2-mediated proliferation and GPCR in TBAmediated proliferation of bovine SC. Studies in non-muscle cells have demonstrated that
E2 binding to the GPER-1 results in activation of matrix metalloproteinases 2 and 9
(MMP2/9), resulting in the proteolytic release of heparin binding epidermal growth
factor-like growth factor (hbEGF), which leads to increased cellular proliferation [135].
As this is the cascade caused by E2 in non-muscle cells, the next thing to do was to
determine if this cascade occurred in proliferating bovine SC. When MMP2/9 and hbEGF
activity were inhibited in proliferating bovine SC, E2-and TBA-mediated increases in
bovine SC proliferation did not occur [133, 134]. These findings suggest that this cascade
could be partially responsible for E2- and TBA-mediated increases in proliferation of
bovine SC.
As discussed earlier, steers receiving an IMP containing 200 mg and 20 mg E2 had
increased circulating oxytocin by 50-fold [111], therefore the next step was to investigate
this at a cellular level in bovine SC. It was found if the oxytocin receptor is inhibited,
there is a decrease in E2- and/or TBA-mediated proliferation of bovine SC. Additionally,
oxytocin mRNA abundance increased in proliferating bovine SC 48 h post-treatment with
E2 or TBA treatment compared to control cultures [87]. Furthermore, when mRNA
abundance of the oxytocin receptor was investigated, it was found 48h after treatment
with E2 or TBA there was an increase in mRNA abundance compared to control cultures
[87]. The oxytocin receptor is a GPCR [112], and supports earlier completed research
demonstrating the importance of GPCR in steroid hormone stimulated bovine SC
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proliferation. These findings suggest a very likely role of oxytocin and the oxytocin
receptor in E2 and TBA mediated increases in proliferation of bovine SC. These studies
combined led to the current hypothesized mechanism (Figure 1.6) to which E2 and TBA
increase proliferation of bovine SC.

Figure 1.6: The current hypothesized mechanism through which steroid
hormones increase proliferation of bovine satellite cells and increase protein
synthesis of fused bovine satellite cells.

Polyamines are amino acid derivatives necessary for normal cellular proliferation
[136], with research emerging suggesting that androgens may interact with the polyamine
biosynthetic pathway [137]. Polyamine concentrations in a cell are regulated by
biosynthesis, interconversion, catabolism, and cellular uptake [137]. Methionine,
ornithine, and arginine are the major substrates utilized in the polyamine biosynthesis
pathway to produce Put, Spd, and Spe [137]. The polyamine biosynthetic pathway has
two rate-limiting enzymes; (1) ornithine decarboxylase and (2) S-adenosylmethionine
decarboxylase [138] (Figure 1.7). The research investigating if TBA altered the
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polyamine biosynthetic pathway to increase proliferation of bovine SC found that TBA
did not alter either rate-limiting step of the polyamine biosynthetic pathway [86].
However, treatment of proliferating bovine SC with TBA did increase mRNA abundance
of Sprouty1 12h post-treatment, while mRNA abundance of Mapk was increased 1 and 24
h post-treatment in proliferating bovine SC [86]. Both Mapk and Sprouty1 are involved in
cellular proliferation [139, 140]. These increases in mRNA abundance demonstrate the
role that TBA has in mediating quiescence and proliferation in bovine SC

Figure 1.7: Overview of the polyamine biosynthesis and interconversion
pathway. Polyamines and the polyamine precursor molecules are shown in bold
and enzymes are shown in italic font. Adapted from Pegg et al [138].
Estradiol, Trenbolone Acetate, and Differentiating Bovine Satellite Cells
When investigating the effects of E2 and TBA on skeletal muscle in vitro, it is
necessary to examine the effects of E2 and TBA on bovine SC differentiation, as SC must
differentiate in order to be able to properly fuse with existing muscle fibers [31]. Current
research examining the impact of TBA and E2 on bovine SC differentiation remains
inconclusive [87, 141]. However, in porcine SC, it has been found that testosterone
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decreases differentiation by 20-30%, eliciting its effects on SC via the androgen receptor
within 48 h [142]. When differentiating bovine SC are treated with E2 or TBA, fusion
indexes are found to be increased at 48 h and 72 h post-treatment [87]. Interesting enough
though, this study did not find any differences in mRNA abundance of Pax7 or MyoD at
48 h or 72 h. However the study did find an increase in mRNA abundance of MyoG [87].
Another study investigating temporal changes in mRNA abundance of bovine SC
induced to differentiate found that TBA increased mRNA abundance of Myf5 4 h postinduction to differentiate [141]. Meanwhile, E2 and a combined E2-TBA treatment
increased MyoD abundance 8 h post-induction to differentiate [141]. These findings when
combined, suggest that TBA and E2 may elicit their effects on bovine SC induced to
differentiate within the first 12 h post-treatment, leading to increased fusion indexes that
are observed at 48 h, and ultimately leading to an increased potential for post-natal
skeletal muscle growth to occur.
An early study investigating fused bovine SC found that once bovine SC fuse, they
have ten times more IGF-1, than proliferating bovine SC [131]. When these fused cells
were treated with E2 or TBA, IGF-1 mRNA abundance was 2.6 times and 1.5 times
greater respectively than control treated fused cells [131]. Although this study did not
examine the effects of E2 or TBA on bovine SC differentiation over time, it may explain
some of the reasons why steers implanted with E2 and/or TBA have increased serum
IGF-1 concentrations [104].
Not only is oxytocin appearing to play an important role in the effects of TBA and
E2 on bovine SC proliferation, but it is also appearing to be a key player in E2- and TBAmediated bovine SC differentiation [87]. During differentiation of bovine SC, oxytocin
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abundance is increased with treatment of E2 or TBA. When oxytocin receptor is
inhibited, there is a decrease in fusion indexes at 72 h even when cells are treated with E2
or TBA [87], and a decrease in mRNA abundance compared to control cultures treated
with only E2 or TBA [87]. These results indicate the importance of oxytocin and the
oxytocin receptor in TBA and/or E2 mediated bovine SC differentiation. Further research
is needed to examine the role of oxytocin in differentiation of bovine SC.
Polyamines are not only beneficial for cellular proliferation, but also for cellular
differentiation [136, 138, 143-145]. S-adenosylmethionine decarboxylase is one of the
rate-limiting steps in the polyamine biosynthesis pathway [137]. In bovine SC induced to
differentiate, TBA has been shown to increase S-adenosylmethionine decarboxylase 8 h
after being treated with differentiation media and 10 nM TBA when compared to control
treated cultures [141]. Meanwhile, treatment of bovine SC induced to differentiate with
E2 leads to a decrease in ornithine decarboxylase mRNA abundance 12 h post-induction
to differentiation [141]. These results suggest that the polyamine biosynthesis pathway
may be involved in TBA and E2 mediated bovine SC differentiation.
One possible explanation for the questions regarding the current research examining
E2 and TBA and the interaction with bovine SC differentiation, is that studies have
shown that in times of extreme skeletal muscle growth, SC differentiation is delayed
[142, 146-148]. As previously mentioned, both E2 and TBA increase bovine SC
proliferation [86, 87, 107, 133, 134, 149]. Myoblasts isolated from double muscled calf
fetuses have increased proliferation rates, but delayed differentiation rates when
compared to control cattle [146]. This same phenomenon has also been observed in
turkeys, with SC from heavier muscled commercial turkeys having increased
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proliferation rates and slower differentiation rates than lighter muscled turkeys [150].
Therefore, future investigations examining the relationship between E2 or TBA on
bovine SC differentiation should include times longer than 48 h and 72 h, as the only two
current studies investigating this did not go examine timepoints past 72 h [87, 141].
Estradiol, Trenbolone Acetate, and in-vitro Protein Synthesis and Degradation of
Fused Bovine Satellite Cells
The early research investigating protein synthesis and degradation, as growth is
the difference between protein synthesis and protein breakdown [8], of fused bovine SC
treated with E2 and/or TBA very much mimics the early studies regarding proliferation
of bovine SC. After what the research team discovered in regard to IGF-1 and
proliferating bovine SC, the researchers decided to see if the same thing occurred in fused
cells. In fused bovine SC cultures, mRNA abundance of IGF-1 was 2.6 times greater in
E2 treated cultures, and 1.5 times greater in TBA cultures than in control cultures [131].
Again myostatin mRNA abundance was not altered by E2 or TBA treatment when
compared to control cultures [131]. This suggests that the myostatin pathway is most
likely not involved in steroid hormone stimulated muscle growth of cattle.
After finding the necessity for the estrogen, androgen, and IGF-1 receptors in E2and/or TBA-mediated proliferation of bovine SC, the group decided to examine the same
previously discussed inhibitors, JB1, Flutamide, and ICI 182 780 in fused bovine SC
cultures. First, the researchers examined the effects of E2 on protein synthesis and
degradation rates in fused bovine SC. It was found that treatment of fused bovine SC with
0.01-10 nM of E2 caused a concentration dependent increase in protein synthesis rates,
with 10 nM of E2 causing a 1.7-fold increase in protein synthesis rates compared to
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control treated cultures [151]. When protein degradation was measured, it was found that
between 0.01 and 10 nM of E2 caused a decrease in protein degradation compared to
control treated cultures [151]. When fused bovine SC were treated with 10 nM of E2,
there was approximately a 70% reduction in protein degradation compared to control
cultures [151]. When ICI 182 780 was used to suppress the estrogen receptor, it was
found that E2 mediated increases in protein synthesis and E2 mediated decreases in
protein degradation did not occur [151]. When the IGF-1R was inhibited by JB1, the
same results were observed with E2 mediated increases in protein synthesis and E2
mediated decreases in protein degradation not occurring [151]. These demonstrate the
need for both the estrogen receptor and IGF-1R in E2 mediated protein synthesis and
protein degradation. Next, protein synthesis and protein degradation rates were measured
in fused bovine SC treated with TBA. Between 0.01 and 10 nM of TBA caused a
concentration dependent increase in protein synthesis, with 10 nM of TBA leading to a
1.7 fold increase in protein synthesis rates compared to control cultures [152]. When
protein degradation rates were examined in fused bovine SC cultures treated with TBA, a
concentration dependent decrease in protein degradation was observed, with 10nM of
TBA decreasing protein degradation by approximately 70% when compared to control
fused bovine SC cultures [152]. When Flutamide was used to suppress the androgen
receptor, TBA mediated increases in protein synthesis and decreases in protein
degradation did not occur [152]. When the IGF-1R was suppressed by JB1, TBA was
unable to decrease protein degradation, and was unable to increase protein synthesis
[152]. This study highlighted the role of the androgen receptor and IGF-1R in TBA
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mediated increases in protein synthesis and TBA mediated decreases in protein
degradation in fused bovine SC cultures.
After unearthing the role of the G protein-coupled cascade in proliferating bovine
SC treated with E2 or TBA, the group examined the roles of the G protein-coupled
cascade in fused bovine SC treated the steroidal hormones. When the GPER-1 is
inhibited in fused bovine SC, E2 stimulated effects on protein synthesis is completely
inhibited [88], however inhibiting GPER-1 had no effect on E2 stimulated decreases in
protein degradation of fused bovine SC [88]. When MMP2/9 activity was inhibited, E2
mediated protein synthesis was suppressed, but again there was no effect on E2 mediated
decreases in protein degradation. When hbEGF activity was inhibited in fused bovine SC,
increases in protein synthesis mediated by E2 was completely suppressed. However once,
again there were no alterations in E2 mediated decreases in protein degradation [88]. The
Akt pathway is often associated with increases in skeletal muscle growth. In fused bovine
SC that were treated with E2, there was an increase in pAKT protein expression 30 min
after treatment when compared to control cultures [88]. The results of this research found
that E2 mediated increases in protein synthesis is associated with the G protein-coupled
cascade, however this cascade is not involved in E2 mediated decreases in protein
degradation. When the G protein-coupled cascade is examined in fused bovine SC that
are treated with TBA similar results are observed to E2 treated bovine SC. Chemically
knocking down all GPCR, MMP2/9, or hbEGF activity in fused bovine SC, TBA
mediated increases in protein synthesis rates is suppressed, while TBA mediated
decreases in protein degradation is not suppressed [89]. Additionally, pAKT protein
expression was increased 30 min after treatment in TBA treated fused bovine SC [89].

34
These data suggest that the G protein-coupled cascade is involved in TBA mediated
increases in protein synthesis in fused bovine SC, while both E2 and TBA activate the
Akt pathway in in fused bovine SC. Taken all together, the current hypothesized
mechanism in which E2 and TBA increase protein synthesis in fused bovine SC can be
found in Figure 1.6.
Conclusions
There are a lot of unanswered questions remaining regarding IMP and their
relationship with cattle breed types, from uncovering both the physiological and
molecular mechanisms they operate through, to examining the effects of cattle type on
response to IMP (heifer vs steer, Bos taurus vs Bos indicus, dairy vs beef, light weight vs
heavy weight). The onset of new technologies allows researchers to investigate multiple
aspects of IMP, from the transcriptome to the proteome, and to the metabolome level to
identify the possible responses that IMP have on both the phenotypic and molecular level.
Due to roughly 90% of cattle on feed in the U.S. receiving an IMP at some point during
production [90] and over 50% of consumers considering IMP usage in cattle production
an issue [7]; it is clear that these mechanisms need uncovered. We hypothesized that the
different hormones utilized in anabolic implants will operate through different molecular
mechanisms. Additionally, we hypothesized that due to the innate physiological
difference between different cattle breed types, anabolic implants will operate in a breed
dependent manner to improve skeletal muscle growth via mechanisms related to muscle
metabolism. Once these mechanisms are uncovered the possibility remains to either
improve the potency of IMP to improve environmental and economic sustainability even
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further, or to identify potential alternatives to IMP without harming the improved
environmental and economic sustainability that are a direct result of IMP.
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CHAPTER II
ANABOLIC IMPLANTS VARYING IN HORMONE TYPE AND CONCENTRATION
INFLUENCE PERFORMANCE, FEEDING BEHAVIOR, CARCASS
CHARACTERISTICS, PLASMA TRACE MINERAL CONCENTRATIONS, AND
LIVER TRACE MINERAL CONCENTRATIONS OF ANGUS SIRED STEERS1

Simple Summary
Though anabolic implants are commonly utilized in U.S. cattle production,
comparisons between hormone type and content of different implants and the effects on
growth and trace mineral stores is limited. The objective of this study was to evaluate the
effects of anabolic implants varying in hormone type and concentration on growth,
carcass characteristics, and trace mineral concentrations in Angus steers. Cattle
administered an estradiol only implant did not experience differences in growth
compared to non-implanted controls. However, cattle implanted with a trenbolone acetate
only implant or a combined (estradiol and trenbolone acetate) implant experienced
improvements in growth and changes in plasma and liver trace mineral concentrations.
Greatest differences in growth and trace mineral concentrations were observed in steers
administered the combination implant compared to non-implanted controls. These data
suggest hormone type and concentration influence implant-induced growth and changes
in plasma and liver trace mineral concentrations.

1

This chapter has been previously published in: Reichhardt C.C., Messersmith E.M.,
Brady T.J., Motsinger L.A., Briggs R.K., Bowman BR, Hansen S.L., Thornton K.J.
Anabolic implants varying in hormone type and concentration influence performance,
feeding behavior, carcass Characteristics, plasma trace mineral concentrations, and liver
trace mineral concentrations of angus sired steers. Animals. 2021 Jul;11(7):1964.

56
Abstract
Fifty Angus-sired steers were utilized to evaluate the effects of anabolic implants
varying in hormone type and concentration on performance, carcass traits, and plasma
and liver trace mineral concentrations over 129 d. Steers were stratified by weight into
one of four (n = 12 or 13/treatment) implant treatments: (1) estradiol (E2; 25.7 mg E2;
Compudose, Elanco Animal Health, Greenfield, IN, USA), (2) trenbolone acetate (TBA;
200 mg TBA; Finaplix-H, Merck Animal Health, Madison, NJ, USA), (3) combination
implant (ETBA; 120 mg TBA + 24 mg E2; Revalor-S, Merck Animal Health), or (4) no
implant (CON). Steers were randomly assigned to pens equipped with GrowSafe bunks
and fed a corn and barley-based finishing ration. Overall average daily gain and body
weight were greater for ETBA and TBA than CON (p ≤ 0.04), but not E2 (p ≥ 0.12).
Feed efficiency and hot carcass weight were only greater than CON for ETBA (p ≤ 0.03).
Plasma and d 2 liver Zn concentrations were lesser for ETBA than CON (p ≤ 0.01) and d
10 liver Mn was lesser (p = 0.0003) for TBA than CON. These data indicate that implants
containing TBA influence growth and trace mineral parameters, though more work
investigating this relationship is necessary.
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1. Introduction

As the global population increases [1], beef production is faced with challenges
related to the changing climate and use of limited resources [2,3]. It is imperative that
efficiency of cattle production is improved to increase both environmental and economic
sustainability aspects of beef production. One method to improve sustainability is through
the use of anabolic implants. Anabolic implants decrease greenhouse gas emissions by
8.9%, and overall land use by 9.1% [2], effectively decreasing the environmental impact
of beef production.

Anabolic implants contain steroid hormones to increase the efficiency and growth
rate of cattle [4–6], and have been routinely used in cattle production since the late 1950s
in the U.S. [7]. Although not all countries allow the use of anabolic implants in cattle
production, there are currently over 40 commercially available implants approved by the
Food and Drug Administration in the United States. These anabolic implants are
approved for all stages of beef production; from suckling calves to finishing cattle [5].
Roughly 90% of all cattle on feed in the U.S. receive at least one anabolic implant during
production, with 80% receiving two or more [8]. Anabolic implants can typically be
classified as estrogenic, typically containing estradiol (E2), androgenic, typically
containing the synthetic testosterone analogue trenbolone acetate (TBA), or as combined,
being composed of both estrogenic and androgenic hormones [7].
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Anabolic implants increase economically viable traits such as average daily gain
(ADG), feed intake, feed efficiency (FE), hot carcass weight (HCW), and ribeye area
(REA) [4,7]. However, the exact physiological and molecular mechanisms by which
anabolic implants operate to increase skeletal muscle growth in cattle remains elusive [9–
12]. Furthermore, the increase in growth caused by anabolic implants, may increase trace
mineral requirements to support skeletal muscle growth [13], as lambs implanted with
zeranol tended to retain greater amounts of Zn, and lose less Cu and Mn in feces and
urine [14]. When trace minerals are supplemented above national research council
recommendations at feedlot consultant recommended concentrations, cattle receiving
anabolic implants increase growth even further [13]. Our hypothesis is that varying
hormone type and concentration will alter economically viable traits and mineral status of
Angus sired steers. Due to the complex nature of anabolic implants, and the unknowns in
their mechanisms of operation to increase skeletal muscle growth, the purpose of this
research was to investigate feedlot performance of steers receiving an estradiol only
implant (E2), a trenbolone acetate only implant (TBA), or a combined estradiol and
trenbolone acetate implant (ETBA) compared to non-implanted steers (CON).
Additionally, due to the importance of trace minerals in growth, liver and plasma mineral
concentrations were evaluated to better understand the relationship between anabolic
implants and trace minerals in beef cattle.

2. Materials and Methods
2.1. Animals, Experimental Design, and Treatments
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All live animal procedures and protocols for this experiment were approved by
the Utah State University Institutional Animal Care and Use Committee (IACUC
Protocol #2817).
This experiment was conducted at the Utah State University feedlot and was run
concurrently with a previously published study [18]. As such, the animals in this study
were treated similarly to the previously published study [18]. Fifty Angus sired steers
(327 kg ± 25 kg) out of commercial Angus cows that had not received any prior growth
promotant treatments were stratified by weight at the start of the trial. Prior to beginning
the trial each steer received an electronic (EID) and visual ear tag. Steers were assigned
to one of four implant treatments: (1) estradiol only implant containing 25.7 mg estradiol
(E2; n = 12; Compudose, Elanco Animal Health, Greenfield, IN, USA), (2) trenbolone
acetate only implant containing 200 mg trenbolone acetate (TBA; n = 12; Finaplix-H,
Merck Animal Health, Madison, NJ, USA), (3) a combined implant containing 120 mg
trenbolone acetate and 24 mg estradiol (ETBA; n = 13, Revalor-S, Merck Animal
Health), or (4) no implant (CON; n = 13). Steers were randomly placed into one of four
covered pens equipped with two GrowSafe bunks (GrowSafe Systems Ltd.; Airdrie, AB,
Canada) per pen to measure individual feed disappearance via radio frequency EID tags.
Steers utilized in this trial were housed with other steers of similar size from the Utah
State University beef herd (n = 15 steers/pen). Steers underwent a two week adaptation
period to the system prior to be-ginning the trial. Steers always had free choice access to
water and were fed the same diet. Diets were stepped up between 10 and 12% (DM basis)
concentrate every 10 d from a backgrounding ration consisting of 40% (DM basis)
concentrate to a finishing ration consisting of 86% (DM basis) concentrate (Table 2.1)
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over a 41 day period after implanting and the start of the trial. Three animals were
removed from the trial due to bloat (n = 1, E2), an abdominal abscess (n = 1, ETBA),
and a hock injury (n = 1, ETBA). These were not related to their respective treatments,
but prompted the removal of all 3 animals from all analyses, except the liver trace
mineral analyses and the serum trace mineral analyses as animal removal occurred after
day 30 of the trial.
2.2.Feedlot Performance and Sample Collection
Individual as-fed feed intake was measured by the GrowSafe system. A minimum
of three feed samples per ration were collected and analyzed at a commercial lab
(Cumber-land Valley Analytical Services, Waynesboro, PA, USA). Daily feed intake was
converted to dry matter intake (DMI) by utilizing as-fed feed intake and the percent DM
of each ration. Steers were weighed individually on a certified scale (TruTrust GR3000,
College Station, Texas) and ultrasound was conducted by a certified ultrasound
technician using a portable ExaGo ultrasound (Universal Imaging, Bedfords Hills, NY,
USA) on days 0, 28, 56, 84, and 112. Weights, ADG, and 12th rib fat thickness were
recorded. Individual ADG was calculated by subtracting the initial body weight (BW) for
the period from the final BW for the period and dividing by the number of days for that
period. Gain to feed (G:F) for individual steers was calculated by dividing ADG by DMI
for each period. Blood was collected and harvested as serum via jugular puncture on days
0, 2, 10, 28, 56, 84, 112, and 129 using 10.0 mL, 16 × 100 mm BD vacutainer serum
blood collection tubes. Blood was collected and harvested as plasma via jugular puncture
on days 0, 2, 10, and 30 using 6 mL, 13 ×100 mm BD vacutainer plasma blood collection
tubes containing trace mineral grade K2EDTA. Blood samples were allowed to coagulate
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and kept on ice and transported approximately 12 km to the laboratory. Blood samples
were centrifuged at 1000× g for 15 min at 4 °C. Supernatants were then collected,
aliquoted, and blood samples were stored at −20 °C until further analysis. Liver biopsies
were performed on days 2 and 10 post-implanting. Liver samples were collected with a
liver biopsy kit performed by Utah State University’s clinical veterinarians using the
TruCut method [15]. Liver was extracted between the 11th and 12th rib space on the
right-hand side of the steer. Plasma and liver samples were collected from all steers, but
only 12 steers/treatment were analyzed to ensure equal numbers across treatments.
2.3. Feeding Behavior Data
All feeding behavior data were analyzed based off the two main categorical traits
calculated by the GrowSafe bunks; (1) bunk visit (BV), which is the single reading of an
EID tag when entering a bunk, whether it consumed feed or not, and (2) feed bouts (FB),
which is the reading of a single animal EID tag when entering a bunk, and a minimum of
10 g of feed were consumed, and following previously published methodology [16].
Based off BV, the average duration of the BV (ABVD), the average amount of feed
consumed per BV (ABVC), and the amount of time an animal spent with its head down
per BV (ABVHD) were analyzed. Regarding FB data, the following was also calculated:
the duration of the FB (DFB), the average amount of feed consumed per FB (AFFB), and
the average time an animal’s head was down while it consumed feed during a BV
(HDFB).
2.4.Trace Mineral Analysis
Plasma and liver samples were shipped overnight on dry ice to Iowa State
University and stored at −20 °C until analysis. Trace mineral analysis of plasma samples
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was conducted using inductively coupled plasma optical emission spectrometry (Optima
7000 DV, Perkin Elmer, Waltham, MA, USA) via previously described methods [17].
Liver samples were analyzed for Cu, Fe, Mn, and Zn via inductively coupled plasma
mass spectroscopy (Analytik Jena Inc., Jena, Thuringia, Germany) at the Iowa State
University Veterinary Diagnostic Laboratory. To ensure instrument accuracy, a quality
control standard for plasma (Trace Elements Serum Control #66816; UTAK Laboratories
Inc., Valencia, CA, USA) and liver (Bovine Liver #1577c; National Institute of Standards
and Technology, Gaithersburg, MD, USA) analysis was utilized on each run.
2.5. Serum Urea Nitrogen
A commercially available colorimetric assay was used to detect serum urea
nitrogen (SUN) in duplicate (Invitrogen, Urea Nitrogen BUN Colorimetric Detection Kit;
ThermoFisher Scientific, Waltham, MA, USA). The plate was read on a BioTek all-inone microplate reader using Gen5d 2.0 all-in-one microplate reader software (BioTek
Instruments, Winooski, VT, USA). Intra-assay CV: 1.94%. Inter-assay CV: 2.41%.
2.6.Carcass Characteristics
Steers were shipped at an average of 7 mm 12th rib fat. This trial occurred in May
2020 during the COVID-19 pandemic; therefore, steers were shipped early to ensure they
could be harvested. The steers were harvested at a commercial facility (Hyrum, UT,
USA). Dressing percentage, HCW, marbling score, REA, ribeye fat thickness, and cold
camera yield grade were recorded at the plant by trained USDA inspectors. Dressing
percentage was calculated by dividing HCW by final live weight with a 4% shrink and
multiplying by 100.

63
Carcass adjusted final BW was calculated by dividing the HCW by the individual
steer’s dressing percentage. To assess overall carcass adjusted gain, initial BW with a 4%
shrink was subtracted from the carcass adjusted final BW. Overall carcass adjusted gain
was divided by the total number of days on feed to determine carcass adjusted ADG and
carcass adjusted G:F was calculated by dividing the total carcass-adjusted gain by the
individual steer’s total DMI.

3. Results
3.1. Live Animal Performance
There were no differences (p ≥ 0.51) in initial steer weights at the start of the trial
between treatments (Figure 2.1). When analyzed with repeated measures, weights of the
steers increased (p < 0.0001) over time. Over the course of the trial, ETBA and TBA
steers were heavier (p ≤ 0.02) than CON steers, while there was no difference in weight
(p = 0.12) between E2 steers and CON steers. Similar results were observed when
evaluating total gain and overall ADG (Table 2.2). There was no difference (p = 0.22)
between E2 and CON steers in total gain and overall ADG. However, both ETBA and
TBA steers had increased (p ≤ 0.04) overall ADG and total gain compared to CON steers,
resulting in 25 and 13.4% improvements in overall ADG for ETBA and TBA steers,
respectively. When DMI data was evaluated with repeated measures, DMI increased (p <
0.0001) over time (Figure 2.2). While on trial, ETBA steers had a 7% greater (p =
0.0003) DMI and TBA tended to have a 3.7% greater (p = 0.08) DMI than CON steers.
No difference (p = 0.74) in DMI was observed between CON and E2 steers over the
course of the trial. When G:F was analyzed over time, it was found that as time went on,
G:F improved (Figure 2.3; p < 0.0001). Gain: feed was not different (p ≥ 0.30) between
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TBA, E2, and CON steers when analyzed as repeated measures. However, ETBA steers
improved (p = 0.03) G:F by 14% when compared to CON steers.
3.2. Feeding Behavior
The effects of different anabolic implants in steers on feeding behavior was
analyzed. Implants had no effect (p = 0.13) on FB or BV when compared to CON steers.
However, as time went on, steers had fewer (p < 0.001) BV and FB (Figure 2.4),
regardless of treatment. When meal events were investigated (Figure 2.5), it was found
that E2 steers spent less time (p = 0.002) with their heads down per BV (Figure 2.5A)
and FB (Figure 2.5B) than CON steers. There was no difference (p = 0.11) between CON
and ETBA or TBA steers with time spent with their heads down per BV and FB.
Estradiol steers also spent less time (p = 0.03) per each BV (Figure 2.5C) and FB (Figure
2.5D) compared to CON steers, while there was no difference (p = 0.79) between CON
and TBA or ETBA steers with amount time spent per each FB and BV.
3.3. Plasma and Liver Trace Mineral Concentrations
The effects of different anabolic implants on plasma trace mineral concentrations
was evaluated. Both E2 and TBA were not different (Table 2.3; p ≥ 0.13) from CON for
plasma Cu, Fe, and Zn. However, ETBA plasma Zn was lesser than CON (p = 0.01),
while not different for Cu and Fe (p ≥ 0.60). No effects of Treatment × Time (p ≥ 0.18)
were observed for plasma measures. Time affected plasma Cu such that plasma Cu
increased (p < 0.0001) from day 2 to 10 before decreasing below day 2 concentrations on
day 30 (Figure 2.6). Additionally, both plasma Fe and Zn appear to decrease (p ≤ 0.0001)
by day 2 followed by a sharp increase (p ≤ 0.0001) in plasma Fe and Zn concentrations
on day 10. Plasma Fe slightly decreased (p = 0.02) by day 30 while plasma Zn remained
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constant (p = 0.28) through day 30 (Figure 6). Two days post-implant, liver Cu and Zn
were lesser (p ≤ 0.04) for TBA than CON, while liver Mn tended (p = 0.06) to be lesser
for TBA than CON (Table 2.4). Additionally, day 2 liver Zn concentrations were lesser
for ETBA than CON (p = 0.04). By day 10, liver Cu and Zn concentrations were no
longer different between TBA and CON (p ≥ 0.11), though TBA day 10 liver Mn
remained lesser than CON (p = 0.0003). Day 10 liv-er Fe tended (p = 0.07) to be greater
for E2 and was greater (p = 0.04) for ETBA than CON. No further effects (p ≥ 0.13) of
E2, TBA, or ETBA vs. CON were observed for day 2 or 10 liver trace mineral
concentrations.
3.4. Serum Urea Nitrogen
Serum urea nitrogen was measured on days 0, 2, 10, 28, and 56 of the trial. When
analyzed as repeated measures, anabolic implants, E2, TBA, or ETBA, had no effects (p
≥ 0.50) on SUN concentrations through day 56 of the trial when compared to the CON
steers, as such the data was then analyzed investigating individual time-points, and once
again anabolic implants had no effect (p ≥ 0.50) on SUN concentrations (Table 2.5).
However, concentrations of SUN in the steers increased (p < 0.0001) over time (Table
2.5).
3.5. Carcass Characteristics
Implant treatments had no effect (p ≥ 0.16) on dressing percentage, 12th rib fat
thickness, or marbling when compared to CON steers (Table 2.6). Hot carcass weight
was increased (p = 0.008) by 8% in ETBA steers compared to CON steers. The TBA
steers had the largest REA compared to CON steers (p = 0.006), with it being increased
by 10.7% (p = 0.006). Additionally, there was a trend for cold camera yield grade to be
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improved (p = 0.06) in TBA steers compared to CON steers. No further differences
between implant treatments and CON were observed for HCW, REA, or cold camera
yield grade (p ≥ 0.16).
3.6. Carcass Adjusted Growth
The effects of different anabolic implants on plasma trace mineral concentrations
was evaluated. Both E2 and TBA were not different (Table 3; p ≥ 0.13) from CON for
plasma Cu, Fe, and Zn. However, ETBA plasma Zn was lesser than CON (p = 0.01),
while not different for Cu and Fe (p ≥ 0.60). No effects of Treatment × Time (p ≥ 0.18)
were observed for plasma measures. Time affected plasma Cu such that plasma Cu
increased (p < 0.0001) from day 2 to 10 before decreasing below day 2 concentrations on
day 30 (Figure 2.6). Additionally, both plasma Fe and Zn appear to decrease (p ≤ 0.0001)
by day 2 followed by a sharp increase (p ≤ 0.0001) in plasma Fe and Zn concentrations
on day 10. Plasma Fe slightly decreased (p = 0.02) by day 30 while plasma Zn remained
constant (p = 0.28) through day 30 (Figure 6). Two days post-implant, liver Cu and Zn
were lesser (p ≤ 0.04) for TBA than CON, while liver Mn tended (p = 0.06) to be lesser
for TBA than CON (Table 4). Additionally, day 2 liver Zn concentrations were lesser for
ETBA than CON (p = 0.04). By day 10, liver Cu and Zn concentrations were no longer
different between TBA and CON (p ≥ 0.11), though TBA day 10 liver Mn remained
lesser than CON (p = 0.0003). Day 10 liver Fe tended (p = 0.07) to be greater for E2 and
was greater (p = 0.04) for ETBA than CON. No further effects (p ≥ 0.13) of E2, TBA, or
ETBA vs. CON were observed for day 2 or 10 liver trace mineral concentrations.
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4. Discussion
In the U.S. over 90% of cattle receive at least one anabolic implant at some point
during production [8], as anabolic implants increase overall performance and efficiency
of beef cattle [4]. Implants have the added benefit of also increasing both the
environmental sustainability of the industry [2] and economic return to producers [18].
However, despite the clear benefits of implanting, the exact physiological and molecular
mechanism that anabolic implants operate through to increase overall growth and
efficiency remains elusive [9,12]. Furthermore, when trace minerals are supplemented at
higher concentrations recommended by feedlot consultants, rather than national research
council recommendations, an increase in growth is observed [13]. This increase in growth
is even further exacerbated when the animals receive anabolic implants, demonstrating
that increased mineral concentrations may be required to support increased growth rates
[13]. Therefore, the purpose of this research was to examine varying hormone type and
concentration, estradiol only, trenbolone acetate only, or a combined estradiol and
trenbolone acetate implant, on performance in the feedlot, feeding behavior, and
concentrations of trace minerals in the plasma and liver of Angus sired steers, to help
improve our understanding of anabolic implants. The brief findings of this study were
that anabolic implants containing TBA improved growth, and altered trace mineral
concentrations, while an E2 only implant altered steer feeding behavior.
Current research suggests anabolic implants decrease land usage by 7.8–9.1%
[2,19], and greenhouse gas emissions by 5.1% to 8.9% [2,19], creating a more
environmentally sustainable end-product. This is through increasing ADG and G:F [4]. In
a review published by Duckett and Pratt, the authors state that anabolic implants increase
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ADG by 18%, feed efficiency by 6%, and feed intake by 6% [4]. We found that a single
anabolic implant containing 120 mg TBA and 24 mg E2 increased overall ADG by 25%,
G:F by 14% and DMI by 7%. More recent research completed examining various implant
protocols has found that anabolic implants can increase DMI from 5% to 12% [20]. One
likely reason steers used in this trial had increased performance compared to the numbers
reported by the review, is that there are variable responses to implants when used in
different stages of production [21]. Specifically, cattle need adequate nutrition before
implants can positively influence G:F and gain [21]. Additionally, the number of implants
and type of implants given [20], the breed of cattle [18], and sex of cattle [22] can all
influence how cattle respond to anabolic implants. The Duckett and Pratt review
published an average of several studies [4], taken together with the multitude of factors
influencing response to anabolic implants, this could explain the increase in performance
that was observed in this trial.
Interestingly in our trial, E2 steers did not have altered performance compared to
CON steers. In a compilation of implant trials published, animals receiving either a single
mild estrogen (around 20 mg estrogen) implant or a single strong estrogen implant
(around 200 mg estrogen) had increased ADG and DMI compared to steers that never
received an anabolic implant [23]. The payout period of anabolic implants is the effective
period of the implant, which typically varies from 90–120 days [24], with the payout
period being impacted by the hormone concentration [24]. The steers in the E2 group
were implanted with Compudose, an implant containing 25.7 mg estradiol (Elanco
Animal Health) with a 200 day payout, and according to the manufacturer, the payout
occurs equally over the 200 days. The steers in this trial were harvested at 129 days,
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which may be part of the reason why E2 did not improve performance of the steers
compared to CON.
Red Angus heifers categorized as having high ADG have longer FB durations
than those heifers with a low ADG [16]. We have previously found that Angus sired
steers have numerically greater feedlot performance and tended to have longer feed bouts
and longer bunk visits than Santa Gertrudis sired steers [18]. In the current study, steers
in the E2 group had shorter FB and BV, and spent less time with their heads down per
BV and FB than CON steers. This is interesting, as there was no difference in
performance between the E2 and CON steers. This suggests feeding behavior is not
always related to feedlot performance, although more research needs to be done to
determine the impacts of anabolic implants on feeding behavior.
Although the relationship between trace mineral nutrition and anabolic implants is
not well understood, trace minerals can be linked to many aspects of growth. A clear
connection between Zn and skeletal muscle protein synthesis has been observed using
rodents to assess growth in response to Zn and protein supplementation [25]. Zinc is vital
to cellular proliferation [26] and is a cofactor to metalloproteinases 2 and 9 [27], both of
which are associated with increased proliferation rates [11], and protein turnover [10] in
bovine satellite cells. Satellite cells are essentially muscle precursor cells [28] and are
required to support skeletal muscle hypertrophy. Increasing satellite cell numbers allows
for an increased capacity for skeletal muscle growth to occur [29]. Furthermore, the Cu
de-pendent enzyme, lysyl oxidase, is responsible for maintaining the structural integrity
of the extracellular matrix [30], a key component to proper muscle development. Given
the strong molecular relationship between trace minerals and pathways associated with
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skeletal muscle growth, it is important that research is conducted to determine how
different anabolic implants impact serum and liver concentrations of trace minerals.
Interestingly, both day 2 liver Cu and Zn were lesser for TBA than CON while
day 2 liver Zn was lesser for ETBA than CON, suggesting the androgenic component of
these treatments is influencing liver Cu and Zn more so than the estrogenic component.
We have previously observed a decrease in liver Cu concentrations of implanted steers 14
days after a combination implant was administered, while liver Zn was greater for
implanted steers than non-implanted at harvest [13]. In agreement with the current work,
a decrease in liver Zn concentrations 14 days post-implant administration was observed,
coinciding with a decrease in plasma Zn concentrations of implanted steers compared to
non-implanted controls on day 13 that remained through day 73 [31]. The current study
design was imperative to finding these TBA driven effects on liver Cu and Zn
concentrations, as Niedermayer et al. [13] and Messersmith [30] both utilized
combination implants that limited data interpretation to the effects of anabolic implant
use rather than hormone type. Together, these data indicate trace mineral concentrations
are influenced by hormone administration and hormone type. Additionally, it appears that
trace minerals such as Cu and Zn, known for roles within many growth processes may be
in greater demand by implanted cattle.
Peak hormonal payout of implants has been observed within the first 40 days
post-implant administration [24], indicating this time period should experience the
greatest growth rates and subsequently, the greatest need for trace minerals to
accommodate that growth. In the present study, the greatest differences in growth
occurred within the first 28 days of implanting, interestingly, coinciding with many
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changes in trace mineral concentrations immediately following implant administration.
These data emphasize the importance of trace mineral nutrition, especially Zn, during
periods of high growth rates. Although liver Zn was lesser for TBA and ETBA than CON
and liver Cu lesser for TBA than CON on day 2, no differences were observed by day 10.
However, Niedermayer et al. [13] and Messersmith [31] still observed differences in liver
trace mineral concentrations 14 days post administration of a combination implant. This
difference may be due to the implant potencies used. Both previously mentioned studies
[13,31] utilized aggressive combination implants (Component TE-200; 200 mg
trenbolone acetate and 20 mg estradiol; Elanco Animal Health) compared to the less
aggressive estrogen or trenbolone acetate only or combination implant (Revalor-S; 120
mg trenbolone acetate and 24 mg estradiol; Merck Animal Health) used in the current
study.
Indeed, implant hormone potency and type can influence mineral stores. The
observed increase in day 10 liver Fe concentrations for E2 and ETBA treatments
compared to CON indicates a role for E2 in Fe metabolism. Research has found that E2
impairs the transcription of the Fe exporter, ferroportin, through an E2 responsive
element [32]. Therefore, steers implanted with E2 appeared to have limited Fe export
from the liver in the current study, however, no effects of E2 implant strategies were
observed for plasma Fe concentrations. In addition to Fe metabolism, emerging research
has found that heifers implanted with an aggressive two implant strategy (Revalor-200,
Merck Animal Health; on days 0 and 91) had lesser liver Mn concentrations than heifers
implanted with an extended-release implant (Revalor-XH, Merck Animal Health) on day
0 [33]. Interestingly, both Niedermayer et al.[13] and Messersmith [31] observed
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decreases in liver Mn concentrations of aggressively implanted steers 14 days post
implant administration. These data are in agreement with the decrease observed in liver
Mn of TBA steers compared to CON on day 2 and 10. However, the lack of differences
in liver Mn due to ETBA suggests either the lesser concentration of TBA in the ETBA
implant did not as aggressively affect skeletal muscle protein degradation as the TBA
implant alone, or that the addition of E2 in the combination implant supported more
skeletal muscle net protein gain. Regardless, the decrease in liver Mn may be due to less
skeletal muscle protein degradation in implanted cattle resulting in lesser demand for the
urea cycle. Therefore, the Mn dependent terminal enzyme of the urea cycle, arginase
[34,35], is likely down regulated leading to the decrease in liver Mn observed. However,
more work is warranted to confirm how liver Mn is being utilized.
Serum urea nitrogen is a marker of lean tissue anabolism, as it inversely indicates
increased N retention [7]. Implant strategies have been shown to impact SUN
concentrations [20], as the hormones used in implants increase protein accumulation in
vivo [36] and protein synthesis rates in vitro [10]. In the present study, SUN was
investigated on days 0, 2, 10, 28 and 56 from CON, E2, TBA, and ETBA steers.
Interestingly, no differences were observed in SUN for these different implant treatments.
Research conducted using a different combination estradiol trenbolone acetate implant
did not find a difference in SUN until day 213 [20]. Another study that investigated the
effects of anabolic implants on plasma urea nitrogen (PUN) found that steers that
received a mild implant (14 mg E2 and 80 mg TBA) and were re-implanted 56 days later
with a more aggressive implant (20 mg E2 and 200 mg TBA) had decreased PUN on day
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70 of the trial [13]. These findings taken together suggest that the implant protocol and
strength of the implant influence SUN concentrations in steers.
As the use of anabolic implants increases, so does the concern with quality grade
of the beef [37,38], which is a key component of the grid system used to determine
payments to producers for producers in the United States [39]. A combined high quality
grade and low yield grade is optimal for producers paid on the grid system [39].
Increased marbling increases quality grade, while increased subcutaneous fat undesirably
increases yield grade [40]. Estradiol and TBA have been shown to decrease both
marbling [6] and subcutaneous fat [37]. In the current study, none of the implant
treatments altered marbling, while TBA steers only tended to have improved yield grade
compared to CON steers. This is most likely explained as the steers were finished at a
group average of 7 mm of rib fat and implants were administered 129 days prior to
harvest, both of which helped to minimize any negative effects of implants on carcass
characteristics. Research has found that giving cattle implants earlier in the feeding
period, rather than later, helps offset potential negative effects of implants on marbling
[41]. Additionally, as previously mentioned, peak payout of the implants typically occurs
within the first 40 days post-implanting with most anabolic implants having an effective
payout period of 90–120 days [24]. As the steers were finished harvest at day 129 postimplanting, the negative effects that anabolic implants sometimes have on marbling were
not observed in this trial. If the steers were finished to a set weight or were kept on feed
longer to reach the U.S. industry standard of 12 mm of rib fat, differences may have been
observed in both marbling and yield grade.
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Steers in the ETBA group did have increased HCW when compared to the CON
steers, with the ETBA implant increasing HCW by 8%. In Duckett and Pratt’s review,
they found that on average implants increased carcass weight by 5% [4]. Interestingly,
TBA implants increased REA by 10.7% compared to CON steers, most likely due to
increased skeletal muscle protein accretion and muscle growth. Additional emerging
research has found that increasing the hormone concentration of anabolic implants leads
to an in-crease in HCW and REA linearly in yearling beef steers [42]. These findings,
taken together, help confirm that anabolic implants increase HCW and REA of cattle.

5. Conclusion
In summary, the present study found that a single moderate potency ETBA (124
mg TBA and 24 mg E2) implant improves ADG by 25%, G:F by 14%, and HCW by 8%
compared to non-implanted steers. In steers that receive only a TBA (200 mg) implant,
REA is increased by 10.7%. However, a single E2 implant did not impact performance
when compared to CON steers. The information gained in this trial adds to the body of
knowledge confirming that implants containing TBA are an effective tool to increase
overall growth and efficiency of cattle and showcases differences in feedlot performance,
feeding behavior, and carcass quality when animals are administered implants with
different hormones and/or concentrations. Additionally, these data indicate hormone
content of anabolic implants influences liver and plasma trace mineral concentrations.
Specifically, provision of a TBA only implant has effects on Zn and Mn liver
concentrations. These data suggest skeletal muscle protein synthesis and degradation are
influenced by administration of a TBA only implant. However, future work is needed to
help decipher the physiological and molecular mechanisms that anabolic implants operate
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through to increase skeletal muscle growth and efficiency in cattle, as well as improving
the understanding of the relationships between trace minerals and anabolic implant
stimulated skeletal muscle growth.
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Table 2.1. Composition and nutritional
analysis of background and finishing diets fed to
Angus steers throughout trial.1
Background Finishing
Diet, (%)
Diet, (%)
Feed (% DM)
17.9
Corn Silage
-17.9
Haylage
15.38
17.2
High Moisture Corn
40.00
17.2
Cracked Barley
35.58
28.7
Alfalfa
7.69
0.89
Background Mineral2
--Finishing Mineral3
1.53
Analysis (% DM)
35.4
Moisture
22.0
15.4
Crude Protein
13.0
22.6
ADF
14.0
29.7
NDF
21.6
4
1.72
Net Energy(m)
1.96
1.10
Net Energy(g)4
1.32
Minerals (DM)
1.09
Calcium (%)
0.68
0.37
Phosphorus (%)
0.34
101
Manganese (mg/kg)
126
104
Zinc (mg/kg)
137
31
Copper (mg/kg)
31
1

Background diet was fed d 0-10 of trial, steers then
received a series of step-up diets incrementally
increasing percent concentrate (DM Basis) until the
finishing ration was reached. Finishing ration was fed d
41-129.
2
Composition of Background Mineral (DM Basis):
12.43% Ca, 8.13% Cl, 0.52% Mg, 8.29% P, 0.52% K,
4.87% Na, 0.81% S, 10.36 mg/kg Co, 2,071 mg/kg Cu,
4,143 mg/kg Fe, 4,972 mg/kg Mn, 26.9 mg/kg Se, 6,215
mg/kg Zn, and 1,825 mg/kg Monensin
3
Composition of Finishing Mineral (DM Basis):
16.73% Ca, 11.09% Cl, 0.23% Mg, 0.31% P, 0.52% K,
6.73% Na, 0.32% S, 10.46 mg/kg Co, 941 mg/kg Cu,
2,614 mg/kg Fe, 5,018 mg/kg Mn, 10.46 mg/kg Se,
6,273 mg/kg Zn, and 921 mg/kg Monensin
4
Net Energy is presented as Mcal/kg

83

Table 2.2. Average daily gain throughout the feedlot period of Angus steers receiving different implant strategies.
Contrasts2
Implant Treatments1
SEM
E2 vs.
TBA vs. ETBA vs.
CON
E2
TBA
ETBA
CON
CON
CON
Steers (n)
13
11
12
11
Average Daily Gain (kg)
0.12
0.03
0.007
0.003
Day 0 – 28
0.93
1.32
1.41
1.46
0.18
0.81
0.93
0.05
Day 28 - 56
1.34
1.39
1.32
1.69
0.18
0.13
0.78
0.30
Day 56 – 84
2.44
2.07
2.50
2.20
0.20
0.17
0.22
0.01
Day 84 – 112
1.21
1.53
1.49
1.80
0.27
0.66
0.39
0.14
Day 112 – 129
1.70
1.87
2.00
2.24
0.07
0.20
0.03
0.0002
Day 0 – 129
1.49
1.61
1.69
1.88
8.80
0.22
0.04
0.0002
Total Gain (kg)
193.07
208.18
217.87
241.83
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol),
Finaplix-H (TBA; 200 mg trenbolone acetate), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
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Table 2.3. Plasma trace mineral concentrations of Angus steers receiving different implant strategies.
Implant Treatments1

Contrasts2
E2 vs.
TBA vs.
CON
CON

ETBA vs.
CON

CON
E2
TBA
ETBA
SEM
Steers (n)
12
12
12
12
Plasma3, mg/L
Cu
1.01
1.01
1.04
1.03
0.027
0.99
0.34
0.60
Fe
1.65
1.60
1.64
1.68
0.089
0.57
0.91
0.73
Zn
1.17
1.16
1.12
1.07
0.029
0.71
0.13
0.01
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol),
Finaplix-H (TBA; 200 mg trenbolone acetate), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
3
Data were analyzed as repeated measures with the repeated effect of time. Plasma was collected on d 0, 2,
10, and 30. Day 0 values were utilized as covariates in analysis. No Treatment × Time effects were observed
(P ≥ 0.18).
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Table 2.4. Liver trace mineral concentrations following implant administration of Angus steers receiving different implant
strategies.

Implant Treatments1
CON
Steers (n)
Liver, mg/kg DM

12

E2
12

Contrasts2
TBA

ETBA

12

12

SEM

E2 vs.
CON

TBA vs.
CON

ETBA vs.
CON

Day 2
Cu
309
273
233
255
26.1
0.31
0.03
0.13
Fe
307
307
277
287
24.5
0.99
0.39
0.57
Mn
9.0
8.5
7.7
8.1
0.50
0.46
0.06
0.19
Zn
111
109
93
93
6.4
0.77
0.04
0.04
Day 10
Cu
333
335
284
319
25.5
0.97
0.18
0.69
Fe
241
289
261
296
22.9
0.07
0.45
0.04
Mn
9.4
8.8
7.3
8.9
0.41
0.26
0.0003
0.29
Zn
119
115
104
124
8.1
0.66
0.11
0.60
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol; Elanco Animal Health),
Finaplix-H (TBA; 200 mg trenbolone acetate; Merck Animal Health), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol; Merck Animal Health).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
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Table 2.5. Serum urea nitrogen concentration of Angus steers receiving different implant strategies.
Implant Treatments1
All
SEM
E2 vs.
3
CON
E2
TBA
ETBA Implants
CON
50
Steers (n)
13
12
12
13

Contrasts2
TBA vs.
CON

ETBA vs.
CON

Serum Urea Nitrogen (mg/dL)

1.36
0.84
0.23
0.40
Day 2
7.08
7.46
9.30
8.52
8.26 a
a
1.05
0.99
0.80
0.76
Day 10
9.43
9.43
9.77
9.83
9.69
b
0.87
0.97
0.24
0.87
Day 28
13.19
13.24
11.79
12.99
12.77
b
1.22
0.53
0.43
0.70
Day 56
11.42
12.47
10.12
10.81
11.24
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol),
Finaplix-H (TBA; 200 mg trenbolone acetate), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
3
Analysis with repeated measures determined serum urea nitrogen concentrations were affected by time (P < 0.0001). Differences (P <
0.05) between time points are indicated by different letters.
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Table 2.6. Carcass characteristics of Angus steers receiving different implant strategies.
Implant Treatments1
SEM
CON
E2
TBA
ETBA
Steers (n)
13
11
12
11

Contrasts2
E2 vs.
TBA vs.
CON
CON

0.46 0.21
0.61
Dressing Percentage
60.1
59.3
60.4
60.2
7.41
0.57
0.16
Hot Carcass Weight (kg)
317
311
330
343
3
36
0.71
0.94
Marbling Score
486
468
483
423
2
2.13 0.51
0.006
Ribeye Area (cm )
70.71
72.65
78.06
74.06
th
0.23 0.91
0.41
12 Rib Fat Thickness (mm)
7.67
7.65
7.49
7.85
0.16
0.67
0.06
Cold Camera Yield Grade
2.99
2.91
2.65
3.08
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol),
Finaplix-H (TBA; 200 mg trenbolone acetate), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
3
300 to 399 = slight, 400 to 499 = small, 500 to 599 = modest

ETBA vs.
CON

0.86
0.008
0.16
0.22
0.59
0.67
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Table 2.7. Carcass adjusted performance of Angus steers receiving different implant strategies.
Contrasts2
Implant Treatments1
SEM
E2 vs. TBA vs.
CON
E2
TBA
ETBA
CON
CON
Steers (n)
13
11
12
11

ETBA vs.
CON

11.69
0.96
0.24
0.01
Final BW3 (kg)
527
526
546
570
4
8.34
0.44
0.10
0.0006
Total Gain (kg)
212
221
231
255
5
0.06
0.44
0.10
0.0006
ADG (kg)
1.64
1.71
1.79
1.98
6
0.004
0.30
0.16
0.0033
G:F
0.14
0.15
0.15
0.16
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2; 25.7 mg estradiol),
Finaplix-H (TBA; 200 mg trenbolone acetate), and Revalor-S (ETBA; 120 mg trenbolone acetate + 24 mg
estradiol).
2
Contrast statements were formed to test differences between E2, TBA, and ETBA vs. CON treatment.
3
Carcass adjusted final body weight of the steers. Calculated by dividing the individual animal’s hot carcass weight by the
individual animal’s dressing percentage.
4
Carcass adjusted total gain. Calculated by subtracting the initial body weight with a 4% shrink applied from the carcass adjusted
final body weight.
5
Carcass adjusted average daily gain. Calculated by taking the carcass adjusted gain and dividing by total days on feed (129).
6
Carcass adjusted gain to feed. Calculated by dividing total carcass adjusted gain by total dry matter intake.
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d

*
*

c
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ETBA
Time: P < 0.001
CON vs. E2: P = 0.12
CON vs. TBA: P = 0.02
CON vs. ETBA: P = 0.0002

a

0

28

E2
TBA

b
400

CON

56

84

112 129

Day
Figure 2.1. Weights were measured as described in the Materials and Methods. Steers were
blocked by weight and assigned to one of four treatments: (1) estradiol (E2) only implant
containing 25.7 mg E2 (n=12; Compudose, Elanco Animal Health), (2) trenbolone acetate
(TBA) only implant containing 200 mg TBA (n=12; Finaplix-H, Merck Animal Health),
(3) a combined estradiol and trenbolone acetate (ETBA) implant containing 120 mg TBA
and 24 mg E2 (n=13, Revalor-S, Merck Animal Health), or (4) no implant (CON; n=13).
Different letters, a,b,c, indicate a difference (P ≤ 0.05) in weights between the time points.
Contrasts were used to compare differences in weight gain over time between treatment
and the control. The P-values for this analysis are displayed on the figure. All data are
reported as LSMEANS ± SEM.
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Dry Matter Intake, kg

16

CON

14

c
b

TBA
ETBA

Time: P < 0.001
CON vs. E2: P = 0.74
CON vs. TBA: P = 0.08
CON vs. ETBA: P = 0.0003

10
8
28

E2
bc

*

12

a

c

56

84

112 129

Day
Figure 2.2. Dry matter intake was measured as described in the Materials and Methods.
Steers were stratified by weight and assigned to one of four treatments: (1) estradiol (E2)
only implant containing 25.7 mg E2 (n=12; Compudose, Elanco Animal Health), (2)
trenbolone acetate (TBA) only implant containing 200 mg TBA (n=12; Finaplix-H, Merck
Animal Health), (3) a combined estradiol and trenbolone acetate (ETBA) implant
containing 120 mg TBA and 24 mg E2 (n=13, Revalor-S, Merck Animal Health), or (4) no
implant (CON; n=13). Different letters, a,b,c, indicate a difference (P ≤ 0.05) between time
points. Contrasts were used to compare differences in dry matter intake over time between
treatment and the control. The P-values for this analysis are displayed on the figure. All
data are reported as LSMEANS ± SEM.
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0.3

CON

Gain to Feed

c
0.2

ab

E2

a

*

b
ab

TBA
ETBA

Time: P < 0.001
CON vs. E2: P = 0.45
CON vs. TBA: P = 0.31
CON vs. ETBA: P = 0.03

0.1

0.0
28

56

84

112 129

Day
Figure 2.3. Gain to Feed (G:F) was measured as described in the Materials and Methods.
Steers were stratified by weight and assigned to one of four treatments: (1) estradiol (E2)
only implant containing 25.7 mg E2 (n=12; Compudose, Elanco Animal Health), (2)
trenbolone acetate (TBA) only implant containing 200 mg TBA (n=12; Finaplix-H, Merck
Animal Health), (3) a combined estradiol and trenbolone acetate (ETBA) implant
containing 120 mg TBA and 24 mg E2 (n=13, Revalor-S, Merck Animal Health), or (4) no
implant (CON; n=13). Different letters, a,b,c, indicate a difference (P ≤ 0.05) between time
points. Contrasts were used to compare differences in gain to feed over time between
treatment and the control. The P-values for this analysis are displayed on the figure. All
data are reported as LSMEANS ± SEM.
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a
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Time: P < 0.001

FB

Feed Events

BV
b

40

b

b

c

20

0
0

28
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Day

Figure 2.4. Feed events, feed bout (FB) and bunk visit (BV) were measured as described
in the Materials and Methods. Feed events were influenced (P ≤ 0.05) by time when
analyzed as a repeated measure. Different letters, a,b,c, indicate a difference (P ≤ 0.05)
between time points . The P-value for this analysis are displayed on the figure. All data are
reported as LSMEANS ± SEM.
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Figure 2.5. Meal events were measured as described in the Materials and Methods. Steers were stratified by weight and assigned
to one of four treatments: (1) estradiol (E2) only implant containing 25.7 mg E2 (n=12; Compudose, Elanco Animal Health), (2)
trenbolone acetate (TBA) only implant containing 200 mg TBA (n=12; Finaplix-H, Merck Animal Health), (3) a combined
estradiol and trenbolone acetate (ETBA) implant containing 120 mg TBA and 24 mg E2 (n=13, Revalor-S, Merck Animal

94
Health), or (4) no implant (CON; n=13). (A) average bunk visit head down, (B), average feed bout head down, (C) average bunk
visit duration, and (D) average feed bout duration. Different letters, a,b,c, indicate a difference (P ≤ 0.05) between time points .
Contrasts were used to compare differences in meal events over time between treatment and the control. The P-values for this
analysis are displayed on the figure. All data are reported as LSMEANS ± SEM.
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Figure 2.6. Plasma trace mineral concentrations were influenced throughout the implant
trial. Plasma samples were collected on d 0, 2, 10, and 30. Day 0 values were utilized as a
covariate in a repeated measures analysis and is displayed on the graph as a point of
reference for initial plasma concentrations. Superscripts indicate differences between (P ≤
0.05) time points for each trace mineral analyzed. All data are presented as LSMEANS ±
SEM. No Treatment × Time effects were observed for all trace minerals tested (P ≥ 0.18).
Plasma Cu concentrations peaked on d 10 and were lesser than initial concentrations on d
30 (Time; P < 0.0001). Plasma Fe concentrations decreased on d 2 but increased by d 10
before decreasing again by d 30 (Time; P < 0.0001). Plasma Zn concentrations were lowest
on d 2 before peaking on d 10 and remained steady through d 30 (Time; P < 0.0001).
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CHAPTER III
ANABOLIC IMPLANTS ALTER ABUNDANCE OF mRNA INVOLVED IN
MUSCLE GROWTH, METABOLISM, AND INFLAMMATION IN THE
LONGISSIMUS THORACIS OF ANGUS STEERS IN THE FEEDLOT

Lay Summary
In the United States, anabolic implants are commonly given to beef cattle to
increase skeletal muscle growth and improve feed efficiency. However, despite their
widespread usage and known benefits, the mechanisms of action through which skeletal
muscle growth is improved have yet to be understood. The purpose of this study was to
improve understanding of how anabolic implants increase skeletal muscle growth of beef
steers. The main findings of this research suggest that steroid hormones, estradiol and
trenbolone acetate, operate through different molecular mechanisms to increase skeletal
muscle growth of beef steers. Overall, it appears that estradiol alters skeletal muscle
growth via nutrient partitioning related to metabolism. Trenbolone acetate improves
skeletal muscle growth by activating pathways involved in skeletal muscle growth.
Meanwhile, when these steroid hormones are administered together, both mechanisms of
action are observed. This research provides important insight into the molecular
mechanism through which different anabolic implants function to improve growth of
skeletal muscle.
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Abstract
The majority of beef cattle in the U.S. will receive at least one anabolic implant
resulting in improved growth, feed efficiency, and environmental and economic
sustainability. However, the physiological and molecular mechanisms through which
anabolic implants increase skeletal muscle growth of beef cattle remain elusive. The
objective of this study was to identify transcriptional changes occurring in skeletal
muscle of steers receiving anabolic implants containing different steroid hormones.
Forty-eight steers were stratified by weight into one of four (n = 12/treatment) implant
treatment groups: (1) estradiol (E2T; 25.7 mg E2; Compudose, Elanco Animal Health,
Greenfield, IN), (2) trenbolone acetate (TBAT; 200 mg TBA; Finaplix-H, Merck Animal
Health, Madison, NJ), (3) combination (ETBAT; 120 mg TBA + 24 mg E2; Revalor-S,
Merck Animal Health), or (4) no implant (CON). Skeletal muscle biopsies were taken
from the longissimus thoracis two and ten d post-implantation. The mRNA abundance of
94 genes associated with skeletal muscle growth were examined. At ten d postimplantation, steers receiving ETBAT had greater (P = 0.02) Myoblast Differentiation
Factor 1 abundance than CON. Citrate synthase abundance was increased (P = 0.04) in
ETBAT steers compared to CON steers. In E2 steers ten d post-implantation, muscle
RING finger protein 1 decreased (P = 0.05) compared to CON steers, and forkhead box
protein O4 decreased (P = 0.05) in ETBAT steers when compared to CON steers.
Interleukin-6 abundance tended to be increased (P = 0.09) in E2T steers compared to
both ETBAT and CON steers. Furthermore, interleukin-10 abundance tended to be
increased (P = 0.06) in TBAT steers compared to ETBAT steers. Leptin receptor
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abundance was reduced (P = 0.01) in both E2T and TBAT steers when compared to
CON steers. Abundance of phosphodiesterase 4B was increased (P = 0.04) in TBAT
steers compared to CON steers two d post-implantation. Taken together, the results of
this research demonstrate that estradiol increases skeletal muscle growth via pathways
related to nutrient partitioning and mitochondria function, while trenbolone acetate
improves steer skeletal muscle growth via pathways related to muscle growth.
Introduction
Skeletal muscle growth is of the utmost importance for livestock producers, as
through a series of predictable changes, skeletal muscle becomes meat (England et al.,
2013). One method to increase skeletal muscle growth of cattle, is through the use of
anabolic implants (Duckett and Pratt, 2014). In the United States, anabolic implants are
routinely administered to beef cattle to increase skeletal muscle growth, feed efficiency,
and economic return (Duckett and Pratt, 2014), with over 90% of all cattle on feed
receiving an anabolic implant at some point during production (APHIS, 2013). Anabolic
implants typically contain the steroid hormones estradiol (E2) and the synthetic
testosterone analogue, trenbolone acetate (TBA) (Smith and Johnson, 2020). It has been
reported that on average, anabolic implants increase average daily gain by 18%, feed
efficiency by 6%, and feed intake by 6% (Duckett and Pratt, 2014). Additionally,
anabolic implants increase economic return anywhere from $15-$163 a head depending
on a number of different variables including cattle prices and implant protocol used
(Donovan et al., 1983; Duckett and Pratt, 2014; Reichhardt et al., 2021a). This improved
performance and economic return ultimately leads to production of a more
environmentally sustainable end product through decreasing land usage by 7.8% - 9.1%
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(Basarab et al., 2012; Capper and Hayes, 2012), and greenhouse gas emissions by 5.1%
to 8.9% (Basarab et al., 2012; Capper and Hayes, 2012). Despite the clear environmental
and economic benefits of using anabolic implants in beef cattle production, over 50% of
consumers consider use of exogenous hormones in cattle production a serious issue
(Capper and Hayes, 2012).
The physiological and molecular mechanisms through which anabolic implants
increase skeletal muscle growth and efficiency of beef cattle are not yet fully understood
(Reichhardt et al., 2020; Reichhardt et al., 2021c). Determining the physiological and
molecular mechanisms through which anabolic implants operate would allow for the
development of new technologies and/or the development of alternative methods to
increase production of beef cattle that do not involve provision of steroidal hormones. In
vivo studies have identified links to mineral status of the animal (Messersmith et al.,
2021; Reichhardt et al., 2021b), as well as breed type (Reichhardt et al., 2021a), sex
(Boles et al., 2009), serum insulin-like growth factor-1 (IGF-1) (Johnson et al., 1996),
serum oxytocin (Jager et al., 2011), serum vitamin D3 (Reichhardt et al., 2021a), and
serum cortisol (Hayden et al., 1992). Meanwhile, in vitro studies have used satellite cells
to investigate the effects of anabolic implants on bovine skeletal muscle growth. Satellite
cells are muscle precursor cells that proliferate, then differentiate and fuse with existing
muscle fibers to support skeletal muscle hypertrophy (Li et al., 2011). In vitro studies
have found links to the IGF1-receptor (IGF-1R) (Kamanga-Sollo et al., 2004; KamangaSollo et al., 2008), the estrogen and androgen receptors (Kamanga-Sollo et al., 2008),
oxytocin (Zhang et al., 2018), the polyamine biosynthesis pathway (Reichhardt et al.,
2020; Reichhardt et al., 2021c), and the G-protein coupled cascade pathway (Kamanga-
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Sollo et al., 2014; Thornton et al., 2015; Thornton et al., 2016; Kamanga-Sollo et al.,
2017). Although several studies have been conducted in this research area, the
mechanism of anabolic implants remains elusive. An improved understanding of how
anabolic implants contribute to improved beef production is necessary for the
development of new technologies and/or the development of alternative methods to
increase production that do not involve provision of steroidal hormones. As such, the
objective of this study was to identify transcriptional changes in skeletal muscle of Angus
sired steers two and ten d post-implantation to better understand what pathways may be
involved when different anabolic implants are administered.
Materials and Methods
Animal Management
All live animal procedures and protocols for this experiment were approved by
the Utah State University Institutional Animal Care and Use Committee (IACUC
Protocol #2817). The animals used in this research were part of a previously published
trial (Reichhardt et al., 2021b). Treatments and feedlot performance parameters of this
trial have been previously published (Reichhardt et al., 2021b). In brief, this trial was
conducted at the Utah State University feedlot. Forty-eight Angus sired steers (327 kg ±
25 kg), out of commercial Angus dams, that had not received any prior growth promotant
treatments were initially stratified by weight at the start of the trial. Prior to beginning the
trial, each steer received an electronic and visual ear tag. Steers were assigned to one of
four implant treatments: (1) estradiol only implant containing 25.7 mg estradiol (E2T;
n=12; Compudose, Elanco Animal Health), (2) trenbolone acetate only implant
containing 200 mg trenbolone acetate (TBAT; n=12; Finaplix-H, Merck Animal Health),
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(3) a combine estradiol trenbolone acetate implant containing 120 mg trenbolone acetate
and 24 mg estradiol (ETBAT; n=12, Revalor-S, Merck Animal Health), or (4) no implant
(CON; n=12). Steers were randomly placed into one of four covered pens equipped with
two GrowSafe bunks per pen, and each pen contained 15 steers. Steers utilized in this
trial were housed with other steers of similar size from the Utah State University beef
herd. Steers always had free choice access to water. All steers were fed the same ration.
Rations were stepped up between 10 and 12% (DM basis) concentrate every 10 d from a
backgrounding diet consisting of 40% (DM basis) concentrate to a finishing ration
consisting of 86% (DM basis) concentrate over a 41-d period (Supplemental Material
Table 1). One steer was removed from the trial due to excessive bloat, and his skeletal
muscle biopsy was not used in any analyses (n=1, E2T).
Sample Collection and Processing
Skeletal muscle samples were taken from the longissimus thoracis (LT) on d two and ten
post-implanting by clinical veterinarians at Utah State University using previously
published methods (Thornton et al., 2012). In brief, a 30 x 30 cm square area was shaved
and prepped following standard procedures. The area was injected with 20 mL of 2%
lidocaine hydrochloride in an inverted L pattern. A 10 cm oblique skin incision was made
in the longissimus thoracis muscle. Samples were taken on the same side of the animal.
The d two samples were taken above the 11th rib, and the d ten samples were taken from
above the 13th rib. A Wheatlander retractor was used to open the incision and a 2 x 2 x 2
cm muscle biopsy was obtained using a Metzenbaum scissor. The incision in the muscle
was closed using 0 chromic gut suture in an interrupted cruciate pattern. The incision was
closed using 0 braunamid suture in a continuous ford interlocking suture pattern. The
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wound was then be sprayed with an antiseptic spray. Skeletal muscle biopsy samples
were then flash frozen in liquid nitrogen and stored at -80°C until isolation of RNA.
Isolation of RNA, Quantification, and cDNA Synthesis
Isolation of RNA was performed using previously published methods (Gardner et
al., 2021). In brief, flash frozen skeletal muscle samples were ground under liquid
nitrogen using mortars and pestles. Extraction of RNA was performed using TriZol
following manufacturer’s protocol (Invitrogen, Carlsbad, CA). Isolated RNA was
quantified using a Take3 plate on a BioTek all-in-one microplate reader with Gen5 2.0
software (BioTek Instruments, Winooski, VT). All RNA samples were treated with
deoxyribonuclease (Ambion, Foster City, CA) before beginning cDNA synthesis using a
high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA)
following the manufacturer’s protocol.
Fluidigm Reverse Transcription qPCR
The 96.96 Dynamic Array Integrated Fluidic Circuit (IFC; Fluidigm, San
Francisco, CA) was utilized for quantitative gene expression as previously described
(Suasnavas et al., 2015). A total of 94 genes were targeted for analysis and examined on
two chips (Supplemental Material 2). Genes were normalized to the housekeeping genes
ribosomal protein S9 (RPS9) and eukaryotic translation elongation factor 1 alpha 2
(EEF1A2) using the per sample ∆Ct method (Baggerman et al., 2021; Wellmann et al.,
2021). The housekeeping genes, RPS9 and EEF1A2, were averaged together prior to
normalization. Primer sets were designed and validated by Fluidigm. In brief, following
the Fluidigm protocol, a Specific Target Amplification (STA) was performed to enrich
each sample for target-specific cDNA prior to quantitative PCR. For STA thermal
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cycling, each reaction consisted of 1.25 µl of primer mix, 2.5 µl of the TaqMan PreAmp
Master Mix (Applied Biosystems; Foster City, CA), and 1.25 µl of cDNA. Enzyme
activation took place at 95°C for 10 min and then the amplification took place over 14
cycles (95°C for 15 s then 60°C for 4 min). The Fluidigm IFC chip was then run on the
Biomark. thermocycler/detection module. Abundance of mRNA was determined by
analyzing the relative expression of each sample calculated as 2-relative threshold cycle
(ΔCt).
Statistical Analysis
Statistical analysis was performed using the MIXED procedure of SAS (version
9.4; SAS Inst. Inc., Cary, NC, USA) with implant treatment as a fixed effect and pen as a
random effect in the model. All data are presented as the least square mean ± SEM. When
treatment differences were found to be significant (P ≤ 0.05), least square means were
separated using Tukey-Kramer adjustments. Significance was determined at P ≤ 0.05 and
tendencies are reported at 0.05 < P ≤ 0.10.

Results
The abundance of mRNA of 94 genes analyzed in the present study were split into
11 different categories based on mRNA function. These categories include genes
involved in skeletal muscle differentiation, metabolism, protein turnover, myokines,
receptors associated with growth, mineral transport and metabolism, amino acid
metabolism, markers of cellular stress, inflammation, lipid uptake and adipogenesis, and
miscellaneous.
Abundance of mRNA Associated with Skeletal Muscle Differentiation
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Abundance of eight different genes involved in skeletal muscle differentiation
were investigated relative to anabolic implant treatment at both two and ten days after
treatment (Table 3.1). At ten d post-implantation there was no difference (P > 0.10) in
mRNA abundance of any of the measured genes involved in skeletal muscle
differentiation between CON, TBAT, E2T, and ETBAT steers, as well as no difference
(P = 0.14) in paired box transcription factor 7: myoblast differentiation factor 1 (MYOD)
(Table 3.1). However, ten d post-implantation, ETBAT steers had greater (P = 0.02)
MYOD abundance than CON steers (Table 3.1). Steers receiving E2T tended to have
decreased (P = 0.09) abundance of myogenic regulatory factor 6 (MRF4A) compared to
ETBAT steers ten d post-implantation, while myocyte enhancement factor 2C abundance
tended to be increased (P = 0.09) in CON steers compared to TBAT steers (Table 3.1).
Overall, these data suggest that within the first ten d post-implanting, mRNA associated
with skeletal muscle differentiation is largely not altered, however MYOD abundance is
greatly increased in ETBAT steers when compared to CON steers.
Muscle Metabolism mRNA Abundance
Abundance of mRNA of 17 genes associated with muscle metabolism was
investigated in the LT of steers receiving different anabolic implants at both two and ten
d after implantation (Table 3.2). Control and TBAT steers each had less (P = 0.03) AMPactivated protein kinase (AMPk) when compared to E2T steers two d post-implantation
(Table 3.2). Additionally, citrate synthase (CS) mRNA abundance was increased (P =
0.04) in ETBAT steers compared to CON steers. There was a tendency (P = 0.09) for
ribosomal protein S6 kinase B1 to be changed by anabolic implant treatment two d postimplantation, however when LSMeans were compared, none of the treatments tended to
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be different from one another. No other muscle metabolism genes analyzed were altered
(P > 0.10) by treatment two d post-implantation (Table 3.2). Ten d post-implantation,
glycogen phosphorylase was decreased (P < 0.01) in E2T steers compared to CON,
TBAT, and ETBAT steers (Table 3.2). Additionally, ten d post-implantation there was a
tendency for glucose-6-phosphate dehydrogenase (G6P) to increase (P = 0.09) in E2T
steers compared to CON steers. An additional tendency was observed ten d postimplantation where glyceraldehyde-3-phosphate dehydrogenase abundance increased (P
= 0.07) in ETBAT compared to E2T steers (Table 3.2).
Abundance of mRNA Related to Protein Turnover
Abundance of mRNA associated with skeletal muscle protein turnover were
examined in the LT of steers receiving different implant treatments at two and ten d postimplantation (Table 3.3). Day two post-implantation, there were no differences (P >
0.10) in abundance of the eleven genes assessed relative to protein turnover between
CON, E2T, TBAT, ETBAT steers (Table 3.3). However, on d ten post-implantation
calpain 6 was increased (P = 0.04) in ETBAT compared to CON steers. In E2T steers,
ten d post-implantation, muscle RING finger protein 1 (MURF-1) decreased (P = 0.05)
compared to CON steers, and forkhead box protein O4 (FoxO4) decreased (P = 0.05) in
ETBAT steers compared to CON steers (Table 3.3). Ten d post-implantation there was a
tendency (P = 0.07) for matrix metallopeptidase 2 (MMP2) to be affected by treatment,
however the LSMeans of the treatment groups were not different from one another (Table
3.3). Steers receiving E2T had an increase (P = 0.02) in mRNA abundance of matrix
metallopeptidase 9 (MMP9) when compared to CON steers ten d after implantation
(Table 3.3). The data examining protein turnover suggests that skeletal muscle mRNA is
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largely not altered two d post-implantation, however by ten d post-implantation, mRNA
abundance related to muscle protein turnover is typically deceased by anabolic implants
when compared to CON steers.
Myokine mRNA Abundance
Abundance of five different myokines in the LT was investigated two and ten d
post-implantation in steers receiving different anabolic implant treatment (Table 3.4).
Anabolic implant treatment had no effect (P > 0.10) on abundance of any of the
myokines assessed two d post-implantation when compared to CON steers. The myokine
brain derived neurotrophic factor (BDNF) was increased (P = 0.03) ten d postimplantation in ETBAT steers compared to both CON and TBAT steers. None of the
other myokines investigated had altered (P > 0.10) mRNA abundance ten d postimplantation (Table 3.4).
Abundance of mRNA of Receptors that are Associated with Growth
The mRNA abundance of twelve different receptors associated with skeletal
muscle growth was examined two and ten d post-implantation in steers receiving
different anabolic implant treatments (Table 3.5). Leptin receptor (LEPR) was reduced (P
= 0.01) in both E2T and TBAT steers compared to CON steers two d post-implantation
(Table 3.5). Additionally, ten d post-implantation anabolic implants tended to alter (P =
0.10) abundance of adiponectin receptor 1 (ADIPOR1), however the LSMeans of the
different treatment groups were not different from one other (Table 3.5). However, none
of the other genes assessed in this group were different (P > 0.10) from one another at
either two or ten d post-implantation.
Mineral Transport and Metabolization mRNA Abundance
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Abundance of mRNA associated with mineral transport and metabolization were
examined in the LT both two and ten d post-implantation in steers receiving different
implant treatments (Table 3.6). No differences (P > 0.05) in abundance of any of the
genes analyzed were found two d post-implantation (Table 3.6). However, there was a
tendency (P = 0.09) for zinc transporter SLC39A7 (ZIP7) to be affected by implant
treatment, but none of the LSMeans were different (P > 0.10) from one another.
Additionally, two d following implantation, E2T steers tended to have greater (P = 0.08)
abundance of zinc transporter 7 (ZNT7) compared to CON steers. Ten d following
implantation, E2T steers had increased (P = 0.02) zinc transporter 10 (ZNT10) compared
to both CON and ETBAT steers. Mineral transporter and metabolization mRNA
abundance did not appear to be altered (P > 0.10) in TBAT steers compared to E2T,
ETBAT, or CON steers. These findings suggest E2 may mobilize minerals in skeletal
muscle, whereas TBA does not appear to affect mineral mobilization at the time points
assessed.
Abundance of mRNA Associated with Amino Acid Metabolism
The effects of implant treatment on mRNA abundance of genes involved in amino
acid metabolism were investigated two and ten d post-implantation in the LT (Table 3.7).
Anabolic implant had no effect (P > 0.10) on the genes involved in the polyamine
biosynthetic pathway on d two or d ten post-implantation. However, two d postimplantation E2T steers had increased (P = 0.02) solute carrier family 3 member 2
(SLC3A2) compared to CON steers. The other amino acid transporter investigated, solute
carrier family 1 member 5, was not altered (P > 0.10) by anabolic implant treatment on d
two or d ten post-implantation. Taken together, these data indicate the E2 implants may

108
mobilize neutral branched amino acids and aromatic amino acids due to the increase in
SLC3A2 at the time points assessed.
Markers of Cellular Stress mRNA Abundance
Abundance of four genes associated with cellular stress in the LT was
investigated two and ten d following implantation (Table 3.8). Abundance of parkinsons
associated deglycase (DJ1) was increased (P = 0.03) in E2T steers compared to both
CON and ETBAT steers at two d post-implantation (Table 3.8), however there was no
difference (P > 0.10) on d ten. The other markers of cellular stress examined were not
altered (P > 0.10) by anabolic implant treatment on either d two or ten following
implanting.
Abundance of mRNA Related to Inflammation
Abundance of mRNA associated with inflammation were also investigated (Table
3.9). No effects (P > 0.10) of anabolic implant treatments relative to abundance of genes
involved in inflammation were observed on d two (Table 3.9). However, ten d postimplantation, abundance of nuclear factor kappa B was altered (P = 0.09), however no
differences (P > 0.10) were observed between individual treatment LSMeans.
Additionally, it was found that abundance of both interleukin-6 (IL-6) and interleukin-10
(IL-10) tended to be influenced (P < 0.10) by treatment. Interleukin-6 abundance was
increased (P = 0.09) in E2T steers compared to both ETBAT and CON steers.
Additionally, IL-10 abundance was increased (P = 0.06) in TBAT steers when compared
to ETBAT steers. Taken together, these data indicate a role for inflammation in anabolic
implant mediated skeletal muscle growth.
Abundance of mRNA Associated with Lipid Uptake and Adipogenesis
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Five genes associated with lipid uptake and adipogenesis were evaluated on d two
and d ten following implantation (Table 3.10). Anabolic implants had no effect (P >
0.10) on mRNA abundance of the five genes associated with lipid uptake and
adipogenesis two or ten d post implantation. These data indicate that anabolic implants do
not alter lipid uptake or adipogenesis at the time points investigated.
Abundance of mRNA Having a Miscellaneous Relationship to Skeletal Muscle
Abundance of four miscellaneous mRNA that are associated with skeletal muscle
were examined (Table 3.11). Fibronectin, E74 like ETS transcription factor 3 and
transforming growth factor beta-3 were not influenced (P > 0.10) by anabolic implants
on d two or d ten post-implantation. However, abundance of phosphodiesterase 4B
(PDE4B) was increased (P =0.04) in TBAT compared to CON steers two d postimplantation. There were no changes (P > 0.10) in PDE4B abundance ten d postimplantation, however. This finding suggests that PDE4B is involved in the early
response of skeletal muscle to TBA.

Discussion
In the United States, over 90% of cattle on feed will receive at least one anabolic
implant at some point during the production cycle resulting in improved growth, feed
efficiency, economic return, and environmental sustainability (APHIS, 2013; Duckett and
Pratt, 2014). Despite the widespread usage of anabolic implants, the molecular
mechanisms they operate through to increase skeletal muscle growth have yet to be fully
characterized (Reichhardt et al., 2021c). Characterizing and determining these
mechanisms is necessary, as over 50% of consumers consider exogenous hormones used
in beef production a serious issue (Capper and Hayes, 2012). A better understanding of
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how anabolic implants function will allow for the development of more efficacious
implants, or alternative strategies to improve growth without the use of exogenous
hormones. Therefore, the purpose of this study was to determine transcriptional changes
that occur in the LT of angus steers receiving an E2 only implant, a TBA only implant, or
an ETBA implant compared to a non-implant control. Despite the novel insight into this
mechanism gained through the present research, there are two potential limitations. First,
the longissimus thoracis was the only muscle sampled. Research has shown that muscles
from different locations are intrinsically different from one another (ŻochowskaKujawska, 2016). Therefore, there is a potential that if muscle from different locations
were sampled, different responses to anabolic implants may be observed. However, it is
important to keep in mind that despite this limitation, the LT is one of the most
economically valuable muscles in the carcass and is the primary muscle used to
determine carcass quality, making it an important muscle to understand. Second, this
study only evaluated 94 genes known to be involved in skeletal muscle growth and
metabolism and did not investigate the whole skeletal muscle transcriptome. Despite this
potential limitation, this allowed for a very targeted approach to help further understand
the mechanisms through which anabolic implants increase skeletal muscle growth.
The first group of genes investigated in the present study included genes involved
in skeletal muscle differentiation. Satellite cells are muscle precursor cells that
proliferate, then differentiate and fuse into myotubes or with existing muscle fibers to
support hypertrophy (Li et al., 2011). Differentiation and phenotypic maturation are
necessary for satellite cells to be able to properly fuse (Gonzalez et al., 2020). Markers of
differentiation in skeletal muscle include increased abundance of MYF5, MYOD, and
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myogenin (MYOG), and decreased expression of paired box transcription factor 7
(Halevy et al., 2004; Yablonka-Reuveni et al., 2008; Yablonka-Reuveni, 2011). In vitro
studies utilizing bovine satellite cells (BSC) to study the effects of steroid hormones on
skeletal muscle growth have consistently demonstrated alterations in mRNA abundance
associated with BSC proliferation and differentiation (Zhang et al., 2018; Reichhardt et
al., 2020; Reichhardt et al., 2021c). In the current study, MYF5 mRNA abundance was
decreased in E2T steers ten d post-implanting when compared to ETBAT steers. In BSC
induced to differentiate, MYF5 mRNA abundance is increased by TBA (Reichhardt et al.,
2021c), suggesting that TBA may be more potent at increasing skeletal muscle
differentiation than E2. Additionally, 8 h post-induction of differentiation in BSC, both
E2 and E2 and TBA together increase mRNA abundance of MYOD (Reichhardt et al.,
2021c). In the current study, both TBAT and ETBAT steers had increased MYOD mRNA
compared to CON steers. Similarly, MYOD protein expression increases when muscle
derived fetal calf cells are treated with TBA (Zhao et al., 2011). Myogenin and MRF4A
are responsible for terminal differentiation of satellite cells (Jin et al., 2007). Anabolic
implants did not alter mRNA abundance of MYOG in the current study, however research
has shown that when BSC are treated with E2 or TBA, there is an increase in MYOG
mRNA abundance (Zhang et al., 2018). Additionally, early anabolic implant research has
found that steers receiving a combined E2 and TBA implant have increased number of
proliferating satellite cells in the longissimus lumborum (Johnson et al., 1998b). Taken
together, these results suggest that steroid hormones alter skeletal muscle growth by
progressing satellite cells through the myogenic lineage, with steers receiving any TBA,
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either alone or in combination with E2, being pushed further along their myogenic
lineage than E2T only steers.
Abundance of mRNA involved in muscle metabolism was investigated as well. In
skeletal muscle, activation of AMPk increases glucose uptake, fatty acid oxidation, and
mitochondrial biogenesis (Jäger et al., 2007). Anabolic implants have been shown to
increase skeletal muscle mRNA abundance of AMPk in the longissimus lumborum of
feedlot steers by d 55 post-implantation (Smith et al., 2017). This was again observed in
the current trial with E2T steers having increased mRNA abundance, except at two d
post-implanting. Citrate synthase is a marker of mitochondria content (Larsen et al.,
2012). In the current study, ETBAT steers had greater mRNA abundance of CS than
CON steers. In skeletal muscle of rats that are treated with E2, an increased activity of CS
has been observed (Beckett and Toth, 2002), however research has also shown that when
women receive testosterone treatments, there is no alterations in CS (Cardinale et al.,
2020). Glucose-6-phosphate (G6P) is an important source for nicotinamide adenine
dinucleotide in mitochondria (Mailloux and Harper, 2010). In rats, injecting either E2 or
testosterone leads to a 50% increase in the specific activity of glucose-6-phosphate
dehydrogenase (Max and Knudsen, 1980). In the present study, G6P abundance was
increased in E2T steers compared to CON steers. Taken all together, it appears
mitochondria play a pivotal role in postnatal steroidal hormone mediated skeletal muscle
growth. Future work is warranted to investigate the relationship between anabolic
implants and mitochondrial activity in skeletal muscle of cattle.
Both protein synthesis and protein breakdown are involved in the growth of
skeletal muscle (Millward et al., 1975). Muscle RING finger protein-1 triggers skeletal
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muscle protein degradation by ubiquitination (Koyama et al., 2008). In rainbow trout, E2
increases mRNA abundance of MURF-1, 12 h after injection (Cleveland and Weber,
2011), however in the present study E2T steers had decreased abundance of MURF-1
compared to CON steers. The difference between these two studies could be that E2
promotes protein catabolism in rainbow trout (Cleveland and Weber, 2011), while in
cattle E2 promotes protein synthesis (Kamanga-Sollo et al., 2010). Additionally, the
present study found that E2T steers had decreased abundance of FoxO4 ten d postimplanting compared to CON steers. In C2C12 cells, E2 protects the cells from apoptosis
by modulating FoxO transcription factors (La Colla et al., 2017). When MMP2/9 are
inhibited in proliferating and fused BSC, TBA and E2 mediated increases in proliferation
and protein synthesis rates do not occur (Kamanga-Sollo et al., 2014; Thornton et al.,
2015; Thornton et al., 2016; Kamanga-Sollo et al., 2017). In the current study, ten d postimplanting, there was an increase in MMP9 mRNA abundance in E2T steers compared to
CON steers. In general, these findings suggest that E2 promotes bovine skeletal muscle
growth by decreasing protein degradation.
Myokines are produced and released by skeletal muscle, and act through autocrine
and paracrine actions to support growth of skeletal muscle (Leal et al., 2018). Brainderived neurotrophic factor has been reported to be involved in myosin heavy chain
repair in mice following trauma, as well as in regulating mouse satellite cell
differentiation (Mousavi et al., 2004; Clow and Jasmin, 2010). Androgens have also been
shown to regulate expression of BDNF in a range of species (Ottem et al., 2013), while in
female mice, it has been found that BDNF is essential to maintain mitochondrial quality
and function (Ahuja et al., 2021). The role of BDNF in bovine skeletal muscle growth has
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not been fully characterized yet, but the current study found that ETBAT steers had
increased mRNA abundance of BDNF compared to CON steers. More research is
necessary to fully understand the relationship between steroid hormones, bovine skeletal
muscle growth, and BDNF.
One of the main pathways commonly associated with anabolic implants and
bovine skeletal muscle growth is the IGF-1 pathway. In the current study, IGF-1R mRNA
abundance was not altered by implanting. However, other research has found changes in
circulating IGF-1, as well as mRNA abundance of IGF-1R increasing following
implanting in the longissimus (Johnson et al., 1996; Johnson et al., 1998a). The
differences between the studies most likely comes down to timing, as the skeletal muscle
biopsies were taken on d two and ten of the current study, while the other studies took
biopsies on d 40. Skeletal muscle leptin is important for nutrient sensing (Wang et al.,
1998). In the current study, abundance of LEPR was decreased by E2T and TBAT when
compared to CON steers two d post-implanting. In humans, there is a gender dimorphism
in skeletal muscle LEPR expression, which is partly explained by testosterone (Guerra et
al., 2008), while in the skeletal muscle of ovariectomized rats, leptin and LEPR are
directly controlled by E2 (Alonso et al., 2007). In human myoblasts, leptin, but not its
receptors, is decreased during differentiation (Solberg et al., 2005). Taken together, these
findings suggest that anabolic implants may alter nutrient sensing and, ultimately,
skeletal muscle growth of cattle.
Previous research has demonstrated that when trace minerals are supplemented
above National Research Council recommendations, the efficacy of anabolic implants
increases (Niedermayer et al., 2018). Furthermore, lambs receiving a Zeranol implant (a
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synthetic estrogen) have increased Zn retention (Hufstedler and Greene, 1995). In a
previous study by our lab group, utilizing the steers and treatments presented in the
current research (Reichhardt et al., 2021b), it was found that ETBAT steers had decreased
plasma Zn concentrations and on d 2 following implanting decreased liver Zn
concentrations (Reichhardt et al., 2021b). In TBAT steers, two d post-implanting liver
Cu, Mn, and Zn were less when compared to CON steers, while E2T steers had increased
liver Fe on d ten post-implanting (Reichhardt et al., 2021b). When mRNA abundance of
mineral transporters of the skeletal muscle of the steers was investigated in the current
study it was found that E2T steers had greater mRNA abundance of ZNT10 and ZNT7 on
d ten and two, respectively. Zinc transporter 10 and ZNT7 are responsible for Zn uptake.
The difference between the plasma and skeletal muscle of the steers could be due to when
mineral stores are being mobilized. It is very possible that mineral stores are mobilized
prior to d two post-implanting in E2T treated steers, while even though mobilization of
minerals was observed two d following implanting with a TBAT implant, the time point
was missed to observe an increase in mRNA abundance of mineral transporters. Overall,
it is appearing that a synergistic relationship between anabolic implants and trace
minerals exists, however, more research is necessary to further examine that relationship.
DJ1 plays an essential role in many biological activities, including transcriptional
regulation, antioxidative stress, and in modulating the mitochondria’s response to
oxidative stress (Kahle et al., 2009; Di Nottia et al., 2017). In Callipyge sheep, DJ1 has
been found to be upregulated in hypertrophied muscle (Fleming-Waddell et al., 2009).
Furthermore, in mice, DJ1 has been found to increase myotube diameter (Yu et al.,
2014). In the current study, E2T increased mRNA abundance of DJ1 compared to CON
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steers. Additionally, TBAT and ETBAT steers had numerically greater mRNA
abundance of DJ1 than CON steers, which although not statistically significant, may be
physiologically relevant. When fiber diameter is examined post-harvest in steers that
have received an anabolic implant containing both E2 and TBA, an increase in fiber size
is observed in the strip loin following harvest and fabrication (Kellermeier et al., 2009).
Taken together, these data suggest that anabolic implants may alter growth via increasing
mRNA abundance of DJ1, which could possibly lead to increases in myofiber diameter.
Phosphodiesterase 4B is involved in cAMP signaling, signaling cross talk, and
cell desensitization (Dostaler-Touchette et al., 2009). In the present study, PDE4B
mRNA abundance was increased two d post-implanting in TBAT steers when compared
to CON steers. Meanwhile, in lambs fed a beta-agonist, another type of growth
promotant, lambs have been reported to have increased abundance of PDE4B in the
semitendinosus when compared to skeletal muscle of lambs not supplemented (Kubik et
al., 2018). These findings suggest that during times of extreme muscle growth, which
occurs when growth promotants are administered, PDE4B is upregulated by the muscle.
Interleukin-6 is associated with energy metabolism, inflammation, muscle wasting
and muscle atrophy (Muñoz-Cánoves et al., 2013). Treatment of mouse satellite cells
with IL-6 leads to increased proliferation rates of the cells (Serrano et al., 2008). In the
present study, E2T steers had increased mRNA abundance of IL-6 on d ten following
implanting, while TBAT steers had numerically greater mRNA abundance than CON
steers. In mice, it has been found that IL-6 influences skeletal muscle sex-dependently,
with IL-6 causing fiber size gain in males and fiber type switching in females (Guerra et
al., 2015). When anabolic implants are administered to steers and heifers, the effects on
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fiber types have been inconsistent (Chung et al., 2012; Ebarb et al., 2016; Ebarb et al.,
2017). A study utilizing crossbred beef heifers and a combined estradiol and trenbolone
acetate implant found that muscles from implanted heifers had an increase in the
percentage of Type I fibers, and a decrease in the percentage of type IIX fibers after
harvest (Ebarb et al., 2017), while as previously mentioned, it has been found that a
combined implant just increases fiber size in steers (Kellermeier et al., 2009). These
findings suggest that anabolic implants alter IL-6, ultimately increasing skeletal muscle
growth of steers.

Summary
In summary, the findings of this research suggest that the steroid hormones, E2
and TBA, may operate through different molecular mechanisms to increase skeletal
muscle growth of beef steers. Overall, it appears that E2 alters skeletal muscle growth via
nutrient partitioning related to metabolism. Trenbolone acetate improves skeletal muscle
growth through hypertrophy and myogenesis. Meanwhile, when these steroid hormones
are administered together, both mechanisms of action are observed. This research
provides important insight into the molecular mechanism through which different
anabolic implants function to improve growth of skeletal muscle. Future work is still
needed to identify proteomic and metabolomic changes that occur in skeletal muscle of
cattle that have been implanted, as well as to answer remaining underlying questions
about the mechanisms of action of anabolic implants in hopes of being able to either
develop alternative methods and/or augment the efficacy of anabolic implant to continue
to produce a sustainable product.
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Table 3.1. Abundance of mRNA involved in skeletal muscle differentiation from longissimus
thoracis of Angus steers 2 and 10 days after receiving different anabolic implant treatments.1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
PAX72
d2
2.54
3.32
2.42
2.13
0.37
P = 0.11
d 10
3.12
4.52
3.80
4.46
0.82
P = 0.56
MYF53
d2
2.04
3.20
3.70
2.16
1.02
P = 0.49
d 10
2.05ab
2.08ab
1.01b
2.32a
0.34
P = 0.03
MYOD4
d2
2.71
3.22
3.65
3.71
0.64
P = 0.52
d 10
1.98a
3.97b
3.22ab
4.17b
0.56
P = 0.02
MYOG5
d2
3.00
3.52
3.37
3.07
0.33
P = 0.57
d 10
2.75
4.25
3.51
4.14
0.52
P = 0.12
MRF4A6
d2
11.10
9.59
10.82
9.29
0.86
P = 0.32
d 10
10.37xy
10.16xy
8.44x
12.07y
1.31
P = 0.09
MEF2A7
d2
5.69
10.02
17.42
10.02
4.16
P = 0.23
d 10
9.27
12.18
15.56
19.94
6.26
P = 0.64
MEF2C8
d2
9.91
12.42
12.03
10.80
1.08
P = 0.21
d 10
19.99x
15.42y
15.95xy
16.65xy
1.54
P = 0.09
Sprouty1
d2
3.01
3.57
3.05
3.03
0.22
P = 0.21
d 10
5.09
4.86
5.19
3.90
0.59
P = 0.35
PAX7:MYOD9
d2
1.05
1.41
1.11
0.53
0.26
P = 0.14
d 10
3.39
1.37
17.61
1.23
7.75
P = 0.37
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2Paired box transcription factor 7. 3Myogenic regulatory
factor 5. 4Myoblast differentiation factor 1. 5Myogenin. 6Myogenic regulatory factor 6. 7Myocyte
enhancement factor 2A. 8Myocyte enhancement factor 2C. 9The paired box transcription factor 7 to
myoblast differentiation factor 1 ratio.
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Table 3.2. Abundance of mRNA involved in metabolism within the longissimus thoracis of
Angus steers receiving different anabolic implant treatments. 1
Steers (n)
MHCI2
d2
d 10
MHCIIa3
d2
d 10
MHCIIx4
d2
d 10
MSTN5
d2
d 10
CKM 6
d2
d 10
AMPk7
d2
d 10
p70S6K8
d2
d 10
G6P9
d2
d 10
GYS110
d2
d 10
LDHA11
d2
d 10
GAPDH12
d2
d 10
CS13
d2
d 10
EEF2K14
d2
d 10
LKB115
d2
d 10
SDHA16
d2
d 10
PYGM 17
d2
d 10
Glycogenin
d2
d 10

CON
12

TBAT
12

E2T
11

ETBAT
12

SEM

P-value

7.40
10.46

9.05
9.55

7.45
9.89

9.29
9.83

0.80
1.13

P = 0.22
P = 0.94

9.95
6.82

9.84
9.25

9.16
8.69

12.11
9.93

1.25
1.28

P = 0.28
P = 0.35

23.19
31.61

28.06
27.61

22.62
31.33

24.66
32.19

1.98
3.32

P = 0.23
P = 0.69

3.48
3.59

3.77
2.99

2.81
3.28

3.23
3.72

0.40
0.68

P = 0.22
P = 0.83

13.19
18.00

14.96
16.84

14.87
14.76

15.10
18.50

0.63
1.85

P = 0.13
P = 0.52

3.00 a
3.39

3.10 a
3.55

4.44 b
3.23

3.66 ab
3.68

0.33
0.60

P = 0.03
P = 0.94

2.11
2.35

2.44
2.47

2.33
2.71

2.00
2.60

0.13
0.36

P = 0.09
P = 0.89

1.38
0.93 x

1.01
1.79 xy

0.88
2.36 y

1.03
1.34 xy

0.20
0.40

P = 0.30
P = 0.09

3.54
4.09

4.33
3.33

4.10
3.48

4.26
4.73

0.29
0.63

P = 0.21
P = 0.40

3.83
6.54

4.89
5.13

4.41
4.42

3.83
5.94

0.35
0.91

P = 0.12
P = 0.39

13.67
13.68 xy

15.09
14.26 xy

13.73
12.73 x

13.84
18.44 y

0.78
1.55

P = 0.55
P = 0.07

2.59 a
4.74

3.20 ab
3.49

2.99 ab
3.54

3.35 b
4.13

0.19
0.79

P = 0.04
P = 0.60

1.35
1.34

1.44
1.52

1.44
1.20

1.42
1.68

0.08
0.17

P = 0.82
P = 0.22

8.78
7.10

7.74
8.72

8.55
7.45

8.25
7.79

0.55
0.50

P = 0.47
P = 0.13

13.17
11.41

14.39
13.45

16.88
13.03

13.77
14.71

1.75
1.49

P = 0.38
P = 0.45

5.59
5.44 b

5.98
5.90 b

5.80
3.72 a

5.74
6.12 b

0.51
0.54

P = 0.96
P = 0.01

3.77
3.99

4.37
3.46

4.40
3.59

4.49
3.95

0.35
0.73

P = 0.45
P = 0.93
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1

Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2Myosin Heavy Chain I. 3Myosin Heavy Chain IIa. 4Myosin
Heavy Chain IIx. 5Myostatin. 6Creatine kinase M. 7AMP-activated protein kinase. 870-kDa ribosomal
protein S6 kinase. 9Glucose-6-Phosphate. 10Glycogen Synthase 1. 11Lactate Dehydrogenase A.
12
Glyceride-3-Phosphate Dehydrogenase. 13Citrase Synthase. 14Eukaryotic Elongation Factor 2 Kinase.
15
Serine/Threonine kinase 11. 16Succinate dehydrogenase. 17Glycogen Phosphorylase.
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Table 3.3. Abundance of mRNA related to protein turnover in the longissimus thoracis of
Angus steers 2 d and 10 d after receiving different anabolic implant treatments.1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
ATROG-12
d2
1.64
1.61
1.87
1.64
0.25
P = 0.87
d 10
2.13
2.39
1.68
2.40
0.26
P = 0.16
FOXO13
d2
4.56
5.69
5.38
5.76
0.94
P = 0.78
d 10
3.14
2.92
4.05
3.40
0.67
P = 0.67
FOXO34
d2
2.02
1.99
1.79
2.02
0.11
P = 0.50
d 10
1.54
1.92
1.63
2.00
0.25
P = 0.45
FOXO45
d2
4.41
4.80
4.43
5.04
0.43
P = 0.69
d 10
5.50 a
5.01 ab
4.02 b
4.56 a
0.38
P = 0.05
MURF-16
d2
11.81
12.41
11.80
9.00
1.18
P = 0.11
d 10
18.84 a
15.13 ab
11.71 b
14.69 ab
1.93
P = 0.05
UTRN7
d2
1.48
1.47
1.51
1.76
0.15
P = 0.49
d 10
2.70
2.21
2.15
1.98
0.23
P = 0.18
MMP28
d2
2.88
2.88
2.14
3.24
0.35
P = 0.19
d 10
5.19
4.72
3.12
3.22
0.38
P = 0.07
MMP99
d2
11.85
12.24
10.72
14.77
5.75
P = 0.96
d 10
0.00 a
10.45 ab
17.30 b
1.06 a
5.23
P = 0.02
TFEB10
d2
3.41
3.38
3.59
3.04
0.32
P = 0.49
d 10
3.63
3.91
3.38
3.25
0.25
P = 0.24
CAPN611
d2
5.23
8.44
7.73
9.74
2.22
P = 0.76
d 10
2.66 a
8.41 ab
7.51 ab
14.22 b
2.83
P = 0.04
CAST12
d2
10.22
12.71
12.08
11.65
0.88
P = 0.24
d 10
15.23
12.53
15.98
12.37
1.71
P = 0.34
mTOR13
d2
6.34
4.85
9.00
13.73
4.72
P = 0.58
d 10
4.96
7.28
13.19
3.95
4.23
P = 0.33
AKT14
d2
8.64
9.68
10.04
9.41
0.53
P = 0.28
d 10
9.93
10.36
9.34
8.92
1.12
P = 0.66
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2Atrogin-1. 3Forkhead Box O1. 4 Forkhead Box O3. 5
Forkhead Box O4. 6Muscle RING-finger protein 1. 7Utrophin. 8Matrix Metallopeptidase 2. 9Matrix
Metallopeptidase 9. 10Transcritpion Factor EB. 11Calpain 6. 12Calpastatin. 13Mammalian target of
rapamycin. 14Protein Kinase B.
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Table 3.4. Myokine mRNA abundance in the longissimus thoracis of Angus steers 2 days and
10 days after receiving different anabolic implant treatments. 1
CONT
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
BDNF2
d2
14.26
12.32
12.4
15.62
4.21
P = 0.94
d 10
6.73 a
9.80 a
21.19 ab
38.54 b
11.03
P = 0.03
FGF213
d2
5.06
21.75
12.30
7.80
9.65
P = 0.59
d 10
2.45
3.54
1.61
0.93
1.64
P = 0.68
SPART4
d2
2.57
2.65
2.52
2.60
0.22
P = 0.98
d 10
2.37
2.90
1.75
2.82
0.35
P = 0.14
Decorin
d2
2.12
2.45
1.87
2.21
0.17
P = 0.17
d 10
4.60
4.02
3.29
3.27
1.07
P = 0.80
Irisin
d2
0.95
1.10
0.87
0.90
0.12
P = 0.59
d 10
1.41
1.15
1.56
1.56
0.25
P = 0.63
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2 Brain Derived Neurotrophic Factor. 3Fibroblast growth
factor 21. 4Spartin.
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Table 3.5. Abundance of mRNA of receptors that are associated with growth in longissimus
thoracis of Angus steers 2 days and 10 days after receiving anabolic implant treatments.1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
IGF-1R2
d2
7.34
7.06
8.33
7.59
1.06
P = 0.85
d 10
8.11
10.90
12.12
9.67
2.06
P = 0.61
OXTR3
d2
6.63
20.09
27.60
19.22
8.60
P = 0.41
d 10
13.85
25.75
25.20
13.09
9.41
P = 0.64
VDR4
d2
7.38
9.82
5.45
6.61
2.21
P = 0.58
d 10
1.32
1.41
0.56
1.03
0.38
P = 0.43
RXRγ5
d2
1.98
2.45
2.36
2.44
0.21
P = 0.30
d 10
1.68
2.61
2.02
2.22
0.33
P = 0.16
ER-α6
d2
4.18
4.40
4.69
4.36
0.56
P = 0.91
d 10
4.29
4.16
3.65
4.23
0.68
P = 0.90
AR7
d2
1.45
1.69
1.72
1.76
0.17
P = 0.49
d 10
1.71
1.61
1.61
2.09
0.25
P = 0.55
LEPR8
d2
2.20 a
1.01 b
0.82 b
1.47 ab
0.30
P = 0.01
d 10
1.85
1.39
2.47
1.79
0.66
P = 0.73
ADIPOR19
d2
5.81
5.68
5.74
6.21
0.40
P = 0.82
d 10
3.49
4.75
3.88
4.87
0.43
P = 0.10
IR10
d2
2.04
2.20
2.07
1.98
0.12
P = 0.66
d 10
2.07
1.92
1.71
2.26
0.28
P = 0.58
GCR11
d2
5.81
6.53
6.16
6.65
0.36
P = 0.37
d 10
7.87
8.04
8.08
6.89
0.60
P = 0.40
GPER12
d2
5.58
11.68
11.24
7.78
2.23
P = 0.20
d 10
16.75
11.34
9.76
15.00
4.88
P = 0.76
EGFR13
d2
1.96
2.08
2.38
2.11
0.24
P = 0.65
d 10
2.09
1.59
2.35
2.26
0.30
P = 0.26
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2Insulin like growth factor-1 Receptor. 3Oxytocin Receptor.
4
Vitamin D Receptor. 5Retinoid X Receptor gamma. 6 Estrogen receptor 1. 7 Androgen Receptor. 8Leptin
Receptor. 9Adiponctin Receptor 1. 10Inuslin Receptor. 11 Glucocorticoid Receptor. 12G-Protein Coupled
Receptor. 13Epidermal Growth Factor Receptor.
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Table 3.6. Abundance of mRNA involved in mineral transport and metabolization in the
longissimus thoracis of Angus steers 2 and 10 days after receiving anabolic implants
treatments. 1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
ATP7A2
d2
2.99
3.33
3.21
3.20
0.25
P = 0.77
d 10
4.77
3.41
4.60
4.28
0.72
P = 0.56
CTRL3
d2
1.48
1.73
1.76
1.39
0.16
P = 0.34
d 10
1.32
1.89
1.82
1.60
0.29
P = 0.51
ZIP84
d2
1.43
1.10
1.81
1.68
0.28
P = 0.34
d 10
1.75
2.44
1.80
1.74
0.49
P = 0.60
ZNT105
d2
5.62
3.84
6.50
12.47
4.96
P = 0.62
d 10
0.00 a
6.79 ab
16.89 b
1.15 a
4.88
P = 0.02
ZNT76
d2
5.21 x
7.33 xy
8.52 y
5.49 xy
1.03
P = 0.08
d 10
7.09
8.96
6.54
7.10
1.68
P = 0.68
MN-SOD7
d2
19.85
22.73
20.57
21.54
1.53
P = 0.45
d 10
23.34
22.48
20.79
19.90
1.76
P = 0.44
ZIP78
d2
0.81
0.75
0.81
0.51
0.10
P = 0.09
d 10
1.33
1.35
1.27
1.20
0.20
P = 0.94
Lysyl oxidase
d2
5.26
5.07
6.24
5.13
1.49
P = 0.94
d 10
11.40
19.08
11.20
9.43
4.04
P = 0.21
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2ATPase Copper Transporting Alpha. 3High affinity copper
uptake protein 1. 4Zinc transporter 8. 5Zinc transporter 10. 6Zinc transporter 7. 7Manganese superoxide
dismutase. 8Zinc transporter 7.
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Table 3.7. Abundance of mRNA associated with amino acid metabolization in the longissimus
thoracis of Angus steers 2 and 10 days after receiving different anabolic implant treatments.1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
ARG22
d2
2.35
3.21
1.31
3.08
0.74
P = 0.29
d 10
1.56
3.11
1.91
2.46
0.76
P = 0.47
ODC3
d2
6.00
6.27
5.56
5.64
0.52
P = 0.77
d 10
6.78
5.84
5.74
6.47
0.68
P = 0.66
AMD14
d2
2.19
2.54
2.72
2.14
0.20
P = 0.15
d 10
3.69
3.03
2.99
3.43
0.65
P = 0.83
SMOX5
d2
12.21
13.55
8.75
11.14
2.40
P = 0.56
d 10
12.90
10.11
8.34
10.22
2.02
P = 0.50
SLC3A26
d2
3.34 a
4.93 ab
5.94 b
4.52 ab
0.60
P = 0.02
d 10
3.10
3.99
3.62
4.04
0.39
P = 0.24
SLC1A57
d2
2.87
3.77
3.28
2.51
0.79
P = 0.66
d 10
2.67
5.32
2.44
2.40
1.03
P = 0.14
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2Arginase 2. 3Ornithine Decarboxylase 1.
4
Adenosylmethionine Decarboxylase 1. 5Spermine Oxidase. 6Solute Carrier Family 3 Member 2. 7 Solute
Carrier Family 1 Member 5.
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Table 3.8. Abundance of mRNA related to cellular stress in the longissimus thoracis of Angus
steers 2 and 10 days after receiving anabolic implant treatments. 1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
DJ12
d2
28.28 a
32.66 ab
33.73 b
28.78 a
1.46
P = 0.03
d 10
40.94
33.23
35.67
38.28
2.76
P = 0.21
HSPβ13
d2
1.82
2.03
1.88
1.66
0.21
P = 0.57
d 10
1.16
1.82
1.34
1.63
0.32
P = 0.42
HSPα4
d2
1.91
2.22
2.16
1.99
0.23
P = 0.68
d 10
2.70
2.92
2.81
2.59
0.50
P = 0.95
PRDX65
d2
11.61
11.99
11.96
11.85
0.71
P = 0.98
d 10
13.44
14.21
12.53
12.94
1.01
P = 0.54
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2 Parkinsonism Associated Deglycase. 3 Small Heat Shock
Protein Beta-1. 4Heat Shock Protein alpha. 5 Peroxiredoxin 6.
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Table 3.9. Abundance of mRNA related to inflammation in the longissimus thoracis of Angus
steers 2 and 10 days after receiving anabolic implant treatments. 1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
NF-kB2
d2
1.08
1.09
1.29
0.87
0.12
P = 0.12
d 10
1.25
2.15
1.29
1.32
0.30
P = 0.09
TNFα3
d2
22.14
36.48
57.72
34.33
13.40
P = 0.34
d 10
6.74
9.47
5.27
4.78
2.98
P = 0.59
IL-64
d2
1.28
2.85
4.73
3.05
1.52
P = 0.49
d 10
2.31x
8.93 xy
21.51 y
1.85 x
6.47
P = 0.09
IL-105
d2
1.50
0.91
1.19
1.32
0.61
P = 0.89
d 10
2.91 xy
16.90 y
6.21 xy
0.00 x
6.30
P = 0.06
IL-156
d2
2.96
4.42
3.89
9.02
2.61
P = 0.37
d 10
5.24
6.92
8.79
6.74
2.05
P = 0.61
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2 Nuclear factor kappa B. 3Tumor Necrosis Factor alpha.
4
Interleukin-6. 5Interleukin-10. 6Interleukin-15.
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Table 3.10. Abundance of mRNA associated with lipid uptake and adipogenesis in the
longissimus thoracis of Angus steers 2 and 10 days after receiving anabolic implant treatments.
1

CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
PPARγ2
d2
6.02
3.59
4.70
5.53
1.55
P = 0.69
d 10
5.26
11.80
10.06
6.11
2.29
P = 0.16
FABP43
d2
5.05
1.91
5.16
2.28
1.80
P = 0.46
d 10
4.16
6.46
5.58
2.78
1.69
P = 0.37
SCD4
d2
10.32
7.11
5.88
6.63
2.55
P = 0.61
d 10
11.47
27.77
25.68
15.56
6.01
P = 0. 18
CCAAT/EBP-α5
d2
2.00
1.36
3.06
3.03
1.01
P = 0.57
d 10
5.76
4.55
4.42
2.33
2.49
P = 0.79
CCAAT/EBP-β6
d2
11.74
10.47
12.89
9.91
2.11
P = 0.76
d 10
5.84
8.85
5.35
5.01
1.43
P = 0.26
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2 Peroxisome proliferator-activated receptor gamma. 3 fatty
acid binding protein 4. 4 Stearoyl-CoA desaturase. 5 CCAAT/enhancer-binding-protein-α.
6
CCAAT/enhancer binding protein-β.
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Table 3.11. Abundance of mRNA having miscellaneous relationships to skeletal muscle
growth in the longissimus thoracis of Angus steers 2 and 10 days after receiving anabolic
implant treatments. 1
CON
TBAT
E2T
ETBAT
SEM
P-value
Steers (n)
12
12
11
12
PDE4B2
d2
3.87 a
6.13 b
4.57 ab
4.04 a
0.58
P = 0.04
d 10
4.82
5.07
3.87
3.72
0.29
P = 0.29
TGFB-33
d2
3.99
3.07
4.26
3.09
0.66
P = 0.39
d 10
3.13
4.16
3.75
2.98
0.68
P = 0.58
ELF-3-F 4
d2
9.91
9.49
10.50
9.30
1.21
P = 0.81
d 10
7.70
8.09
7.72
7.33
1.21
P = 0.98
Fibronectin
d2
2.03
3.29
1.46
2.10
0.69
P = 0.20
d 10
5.84
7.23
4.71
5.04
2.11
P = 0.78
1
Implant treatments administered on d 0 include: no implant (CON), Compudose (E2T; 25.7 mg
estradiol; Elanco Animal Health), Finaplix-H (TBAT; 200 mg trenbolone acetate; Merck Animal
Health), and Revalor-S (ETBAT; 120 mg trenbolone acetate + 24 mg estradiol; Merck Animal Health).
Skeletal muscle biopsies were collected on d 2 and 10 post-implanting, and RNA isolation and
quantitative PCR were performed as described in the Materials and Methods. aDifferent letters indicate a
difference (P < 0.05) between implant treatments within each time point. xDifferent letters indicate a
tendency (0.05 < P ≤ 0.10) between different implant treatments within a time point. All data are
presented as the least square means ± SEM. 2 Phosphodiesterase 4B. 3 Transforming Growth Factor Beta
3. 4 E74 Like ETS Transcription Factor 3.
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CHAPTER IV
INTERACTIONS BETWEEN CATTLE BREED TYPE AND ANABOLIC IMPLANT
STRATEGIES IMPACT CICURLATING SERUM METABOLITES, FEEDLOT
PERFORMANCE, FEEDING BEHAVIOR, CARCASS CHARACTERSTICS, AND
ECONOMIC RETURN2

Abstract
Introducing Bos indicus (BI) genetics into a beef herd has the potential to increase
environmental sustainability. When introducing BI genetics, there are concerns regarding
negative impacts on temperament, growth, and carcass characteristics. Implants are
routinely used in the US, with majority of cattle on feed receiving an anabolic implant to
improve growth and efficiency, however research regarding the interaction between cattle
breed type and anabolic implants is limited. This research compared the use of implants
in BI influenced animals versus Bos taurus in a feedlot setting. Twenty steers were
stratified by initial weight in a 2 x 2 factorial design examining two different breeds:
Angus (AN; n=10) or Santa Gertrudis influenced (SG; n=10), and two implant strategies:
no implant (CON; n=10) or a combined implant containing 120 mg TBA and 24 mg E2
(IMP; n=10; Revalor-S, Merck Animal Health). We hypothesized that anabolic implants
would improve growth and feedlot performance of BI influenced animals. Steers were
randomly placed into covered pens equipped with GrowSafe® bunks and fed the same

2

This chapter has been previously published in: Reichhardt C.C., Feuz R., Brady T.J.,
Motsinger L.A., Briggs R.K., Bowman B.R., Garcia M.D., Larsen R., Thornton K.J.
Interactions between cattle breed type and anabolic implant strategy impact circulating
serum metabolites, feedlot performance, feeding behavior, carcass characteristics, and
economic return in beef steers. Domestic animal endocrinology. 2021 Oct 1;77:106633.
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ration for 129 d. Steers were weighed every 28 d. Dry matter intake, feeding behavior,
and carcass data of the steers was collected. Blood was collected and harvested as serum
on d 0, 2, 10, 28 and every 28 d after that, and analyzed for serum urea nitrogen (SUN),
haptoglobin, and 25HydroxyVitamin D. Angus steers tended to gain more (P=0.06)
weight than SG, while IMP tended to gain more (P=0.10) weight than CON with no
breed × treatment interaction observed (P>0.10). A breed × treatment interaction was
observed when analyzing SUN (P=0.05) and haptoglobin (P=0.02) concentrations.
Serum 25HydroxyVitmain D concentrations tended to be increased (P=0.09) in SG-IMP
steers compared to SG-CON steers. Angus steers tended (P=0.10) to have greater
amounts of marbling compared to SG steers, while SG steers had improved (P=0.04)
yield grade. Economic return was decreased by $46 a head when introducing SG
genetics, while implanting steers improved economic return by $46 a head. This research
provides evidence suggesting that BI influenced animals may respond differently to
anabolic implants when compared to BT animals. Economic analyses demonstrate that
anabolic implants improve economic return to beef producers, while introducing SG
genetics decreases economic return in animals raised in more temperate climates.

1. Introduction
Cattle production is faced with challenges related to the changing climate and use
of limited resources, such as water [1]. As such, it is imperative that efficiency of cattle
production is improved to increase sustainability and decrease negative impacts on the
environment. A potential method for improving the sustainability of the US beef industry
is to increase the percentage of Bos Indicus (BI)-influenced animals in the US, as they are
able to withstand higher temperatures [2], while consuming less water [2, 3].
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Additionally, BI influenced cattle are better adapted to nutritional stress [2], can carry a
higher parasite load, are more heat index tolerant, and have increased production
longevity compared to Bos taurus (BT) cattle which tend to be earlier maturing and
possess superior carcass traits [2].
Despite their positive environmental attributes, the US cow herd is currently only
8% BI-influenced [4], and BI type cattle possess several potential drawbacks. First, BIinfluenced animals commonly have a more excitable temperament, which is correlated
with decreased animal performance [5-7]. Additionally, BI-influenced animals tend to
possess less desirable carcass and palatability characteristics compared to the typical BTinfluenced steer [8]. Negative impacts on carcass quality of BI animals can be minimized
by crossing BI cattle with BT cattle [9]. An example of a cross between BI and BT cattle
is the Santa Gertrudis (SG) breed, which is a cross between Brahman (BI; 3/8) and
Shorthorn (BT; 5/8) breeds.
Another important concern regarding the utilization of BI genetics in addition to
BT genetics is growth. Bulls that are by Angus (AN) and Hereford sires grew more
rapidly post-weaning than bulls sired by BI sires [10]. Furthermore, it has been found that
increasing the percentage of BI influence leads to heifers that tend to be lighter as
yearlings [11]. However, when comparing AN BI crosses to straight-bred Brahmans, the
crosses have increased average daily gains and weaning weights [12], as well as AN-SG
crosses having increased growth compared to purebred SG [13].
In the U.S. approximately 90% of all cattle on feed receive at least one anabolic
implant during production [14] to further increase growth and efficiency by 15-20% [15].
This increase in production leads to an increase in economic return to producers and
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increased environmental sustainability [15]. Research has shown that size at time of
implanting can impact response to anabolic implants [16], however very little is known
about whether different breeds of cattle respond differently to anabolic implants.
Therefore, the objective of this research was to determine how BI-influenced steers
respond to anabolic implants and perform in a feedlot setting compared to BT steers. We
hypothesized that anabolic implants would increase growth and feedlot performance of
BI-influenced animals, such that gains would be comparable to BT animals. This
hypothesis was tested through evaluating performance in the feedlot, carcass
characteristics, serum metabolites, and performing an economic analysis.

2. Materials and Methods
2.1. Animals, Experimental Design and Treatments
All live animal procedures and protocols for this experiment were approved by
the Utah State University Institutional Animal Care and Use Committee (IACUC
Protocol #2817).
This experiment utilized a 2 x 2 factorial design and was conducted at the Utah
State University feedlot. Twenty steers, 10 AN sired (362 ± 5.7 kg) and 10 SG sired (365
± 8.5 kg), that had not previously received any growth promotants, were stratified by
weight at the start of the trial. All steers used in the trial were out of commercial Angus
dams. Prior to beginning the trial, each steer received an electronic and visual ear tag.
Steers were assigned to one of two implant treatments: (1) no implant (CON; n=10) or (2)
a combined implant containing 120 mg TBA and 24 mg E2 (IMP; n=10; Revalor S,
Merck Animal Health). Steers were randomly placed into one of four covered pens each
equipped with two GrowSafe bunks. Each pen housed a total of 15 steers. Steers utilized
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in this trial were housed with other steers of similar size from the Utah State University
beef herd. Steers always had free choice access to water. All steers were fed the same
typical ration. Rations were stepped up between 10 and 12% (DM basis) concentrate
every 10 d from a backgrounding ration consisting of 40% (DM basis) concentrate to a
finishing ration consisting of 86% (DM basis) concentrate (Table 4.1) over a 41 d period.
2.2. Feedlot Performance and Sample Collection
Individual as-fed feed intake was calculated by the GrowSafe system. A minimum of
three feed samples per ration were collected and analyzed at a commercial lab
(Cumberland Valley Analytical Services, Waynesboro, PA). Daily feed intake was
converted to dry matter intake (DMI) by utilizing as-fed feed intake and the percent DM
of each ration. Steers were weighed on a certified scale (Tru-Trust GR3000, College
Station, TX) and a certified ultrasound technician measured ribeye fat thickness (REFT)
using a portable ExaGo ultrasound (Universal Imaging, Bedford Hills, NY) on d 0, 28,
56, 84, and 112. Average daily gain (ADG), 12th rib REFT, and weights were recorded.
A 4% shrink was calculated for all weights to account for rumen fill as previously
described [17]. Shrunken body weights were used for ADG and feed efficiency
calculation. Individual ADG was calculated by subtracting the initial BW for the period
from the final BW for the period and dividing by the number of d for that period. Gain to
feed (G:F) for individual steers was calculated by dividing ADG by DMI for each period.
Blood was collected via jugular puncture and harvested as serum on d 0, 2, 10, 28, 56, 84,
112, and 129 using 10.0 mL, 16 x 100 mm BD Vacutainer Serum Blood Collection
Tubes. Blood samples were allowed to coagulate, kept on ice and transported
approximately 12 km to the laboratory. Blood samples were centrifuged at 1,000 x g for
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15 min at 4°C. Supernatants were then collected, aliquoted, and serum samples were
stored at -20°C until further analysis.
2.3. Feeding Behavior Data
All feeding behavior data were analyzed based off of the two main categorical traits
calculated by the GrowSafe bunks; (1) bunk visit (BV), which is the single reading of an
EID tag when entering a bunk, whether feed is consumed or not, and (2) feed bouts (FB),
which is the reading of a single animal EID tag when entering a bunk, and a minimum of
10 g of feed were consumed, and following previously published methodology [18].
Based off BV, the average duration of the BV (DBV), the average amount of feed
consumed per BV (ABVC), and the amount of time an animal spent with its head down
per BV (BVHD) were analyzed. Regarding FB data, the following was also calculated:
the duration of the FB (DFB), the average amount of feed consumed per FB (AFFB), and
the average time an animal’s head was down while it consumed feed during a BV
(HDFB).
2.4. Serum Urea Nitrogen Assay
A commercially available colorimetric assay was used to detect serum urea
nitrogen (SUN) in duplicate (Invitrogen, Urea Nitrogen BUN Colorimetric Detection Kit;
ThermoFisher Scientific). The plate was read on a BioTek all-in-one microplate reader
using Gen5d 2.0 all-in-one microplate reader software (BioTek Instruments, Winooski,
VT). Intra-assay CV: 1.94%. Inter-assay CV: 2.41%.
2.5. Serum 25-HydroxyVitamin D Assay
The concentration of 25-HydroxyVitamin D (25(OH)D; combined 25hydroxyvitamin D2 and 25-hydroxyvitamin D3) were determined in duplicate for d 0, 2,
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10 and 28 using a commercially available ELISA for serum 25(OH)D (MultiSpecies VD3
ELISA; Eagle BioSciences, Nashua, NH) following the manufacturer’s protocol and
previously published methods [19]. The plate was read on a BioTek all-in-one microplate
reader using Gen5d 2.0 all-in-one microplate reader software (BioTek Instruments,).
Intra-assay CV: 4.76%. Inter-assay CV: 2.48%.
2.6. Serum Haptoglobin Assay
Serum haptoglobin concentrations were determined in duplicate for d 0 and d 28
using a commercially available ELISA for bovine serum haptoglobin (Bovine
Haptoglobin ELISA Kit; MyBioSource Inc, San Diego, CA) following manufacturer’s
protocol. The plate was read on a BioTek all-in-one microplate reader using Gen5d 2.0
all-in-one microplate reader software (BioTek Instruments). Intra-assay CV: 4.09%.
Inter-assay CV: 5.53%.
2.7. Carcass Characteristics
Steers were shipped when an average of 7 mm 12th rib fat thickness was
measured via ultrasound. This level of REFT was chosen since BI steers are known to
deposit less fat than BT steers [9] and we didn’t want too much variation in days on feed.
Additionally, this trial occurred in May 2020 during the Covid-19 pandemic, so steers
were shipped early to ensure they could be harvested. The steers were harvested at a
commercial facility (Hyrum, UT). Dressing percentage, hot carcass weight (HCW),
marbling score (100 to 199 = practically devoid, 200 to 299 = traces, 300 to 399 = slight,
400 to 499 = small, 500 to 599 = modest, 600 to 699 = moderate, 700 to 799 = slightly
abundant, 800 to 899 = moderately abundant, and 900 to 999 = abundant), ribeye area
(REA), REFT, and cold camera yield grade were recorded at the plant by trained USDA
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inspectors. Dressing percentage was calculated by dividing HCW by final live weight
with a 4% shrink, and multiplying by 100.
2.8. Economic Analysis
To compare the economic performance of the four treatments (AN-CON, ANIMP, SG-CON, and SG-IMP) within this study, separate budgets were created for each
treatment. The expected net return per head was calculated within each budget and
compared across the four treatments. The budgets are simplified to hold all costs constant
across treatments except for the cost of feed. Thus, the expected net return per head was
calculated as
1)

𝑁𝑅𝑖 = 𝐷𝑃𝑖 (𝐷𝑊𝑖 )/100 − 𝑆𝑃𝑖 (𝐼𝑊)/100 − 𝐹𝐶𝑖

where 𝑁𝑅𝑖 is the net return ($/head) above feed costs of treatment 𝑖, 𝐷𝑃𝑖 is the dressed
price ($/cwt) of treatment 𝑖, 𝐷𝑊𝑖 is the dressed weight (lbs.) of treatment 𝑖, 𝑆𝑃𝑖 is the
stocker price ($/cwt) of treatment 𝑖, 𝐼𝑊 is the initial weight (lbs.), and 𝐹𝐶𝑖 is the feed
cost for treatment 𝑖.
The dressed price used in each treatment is calculated using grid pricing. The grid used
for the analysis was taken from a cattle settlement worksheet for U.S. Premium Beef
[20]. The five-year average of the 5-market average dressed price [21] was used as the
grid base price with premiums and discounts added based on quality grade and yield
grade averages for each treatment. The measured cold camera yield grade was used
within this analysis rather than the USDA yield grade as the continuous nature of the cold
camera yield grade provided a greater insight into yield grade variability as compared to
the discrete nature of USDA yield grading. The grid valued Prime and Choice quality
grade at $14.12 and $11.47/cwt above Select while Standard was discounted $10/cwt.
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Yield grade 1 and 2 were valued at $7 and $4/cwt above yield grade 3 while yield grade 4
and 5 were discounted by $10 and $20/cwt, respectively. The stocker price used for ANCON and AN-IMP was $142.00/cwt (the past five-year average of the Colorado
combined auction prices for feeder steers 700-900lbs, [22]. The stocker price for the SGCON and SG-IMP cattle was discounted $3.50/cwt ($138.50) to coincide with findings in
the literature [23-26] that support discounts of this approximate size for BI influenced
feeder cattle. The initial weight for each treatment was assumed constant at 800 lbs, while
the dressed weight was calculated as the initial weight plus the product of days on feed
(DOF), treatment ADG, and the average treatment dressing percentage. The costs for
individual feed components (alfalfa, haylage, corn, etc.) for each treatment were
estimated by using five-year historical averages for the feed prices ($/lb) multiplied by
the total pounds of intake as measured by the GrowSafe® feed bunks and the
corresponding percentage of the feed components within the feed ration. The assumptions
used in individual treatment budgets are summarized in Table 4.2.
Through calculating the net return per head for each treatment as in equation 1), a direct
comparison between the treatments can be made that properly accounts for expected
differences in revenues and costs as indicated by the data gathered throughout the study.
At the same time, all other costs of production not effected by treatment can be held
constant and assumed equal to zero. This not only simplifies the analysis but also adds
transparency to the results by allowing for ease in identification of key drivers in
differences in economic performance.

2.9. Statistical Analyses
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A 2 x 2 factorial design was utilized for this trial, where steers of two different
breeds (AN or SG) were initially stratified by weight and assigned to one of two
treatments (CON or IMP). Statistical analysis was performed using the MIXED
procedure of SAS (version 9.4; SAS Inst. Inc., Cary, NC). All data are presented as the
least square means ± standard error of the mean (SEM). Weight, feeding behavior, SUN,
and 25(OH)D were analyzed as repeated measures for differences between breed,
treatment, breed × treatment, day, day × breed, day × treatment, and day × treatment ×
breed. Serum haptoglobin, ADG, DMI, G:F and carcass data were analyzed for
differences between breed, treatment and breed x treatment at each time point separately.
Individual steer and pen were included as random variables in all analyses. When
treatment differences were found to be significant (P < 0.05), least square means were
separated using Tukey-Kramer adjustments. When interactions were found to be
significant, the main of effects of that variable were not discussed individually.
Significance was declared at P ≤ 0.05 and tendencies are discussed between 0.05 ≤ P ≥
0.10.

3. Results
3.1. Live Animal Performance
There were no breed × treatment interactions (P > 0.10) found for DMI, G:F, or
ADG (Table 4.3). No differences in DMI were found between steers of different breeds
(P = 0.14) or different anabolic implant treatments (P = 0.29) (Table 4.3). However,
there was a tendency for IMP steers to consume more (P = 0.06) feed from d 84 to d 112
of the trial (Table 4.3). SG steers also consumed less feed from d 56-84 (P = 0.09) and
112-129 (P = 0.09) of the trial (Table 4.3). Gain:Feed was not different (P > 0.10)
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between steers of different breed or those who received different anabolic implant
treatments throughout the duration of the trial or in 28 d intervals (Table 4.3). However,
ADG tended (P = 0.06) to be increased in AN compared to SG (Table 4.3). Anabolic
implant treatment did not affect (P = 0.12) ADG over the duration of the trial (d 0-129),
but IMP steers gained more (P = 0.05) than CON animals d 84-112 of the trial. Total
weight gain over the 129 d trial tended (P = 0.06) to be increased in AN compared to SG
steers, while IMP steers tended (P = 0.10) to gain more than CON steers (Table 4.3).
3.2. Feeding Behavior
When feeding behavior was analyzed as a repeated measure (Figure 4.1), no
effect of breed × treatment (P > 0.10) or treatment (P > 0.10) were found for ABVC,
AFFB, BVHD, or HDFB (data not shown). Breed did effect ABVC (P = 0.07) and AFFB
(P = 0.09) such that AN steers consumed more per BV and FB than SG steers (data not
shown). Angus steers also spent more (P =0.02) time with their heads down per BV and
FB than SG steers (data not shown). A breed × treatment interaction was found (P =
0.0084) for duration of BV, where SG-CON had shorter (P < 0.05) BV than AN-IMP,
AN-CON, or SG-IMP (Figure 4.1A). Similarly, a breed × treatment interaction (P = 0.01)
was also observed for duration of FB, where SG-CON had shorter (P < 0.05) FB than
AN-IMP, AN-CON, or SG-IMP (Figure 4.1B).
3.3. Serum Urea Nitrogen, Serum Haptoglobin, and Serum 25-HydroxyVitaminD
Serum urea nitrogen was measured on 0, 2, 10, 28, and 56 d. A breed × treatment
effect (P = 0.05) and effect of time (P = 0.03) were observed when values were analyzed
as repeated measures (Figure 4.2). Despite there being a breed × treatment interaction (P
= 0.05), there were no differences (P > 0.10) between the four different treatment groups
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analyzed (Figure 2). Further, there were no differences (P < 0.10) in SUN between the
different time points analyzed (Figure 4.2).
Serum haptoglobin was measured on d 0 and d 28 of the trial (Figure 4.3). On d 0
of the trial there was not effect of breed × treatment (P > 0.10), breed (P > 0.10), or
treatment (P > 0.10) (Figure 4.3). A breed × treatment interaction was observed (P =
0.02) on d 28 with AN-CON having lower (P = 0.02) serum haptoglobin concentrations
than SG-CON and SG-IMP on d 28 (Figure 4.3).
Serum 25(OH)D was analyzed on d 0, 2, 10, and 28 with repeated measures. No
effects of treatment x breed x time (P = 0.21), breed x time (P = 0.61), or treatment x
time (P = 0.31) were found (Figure 4.4). A breed × treatment interaction (P < 0.001)
demonstrates that the SG-CON steers had lower (P < 0.05) serum 25(OH)D than ANCON steers (Figure 4.4).
3.4. Carcass Characteristics
No breed × treatment effects (P > 0.10) were found regarding carcass
characteristics. However, breed tended to impact marbling (P = 0.10) and yield grade (P
= 0.04) (Table 4.4). Angus sired steers tended (P = 0.10) to have an improved marbling
score compared to SG sired steers. Additionally, the SG sired steers had improved (P =
0.04) yield grades compared to AN sired steers (Table 4.4). Neither breed nor implant
had an effect (P > 0.10) on dressing percentage, HCW, or REA (Table 4.4).
3.5. Economics
The difference in net return between AN-IMP and AN-CON was $19.96/hd,
while the same difference with SG sired steers was found to be $72.14/hd (Table 4.5).
The average of both differences ($19.96 and $72.14) is $46.05, representing the increase

156
in net return attributable to using an anabolic implant across both breed types (Table 5).
The difference between net return of SG-IMP and AN-IMP was -$19.73, while the
difference between SG-CON and AN-CON was -$71.90 (Table 4.5).

4. Discussion
It is imperative that efficiency of cattle production is improved in order to
increase sustainability and decrease negative impacts on the environment. A potential
method for improving the sustainability of the US beef industry is to increase the
percentage BI-influenced animals in the US, as they are able to withstand higher
temperatures [2], while consuming less water [2, 3]. However, despite their positive
attributes, there is concern when using BI genetics related to temperament, which is
correlated with animal performance [5-7], growth [10], and carcass characteristics [8].
One method for improving these characteristics is through crossing BI genetics with BT
genetics [9] [13].
A method to augment growth further is through the use of anabolic implants [15].
Roughly 90% of cattle on feed in the US receive at least one anabolic implant during
production [14], which results in a 15-20% increase in growth and efficiency of cattle
[15]. The research presented here examines how BI-influenced steers respond to anabolic
implants and perform in a feedlot setting compared to BT steers to help further
understand how to increase the overall environmental and economic sustainability of the
beef industry. The BI-influenced steers utilized in this study were approximately 19%
Brahman.
A number of studies have reported the positive attributes of anabolic implants
relative to performance of beef animals in the feedlot [15, 27-29]. The present study

157
found that IMP steers had numerically increased DMI (5%), ADG (9%) and G:F (4%)
compared to CON steers. However, when analyzed over the whole 129 d period, none of
these values were statistically different. This is likely due to the relatively small number
of animals utilized in the present study and that only one milder implant was
administered. In Duckett and Pratt’s 2014 review of anabolic implants, it was found that
implants increase DMI and feed efficiency by approximately 6%, and ADG by 18% [15].
Research published since then has found that various implants and implant protocols can
increase DMI anywhere from 5% to 12%, and G:F ratios range from 9% to 14% [30].
However, it is important to note that the percentage increases in the present study are
similar to those that were previously reported.
The present study also found that SG sired steers consistently consumed 7% less
feed than AN sired steers regardless of if they were implanted or not, however this data
was not significantly different. Further, the present study did not find a difference in G:F
between CON and IMP steers. There was also a breed tendency with AN sired steers
tending to have a 12% increase in ADG compared to SG steers. In a study comparing
Brahman and Herefords, Brahman cattle consumed approximately 12% less feed, but no
effects on G:F were observed [31]. In a recent study examining Holstein steers and
implants, it was reported that implanting did not improve G:F [32]. Interestingly, in the
present study, when individual breeds were compared between implant treatments,
implants numerically, but not statistically, increased overall gain by 7% in AN, and by
13% in SG. A possible explanation for this difference in response to implants is that the
SG steers are 13/16 BT and 3/16 BI, with research demonstrating that ¾ BT and ¼ BI
cross-bred animals have a different fiber type ratio, possessing more type IIa fibers and
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less type IIx fibers [8]. Type IIa fibers are known to have more satellite cells [33], which
are essentially muscle precursor cells [34] and are required to support muscle
hypertrophy. When bovine satellite cell cultures are treated with TBA and/or E2 in vitro,
proliferation rates are shown to increase [35-37]. When satellite cell numbers are
increased, there is an increased capacity for muscle growth [38]. Due to this, it would be
beneficial for future research to investigate the relationship between breed type and
skeletal muscle growth in response to anabolic implants.
Anabolic implants are known to improve feed efficiency, which was
demonstrated through this research and previous research [15, 28, 30]. Research has
demonstrated that feed efficiency of cattle and feeding behavior are intimately linked [18,
39, 40]. Despite feed efficiency not being altered in the current study, anabolic implants
and breed altered feeding behavior of beef steers. It was found that AN-CON steers
tended to have longer FB and longer BV than SG-CON steers. In an earlier completed
study, it was observed that there was an association with duration of bunk visits and
duration feed bouts and ADG in Red Angus heifers [18]. This could explain why ANCON had longer DBV and longer DFB than SG-CON, as AN sired steers had improved
ADG compared to SG sired steers numerically, but not statistically. Additionally, this
research observed that implants mainly altered feeding behavior of the SG sired steers but
did not alter feeding behavior of AN sired steers. Research has demonstrated that animals
with improved feed efficiency have less BV, and fewer FB than their less feed efficient
counterparts [39, 40]. This research found that implants increased the duration of FB and
BV and the amount of time animals spent with their heads down. Research is beginning
to emerge that highlights the relationship between temperament and feeding behavior as

159
well. Calm heifers have longer and larger FB than excitable heifers [41]. Additionally,
the research presented here found that AN steers spent more time per BV and FB and
with their head down then SG. Although our research did not measure animal
temperament, it has been observed that BI genetics can be more excitable than BT
genetics [5].
Serum urea nitrogen is a marker of lean tissue anabolism, as it increases nitrogen
retention [29]. The present study found that breed x treatment affected BUN such that an
IMP in SG steers decreased SUN, but SUN in AN remained similar regardless of IMP
treatment. No previous research has examined the effects of breed x treatment on SUN
levels. As such, we will discuss previous research that has analyzed SUN levels between
breeds and administration of anabolic implants. Previous research conducted using a
combined TBA/E2 implant did not find a difference in serum urea nitrogen until d 213
[30], which could explain why an IMP treatment response was not observed from d 0 to
56. Furthermore, steroid hormone concentrations differed between the two studies. When
nitrogen retention is compared between Hereford and Brahmans, Brahmans had greater
nitrogen retention than Herefords [42]. This increase in nitrogen retention in BI cattle
could explain the breed × treatment effect that was observed in this study. Additionally,
as SUN is a marker of lean tissue anabolism, BI steers may have a greater potential for
skeletal muscle growth to occur when they are implanted.
Bos indicus-influenced animals have been shown to have more excitable
temperaments [5]. Animals with more excitable temperaments have increased levels of
cortisol [43], with increased cortisol being associated with decreased growth and animal
performance [5-7]. Haptoglobin is an acute phase protein that can be used as a marker of
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cortisol and stress [7, 44]. A breed × treatment interaction was observed with AN-CON
steers having lower serum haptoglobin levels than SG-CON steers on d 28 of the present
study. Haptoglobin can be used as a marker for cortisol [7], with research consistently
demonstrating that when steers are implanted, they have a decreased concentrations of
circulating cortisol [45-47]. Decreases in circulating cortisol have been suggested to aid
in protein accretion by decreasing protein catabolism [47], with steers that receive
anabolic implants having increased protein accretion [45], although in this study changes
in SUN were not observed between treatments.
There is a growing body of evidence that an adequate vitamin D status is required
for adult skeletal muscle maintenance and growth [48]. Vitamin D can be acquired from
sunlight and the diet [49]. The steers used in this study were housed and fed from covered
pens and bunks. When cattle are fed diets inadequate in vitamin D, vitamin D is released
from the liver to sustain the serum 25(OH)D concentrations to allow for normal function
to continue [50]. In the current study, a breed × treatment interaction was observed in
regards to circulating concentrations of 25(OH)D such that SG-CON had lower 15(OH)D
than AN-CON and SG-IMP. Similar to the results observed with SUN, this data
demonstrates that the metabolism and growth of these two breeds is different. One
possible explanation is that for skeletal muscle growth to be maintained, steers needed to
increase circulating 25(OH)D. Another possible explanation is that steers that receive
anabolic implants have increased insulin like growth factor -1 (IGF-1) 27 d after being
implanted [51], as well as insulin like binding protein 3 (IGF-BP3) [52, 53]. Insulin like
growth factor-1 increases the concentration of 25(OH)D by stimulating the hydroxylation
of 25-(OH) D3 [54], as well as 25(OH)D promoting the action of IGF-I by increasing the
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amount of IGF-I receptors [54, 55]. Additionally, increasing vitamin D supplementation
in proliferating cancer cells enhances IGF-BP3 expression [56]. Insulin like binding
protein 3 increases the cellular responsiveness to IGF-1 through increased receptor
reactivity to IGF-1 [53]. Future work is needed to investigate potential relationships
between vitamin D, IGF-1, cattle breed type and anabolic implants to increase skeletal
muscle growth, as well as optimizing the proper vitamin D3 requirements for implanted
steers of varying breeds.
In the U.S., producers are typically paid on the grid system, therefore yield grade
and quality grade are of the utmost importance [26]. One of the main concerns when
producers use implants is the possible negative effects on quality grade, primarily
marbling [57, 58]. In the research presented here, it was found that breed or treatment did
not impact dressing percentage, HCW, or REA, with implants also not having an impact
on yield grade, marbling score or REA. The findings related to carcass data presented
here suggest that a mild anabolic implant may not have negative effects on quality grade,
however due to the small sample size of the study more research is needed to be
conducted.
Additionally, it has been shown that BI-influenced animals possess less desirable
carcass and palatability characteristics compared to BT influenced animals [8]. In the
current study, AN sired steers tended to have greater marbling compared to SG sired
steers, which is consistent with the literature [59], while SG sired steers had improved
yield grades. This is possibly due to the less fat that is associated with BI influenced
animals [60] even though this was not observed in this study, as there is an association
with degree of marbling and yield grade [60]. The steers in this study were harvested
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earlier than industry standards due to the Covid-19 pandemic. Taking the steers to an
endpoint with greater 12th rib fat thickness more typical of the industry standard may
have a greater impact on yield grade, marbling, and days on feed.
Depending on cattle prices, the economic return of implants can vary from $15$163 per head [15, 61]. In the current study, anabolic implants increased economic return
by $46 per head regardless of breed, while introducing SG genetics decreased economic
return by $45.82 per head when compared to AN sired animals, which is intriguing as the
percentage of BI influenced steers currently being marketed is declining compared to BT
steers [62]. When anabolic implants were utilized in SG influenced steers however, profit
increased by $72.14 per head compared to SG-CON. Therefore, future work is needed to
optimize production of BI-influenced animals to help increase the environmental and
economic sustainability of the beef industry. A potential limitation of this study is the
small sample size utilized, however to the best of the authors’ knowledge this is one of
the first studies investigating cattle type and anabolic implant response.

5. Conclusion
The breed × treatment interactions that were observed in this study provide very
interesting preliminary evidence that cattle breed type and anabolic implants interact with
each other to cause differences in production. Future work is needed to optimize different
implant protocols for different breeds and types of cattle. On average, a mild anabolic
implant increased return to producers by $46 a head, while using BI genetics decreased
economic return to feedlot producers by $46 a head. These results indicate that producers
that wish to utilize BI genetics, can increase economic return and improve performance
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by implanting their cattle, while using BI genetics can help improve yield grade if the
producers are paid on a grid-based system.
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Table 4.1. Composition and
nutritional
analysis of finishing rationa.
Ration, (%)
Feed (% DM)
Haylage
15.4
High Moisture Corn 40.0
Cracked Barley
35.6
Alfalfa
7.7
Feedlot Mineral
1.5
Analysis (DM)
Moisture
22.0
Crude Protein
13.0
ADF
14.0
NDF
21.6
Net Energy(m)1
0.89
1
Net Energy(g)
0.60
Minerals
Calcium (% DM)
0.68
Phosphorus (%DM) 0.34
Manganese (ppm)
126
Zinc (ppm)
137
Copper (ppm)
31.0
1
Net Energy is presented as Mcal/lb
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Table 4.2. Budget Assumptions by Treatment1
Assumption
AN-IMP
SG-IMP
AN-CON
SG-CON
Feeder Price ($/kg)
$3.13
$3.05
$3.13
$3.05
Starting Weight (kg)
363
363
363
363
Days on Feed
126
126
126
126
Dressing Percentage, %
60.2
59.7
59.9
59.8
Average Daily Gain (kg/day)
1.82
1.66
1.69
1.46
Ending Weight (kg)
592
572
576
547
CWT produced
5.05
4.61
4.69
4.07
Total Intake (kg as fed)
2086
2011
2048
1854
2
Yield Grade
3.2
2.68
3.12
2.72
3
Quality Grade
2.2
2.4
2
2.8
Aver. Total Revenue ($/head)
$1,555
$1,497
$1,530
$1,403
Fed Dressed Price ($/kg)
$4.37
$4.39
$4.43
$4.28
1
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa
Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and
Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol).
2
Yield Grade averages reported within this table are from cold camera measurements
3
Quality Grade ranked 1-4 with prime=1, choice=2, select=3, and standard=4
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Table 4.3. Dry Matter Intake, Feed Efficiency, and Average Daily Gain
Implant and Breed Treatments1
AN-IMP
SG-IMP
AN-CON SG-CON
Steers (n)
5
5
5
5
Dry Matter Intake (kg)
Day 0 – 28
9.98
9.94
9.78
9.84
Day 28 - 56
11.8
11.32
11.5
10.92
Day 56 – 84
12.38
11.7
12.32
10.48
Day 84 – 112
13.3
13.1
12.9
10.98
Day 112 – 129
12.44
10.96
12.46
10.24
Day 0 – 129
11.98
11.52
11.76
10.54
Gain to Feed
Day 0 – 28
0.14
0.16
0.13
0.12
Day 28 - 56
0.14
0.09
0.11
0.11
Day 56 – 84
0.17
0.19
0.21
0.19
Day 84 – 112
0.13
0.13
0.08
0.11
Day 112 – 129
0.17
0.18
0.18
0.15
Day 0 – 129
0.15
0.14
0.14
0.14
Average Daily Gain (kg)
Day 0 – 28
1.24
1.46
1.20
1.13
Day 28 – 56
1.62
1.14
1.34
1.32
Day 56 – 84
2.20
2.20
2.65
2.00
Day 84 – 112
1.68
1.73
1.09
1.20
Day 112 –129
2.23
2.29
2.33
1.65
Day 0 – 129
1.73x
1.59xy
1.62xy
1.41y
Total Gain (kg)
225.3x
205.4xy
209.2xy
181.6y
1

SEM

P-Values2
Breed
Trt

BxT

0.25
0.43
0.50
0.43
0.67
0.38

0.98
0.36
0.09
0.11
0.07
0.14

0.71
0.54
0.38
0.06
0.74
0.29

0.90
0.91
0.42
0.18
0.67
0.50

0.01
0.02
0.02
0.02
0.04
0.003

0.84
0.32
0.84
0.41
0.28
0.18

0.24
0.85
0.41
0.15
0.40
0.12

0.34
0.35
0.41
0.49
0.50
0.77

0.18
0.25
0.30
0.21
0.30
0.08
16.4

0.68
0.31
0.30
0.76
0.25
0.06
0.06

0.33
0.83
0.67
0.05
0.34
0.12
0.10

0.47
0.31
0.30
0.89
0.17
0.73
0.74

Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa Gertrudis (SG-CON), Revalor-S + Angus (ANIMP; 120 mg trenbolone acetate + 24 mg estradiol) and Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol). 2Pvalues indicate the effect of Breed, Treatment (TRT), or B x T (Breed x Treatment). aValues within a row with different letters are different (P < 0.05)
from one another. xDifferent letters tend (0.05 ≤ P ≥ 0.10) to be different from one another.
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Table 4.4. Carcass Data

Steers (n)

AN-IMP
5

Implant and Breed Treatments1
SG-IMP
AN-CON SG-CON
5
5
5

SEM

P-Values2
Breed
Trt
BxT

0.58
0.61
0.96
0.73
Dressing Percentage
60.1
59.6
59.9
59.8
10.5
0.21
0.37
0.83
Hot Carcass Weight (kg)
342.92
331.39
335.48
319.33
53.9
0.10
0.29
0.61
Marbling Score
439.17
382.38
517.52
410.72
2
3.55
0.41
0.79
0.52
Ribeye Area (cm )
72.13
77.10
73.41
74.06
0.36
0.27
0.59
0.59
Ribeye Fat Thickness (mm)
7.87
7.29
7.87
7.67
0.20
0.04
0.93
0.76
Cold Camera Yield Grade
3.20
2.67
3.12
2.72
1
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa Gertrudis (SG-CON),
Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and Revalor-S + Santa Gertrudis (SG-IMP;
120 mg trenbolone acetate + 24 mg estradiol). 2P-values indicate the effect of Breed, Treatment (TRT), or B x T (Breed x
Treatment).aValues within a row with different letters are different (P < 0.05) from one another. xDifferent letters tend (0.05
≤ P ≥ 0.10) to be different from one another.
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Table 4.5. Gross Return, Feed Costs, and Profit by Treatment3
AN-IMP
SG-IMP
AN-CON
SG-CON
1
Gross Return
$419.27
$389.04
$393.97
$295.38
Costs
Haylage
$37.51
$36.46
$36.88
$34.30
Silage
$0.85
$0.84
$0.83
$0.84
Alfalfa
$40.79
$39.64
$39.99
$37.33
Corn
$99.40
$95.24
$97.48
$86.71
Barley
$89.79
$86.04
$88.04
$78.34
Mineral
$10.74
$10.35
$10.54
$9.55
Total Feed Costs
$279.09
$268.58
$273.74
$247.06
2
Net Return
$140.19
$120.46
$120.23
$48.32
1
Gross Return is the difference between sales revenue and the cost of the feeder steer
2
Net Return is the difference between Gross Return and Total Feed Costs
3
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no
implant + Santa Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg
trenbolone acetate + 24 mg estradiol) and Revalor-S + Santa Gertrudis (SG-IMP;
120 mg trenbolone acetate + 24 mg estradiol).
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Figure 4.1. Feeding behavior was analyzed over time examining the duration of bunk visits
(A) and feed bouts (B) as described in the Materials and Methods. Steers were stratified by
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weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of two
treatments: (1) Control, no implant (CON), or (2) implanted with 120 mg trenbolone
acetate and 24 mg estradiol (IMP). Data represent time (s) spent per feed bout and bunk
visit, and are presented as LS mean ± SE.M
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Figure 4.2. Serum urea nitrogen concentrations (ng/dL) were determined on d 0, 2, 10, 28,
and 56 using a commercially available kit (Invitrogen, Urea Nitrogen BUN Colorimetric
Detection Kit; ThermoFisher Scientific) as described in the Materials and Methods. Steers
were stratified by weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned
to one of two treatments: (1) Control, no implant (CON), or (2) implanted with 120 mg
trenbolone acetate and 24 mg estradiol (IMP). Data represent SUN concentrations (ng/dL)
and are presented as LS mean ± SEM.
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Figure 4.3. Serum haptoglobin concentrations (ng/mL) were determined on d 0 and 28
using a commercially available kit (Bovine Haptoglobin ELISA Kit; MyBioScience Inc,
San Diego, CA) as described in the Materials and Methods. Steers were initially stratified
by weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of two
treatments: (1) Control, no implant (CON), or (2) implanted with 120 mg trenbolone
acetate and 24 mg estradiol (IMP). Bars with different letter designations are significantly
different from each other (P < 0.05) within each time point. Day 0 and 28 data are presented
as LS mean ± SEM.
.
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Figure 4.4. 25-HydroxyVitamin D (25(OH)D concentrations were determined on days 0,
2, 10, and 28 using a commercially available kit (MultiSpecies VD3 ELISA; Eagle
BioSciences, Nashua NH) as described in the Materials and Methods. Steers were stratified
by weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of two
treatments: (1) Control, no implant (CON), or (2) implanted with 120 mg trenbolone
acetate and 24 mg estradiol (IMP). Data represent 25-HydroxyVitamin D (25(OH)D
concentrations and are presented as LS mean ± SEM.
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CHAPTER V
CATTLE BREED TYPE AND ANABOLIC IMPLANTS IMPACT CALPASTATIN
EXPRESSION AND ABUNDANCE OF mRNA ASSOCIATED WITH PROTEIN
TURNOVER IN THE LONGISSIMUS THORACIS OF FEEDLOT STEERS3

Lay Summary
Two methods that the beef cattle industry can use to potentially improve
efficiency, sustainability, and economic viability are growth promotants and
crossbreeding cattle of different breed types. In the U.S. over 90% of cattle receive at
least one anabolic implant during the production cycle resulting in improvements in
production and overall economic and environmental sustainability. Research suggests
that the two main cattle breed types, Bos indicus and Bos taurus, respond differently to
different anabolic implant strategies. The objective of this study was to characterize
changes that occur in the skeletal muscle following implanting in Bos indicus influenced
animals and Bos taurus animals. This research measured mRNA abundance of 24 genes
associated with skeletal muscle growth, and protein expression of calpain-1 and
calpastatin. The findings of this research suggest that anabolic implants and cattle breed
type interact to cause changes in mRNA abundance in the longissimus thoracis that are
related to protein turnover of skeletal muscle. Furthermore, calpastatin protein abundance
was also altered by this breed×treatment interaction. This research demonstrates that

3

This chapter is published in: Reichhardt C.C., Stafford, C.D., Cuthbert, J.M., Dang,
D.S., Motsinger L.A., Taylor, M.J., Briggs R.K., Brady, T.J., Thomas, A.J., Garcia,
M.D., Matarneh, S.K., Thornton K.J. Cattle breed type and anabolic implants impact
calpastatin expression and abundance of mRNA associated with protein turnover in the
longissimus thoracis of feedlot steers. Journal of Animal Science. 2022.
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anabolic implants cause molecular changes in skeletal muscle of feedlot steers, with some
of these changes being breed dependent.

Abstract
Two methods that the beef cattle industry can use to improve efficiency,
sustainability, and economic viability are growth promotants and crossbreeding cattle of
different breed types. In the U.S. over 90% of cattle receive an anabolic implant at some
point during production resulting in an overall increase in skeletal muscle growth. Recent
research suggests that the two main cattle breed types, Bos indicus and Bos taurus,
respond differently to anabolic implants. The objective of this study was to characterize
changes that occur in skeletal muscle following implanting in Bos indicus influenced
steers or Bos taurus steers. Twenty steers were stratified by initial weight in a 2×2
factorial design examining two different breeds: Angus (AN; n=10) or Santa Gertrudis
influenced (SG; n=10), and two implant strategies: no implant (CON; n=10) or a
combined implant containing 120 mg TBA and 24 mg E2 (IMP; n=10; Revalor-S, Merck
Animal Health). Skeletal muscle biopsies were taken from the longissimus thoracis (LT)
two and ten d post-implantation. The mRNA abundance of 24 genes associated with
skeletal muscle growth were examined, as well as the protein expression of µ-calpain and
calpastatin. Succinate dehydrogenase mRNA abundance was impacted (P = 0.05) by a
breed×treatment interaction two d post-implanting, with SG-CON having a greater
increased abundance than all other steers. A tendency for a breed×treatment interaction
was observed for calpain-6 mRNA (P = 0.07), with SG-CON having greater abundance
than AN-CON and SG-IMP. Additionally, calpastatin protein expression was altered (P
= 0.01) by a breed×treatment interaction, with SG-CON and SG-IMP steers having
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increased expression (P = 0.01) compared to AN-CON steers. At two d post-implanting,
a breed×treatment interaction was observed with SG-CON steers having greater (P =
0.05) mRNA abundance of mitogen activated protein kinase compared to AN-CON
steers. Furthermore, breed affected (P = 0.05) calpastatin abundance with AN steers
having increased (P = 0.05) abundance two d post-implanting compared to SG steers.
Meanwhile, implants tended to affect (P = 0.09) muscle RING finger protein-1 mRNA
abundance, with CON steers having increased (P = 0.09) abundance compared to that of
IMP steers. These findings suggest that cattle breed type and anabolic implants impact
calpastatin expression and mRNA abundance associated with protein turnover in the LT
of feedlot steers two and ten d post-implantation.

187
Introduction
The cattle industry can take advantage of both heterosis gained through
crossbreeding and the use of growth promotants to help further improve environmental
and economic sustainability of the beef industry (Capper and Hayes, 2012). The two
main cattle breed types, Bos indicus and Bos taurus are physiologically different from
one another (Frisch, 1987; Marshall, 1994). Bos indicus cattle tend to be better adapted to
higher temperatures, nutritional stress (Forbes et al., 1998), and are more disease resistant
than Bos taurus (Glass et al., 2005), while consuming less water (Winchester and Morris,
1956; Forbes et al., 1998). However, in the U.S., taurine breeds, including the Angus
(AN) and Hereford breeds, are typically favored by producers as they are known to have
improved carcass characteristics and temperaments (Cooke, 2014). When utilizing Bos
indicus genetics, producers have concerns related to growth, carcass characteristics, and
animal temperament (Cooke, 2014; Wright et al., 2018). However, these negative traits
can be minimized by crossbreeding Bos taurus with Bos indicus cattle (Elzo et al., 2016).
The Santa Gertrudis (SG) breed is one example of these crosses, being a composite breed
composed of 5/8 Shorthorn (a Bos taurus breed) and 3/8 Brahman (a Bos indicus breed)
(Ferraz et al., 2000).
In the United States over 90% of cattle on feed receive an anabolic implant at
some point during the production cycle (APHIS, 2013). Anabolic implants are used to
increase growth and efficiency of beef cattle, where on average, anabolic implants
improve average daily gain by 18%, feed efficiency by 6%, and feed intake by 6%
(Duckett and Pratt, 2014). Anabolic implants are typically composed of the steroid
hormone estradiol (E2), and the synthetic testosterone analogue trenbolone acetate (TBA)
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(Smith and Johnson, 2020). However, the physiological and molecular mechanisms that
anabolic implants operate through to improve skeletal muscle growth have yet to be
determined (Reichhardt et al., 2021b).
Recent research has demonstrated that anabolic implants and cattle breed type
interact, suggesting that there is a need to identify optimal anabolic implant protocols for
different cattle breed types (Reichhardt et al., 2021a; Rivero et al., 2021). However, the
extent of these interactions have yet to be fully characterized. In the present study, we
hypothesized that due to the innate physiological differences between the two cattle breed
types, anabolic implants would elicit changes in skeletal muscle of feedlot steers in a
breed dependent manner resulting in increased growth. The objective of this trial was to
identify changes that occur in mRNA abundance and protein expression of the
longissimus thoracis (LT) of feedlot steers sired by two different beef breeds two and ten
d post-implantation to better understand the interactions that occur between cattle breed
type and anabolic implants.

Materials and Methods
Animal Management
All live animal procedures and protocols for this experiment were approved by
the Utah State University Institutional Animal Care and Use Committee (IACUC
Protocol #2817). The animals used in this research were part of a previously published
trial (Reichhardt et al., 2021a). Treatments and feedlot performance parameters of this
trial have been previously published (Reichhardt et al., 2021a). Briefly, this trial was
conducted at the Utah State University feedlot and used a 2×2 factorial design. Twenty
steers, 10 AN sired (362 ± 5.7 kg) and 10 SG sired (365 ± 8.5 kg), that had not previously
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received any growth promotants, were initially stratified by weight. All steers used in the
trial were out of commercial Angus dams, and three unrelated sires of each breed type..
Prior to beginning the trial, each steer received an electronic and visual ear tag. Steers
were assigned to one of two implant treatments: (1) no implant (CON; n=10) or (2) a
combined implant containing 120 mg TBA and 24 mg E2 (IMP; n=10; Revalor S, Merck
Animal Health). Steers were randomly placed into one of four covered pens each
equipped with two GrowSafe bunks. Each pen housed a total of 15 steers. Steers utilized
in this trial were housed with other steers of similar size from the Utah State University
beef herd. Steers always had free choice access to water. All steers were fed the same
typical feedlot ration. Rations were stepped up between 10 and 12% (DM basis)
concentrate every ten d from a backgrounding ration consisting of 40% (DM basis)
concentrate to a finishing ration consisting of 86% (DM basis) concentrate (Supplemental
Table 1) over a 41-d period.
Sample Collection and Processing
Skeletal muscle samples were collected from the LT on d two and ten postimplanting by clinical veterinarians at Utah State University using previously published
methods (Thornton et al., 2012). In brief, a 30 × 30 cm square area was shaved and
prepped following standard procedures. The area was injected with 20 mL of 2%
lidocaine hydrochloride in an inverted L pattern. A 10 cm oblique skin incision was made
in the longissimus thoracis muscle. Samples were taken on the same side of the animal.
The d two samples were taken above the 11th rib, and the d ten samples were taken from
above the 13th rib. A Wheatlander retractor was used to open the incision and a 2 × 2 × 2
cm muscle biopsy was obtained using a Metzenbaum scissor. The incision in the muscle
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was closed using 0 chromic gut suture in an interrupted cruciate pattern. The incision was
closed using 0 braunamid suture in a continuous ford interlocking suture pattern. The
wound was then sprayed with an antiseptic spray. Skeletal muscle biopsy samples were
then flash frozen in liquid nitrogen and stored at ̶ 80°C for subsequent analyses.
Isolation of RNA, Quantification, and cDNA Synthesis
Flash frozen skeletal muscle samples were ground under liquid nitrogen using
mortar and pestle. Isolation of RNA was performed using TriZol (Invitrogen, Carlsbad,
CA, USA) as per the manufacturer’s protocol and as previously described (Gardner et al.,
2021). Isolated RNA was quantified using a Take3 plate on a BioTek all-in-one
microplate reader with Gen5 2.0 software (BioTek Instruments, Winooski, VT, USA).
All RNA samples were treated with deoxyribonuclease (Ambion, Foster City, CA, USA)
before beginning cDNA synthesis using a high-capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA, USA) following the manufacturer’s protocol.
Fluidigm Reverse Transcription qPCR
The 48.48 Dynamic Array Integrated Fluidic Circuit (Fluidigm, San Francisco,
CA, USA) was utilized for quantitative gene expression as previously described
(Suasnavas et al., 2015). A total of 24 genes were targeted for analysis and examined on a
single chip (Supplemental Table 2). Primer sets were designed and validated by
Fluidigm. In brief, following the Fluidigm protocol, a specific target amplification (STA)
was performed to enrich each sample for target-specific cDNA prior to quantitative PCR.
For STA thermal cycling, each reaction consisted of 1.25 µl of primer mix, 2.5 µl of the
Taqman PreAmp Master Mix (Applied Biosystems, Foster City, CA, USA), and 1.25 µl
of cDNA. Enzyme activation took place at 95°C for 10 min and then the amplification
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was done for 10 cycles (95°C for 15 s then 60°C for 4 min). The Fluidigm IFC chip was
then run on the Biomark thermocycler/detection module. Genes were normalized to the
housekeeping gene eukaryotic translation elongation factor 1 alpha 2 (EEF1A2) using the
per sample ∆Ct method. Eukaryotic translation elongation factor 1 alpha 2 mRNA
abundance was checked, and neither breed, treatment, nor their interaction impacted (P >
0.10) mRNA abundance of EEF1A2. Furthermore, EEF1A2 has been previously
published and used as a housekeeping gene when evaluating beef cattle skeletal muscle
(Wellmann et al., 2021). Abundance of mRNA was determined by analyzing the relative
expression of each sample calculated as 2-relative threshold cycle (ΔCt).
Protein Extraction
For the analysis of calpastatin and calpain-1 abundance, frozen biopsy samples
collected at two- and ten-day post-treatment were homogenized at 100 mg/ml with a
solubilization buffer composed of 2 M thiourea, 50 mM Tris-HCl, 3% (w/v) SDS, 8 M
urea, and 75 mM dithiothreitol (pH 6.8) (Warren et al., 2003). Samples were subjected to
a bead-beating homogenizer and heated at 60 °C for 10 min. Then, samples were
centrifuged at 10,000 ×g for 10 min at room temperature. Resulting supernatants were
transferred to new tubes and utilized for protein concentration determination using the
RC DC protein assay kit (BioRad Laboratories, Hercules, CA, USA). Following protein
determination, samples were diluted to the same protein concentration by the
solubilization buffer with 0.05% (w/v) bromophenol blue added. All samples were stored
at −80 °C until loaded in gels.
SDS-PAGE and Immunoblotting
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Calpastatin and calpain-1 abundance were determined with SDS-PAGE followed
by immunoblotting as previously described (Dang et al., 2020). Samples were thawed at
room temperature and heated at 60 °C for 10 min in a dry heating block. Self-casted 8%
polyacrylamide gels (26.7% [v/v] 30% acrylamide/0.8% bisacrylamide, 0.37 M Tris,
pH 8.8, 0.1% [w/v] SDS, 0.13% [w/v] ammonium persulfate, and 0.07% [v/v] TEMED)
were used for the separation of calpastatin and calpain-1. Four samples from each breed
at the same time point were included on one gel along with a reference sample and a
protein standard. Separated proteins were transferred to nitrocellulose membranes and
reversibly stained with Ponceau S. UVP Chemstudio Imaging System and software
(Analytik Jena, Upland, CA, USA) was used to image and quantify total protein within
each lane. Membranes were destained and subsequently blocked with 1.5% (w/v) casein
in PBS-T (phosphate-buffered saline and 0.1% [v/v] tween-20) for 1 h at 25°C. All
membranes were immunoblotted with primary antibodies at 4 °C overnight. Primary
antibodies were diluted with PBS-T at specified ratios. Calpastatin primary antibody was
diluted at 1:1000 (MA3-944, Thermo Scientific, Rockford, IL, USA), while calpain-1
was diluted at 1:2000 (MA3–940, Thermo Scientific, Rockford, IL, USA). Membranes
were washed 3 times (each for 5 min) with PBS-T and incubated with fluorescent
secondary antibodies (CF680, Biotium Inc., Fremont, CA, USA) for 1 h at room
temperature. Final imaging took place using the same imaging system and software
mentioned above. Band intensities were quantified and normalized to the intensity of the
total protein within each lane.
Statistical Analysis
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Statistical analysis for all data was performed using the MIXED procedure of
SAS (version 9.4; SAS Inst. Inc., Cary, NC, USA) with implant, breed, and their
interaction as fixed effects, and animal and pen as a random effect in the model. All data
are presented as the least square mean ± SEM. When treatment differences were found to
be significant (P ≤ 0.05), least square means (LS means) were separated using TukeyKramer adjustments. Significance was determined at P ≤ 0.05 and tendencies were
declared at 0.05 < P ≤ 0.10.

Results
The mRNA abundance of 24 genes analyzed in the present study were split into
four groups. The groups include abundance of mRNA associated with skeletal muscle
differentiation, protein turnover, skeletal muscle metabolism, and receptors that are
associated with growth. Protein expression was examined for two proteins, calpain-1 and
calpastatin.
Abundance of mRNA Associated with Skeletal Muscle Differentiation
Abundance of four different genes relative to skeletal muscle differentiation were
investigated two and ten d post-implanting (Table 5.1). No breed×treatment interactions
(P > 0.10) were observed for any of the genes investigated at either time point (Table
5.1). Two d post-implanting, there was no difference (P > 0.10) in mRNA abundance of
any of the genes relative to breed or implant (Table 5.1). However, two d post-implanting
SG steers had a greater (P = 0.05) Paired box transcription factor 7 : Myoblast
differentiation factor 1 (PAX7:MYOD) ratio compared to AN steers. Furthermore, ten d
post-implanting, it was found that CON steers had greater (P = 0.05) abundance of
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myogenic regulatory factor 5 (MYF5) than IMP steers. None of the other genes
investigated on d ten were affected (P > 0.10) by breed or treatment (Table 5.1).
Abundance of mRNA Associated with Protein Turnover
Abundance of mRNA associated with skeletal muscle protein turnover were
examined in the LT of AN and SG steers two and ten d post-implanting (Table 5.2). Two
d post-implanting, there was a breed×treatment interaction, with SG-CON steers having a
greater (P = 0.05) mRNA abundance of mitogen activated protein kinase (MAPK) than
AN-CON steers. Additionally, abundance of Calpain-6 (CAPN6) tended to be altered (P
= 0.07) by a breed×treatment interaction two d post-implanting. However, when LS
Means were examined, the means were not different (P > 0.10) from one another despite
SG-CON having numerically increased abundance of CAPN6 compared to SG-IMP
steers (Table 5.2). Furthermore, breed affected (P = 0.05) Calpastatin (CAST) abundance.
Two d post-implanting, CAST abundance was greater (P = 0.05) in AN steers than in SG
steers (Table 5.2). Anabolic implants did not alter (P > 0.10) mRNA abundance of CAST
on either d two or d ten. Ten d post-implanting there was a tendency for CON steers to
have greater (P = 0.09) mRNA abundance of muscle RING finger protein 1 (MURF-1).
Anabolic implants, breed, or their interaction did not alter (P > 0.10) mRNA abundance
of any other genes investigated ten d post-implanting (Table 5.2).
Abundance of mRNA Associated with Skeletal Muscle Metabolism
Abundance of mRNA of nine genes associated with muscle metabolism was
investigated in the LT of AN and SG steers two and ten d post-implanting (Table 5.3).
There was a breed×treatment interaction (P = 0.05) in respect to succinate dehydrogenase
(SDHA) mRNA abundance (Table 5.3). When LS Means were examined, none of the
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means were different (P > 0.10) from one another, however, SG-CON had numerically
increased abundance of SDHA compared to AN-CON steers. There were no other
interactions (P > 0.10) regarding mRNA associated with skeletal muscle metabolism
observed on either day (Table 5.3). Additionally, neither breed nor treatment affected (P
> 0.10) abundance of any of the genes investigated on either day (Table 5.3).
Abundance of mRNA of Receptors that are Associated with Growth
Abundance of the oxytocin receptor (OXTR), insulin like growth factor-1 receptor
(IGF-1R), and the vitamin D receptor (VDR) were examined two and ten d postimplanting in AN and SG steers (Table 5.4). Implant, breed, or their interaction had no
effect (P > 0.10) on the IGF-1R at either timepoint (Table 5.4). There was no interaction
or implant effect (P > 0.10) regarding OXTR abundance. However, ten d post-implanting
the OXTR was affected by breed, with SG steers having increased (P = 0.03) mRNA
abundance compared to AN steers. Ten d post-implanting, there was a breed×treatment
interaction, with the VDR having greater (P = 0.03) mRNA abundance in the SG-CON
steers than all other steers (Table 5.4)
Protein Expression of Calpain-1 and Calpastatin
Relative abundance of CAST (Figure 5.1) and calpain-1 (CAPN1; Figure 5.2),
were evaluated within and between SG and AN group at two and ten d post-treatment.
Two d post-implanting, CAST expression was affected by a breed×treatment interaction
(P = 0.01; Figure 5.1A) with SG-CON and SG-IMP having a greater expression of
CAST than AN-CON. Furthermore, ten d post-implanting, CAST expression was
affected by breed with SG steers having increased (P < 0.0001) expression of CAST
compared to AN steers (Figure 5.1B). However, CAPN1 evaluation showed no
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differences (P ≥ 0.11) in relative abundance when accounting for breed, treatment, or
their interactions on two (Figure 5.2A) or ten (Figure 5.2B) d post-implanting.

Discussion
Improving our understanding of skeletal muscle growth is imperative to continue
to produce environmentally and economically sustainable products, as skeletal muscle
eventually becomes the marketable end-product; meat (England et al., 2013). Anabolic
implants are currently one of the best tools that beef producers can utilize to improve
skeletal muscle growth in an environmentally and economically sustainable manner
(Crawford et al., 2022), as anabolic implant improve important animal production traits
as previously discussed (Duckett and Pratt, 2014). Furthermore, Bos taurus and Bos
indicus cattle breeds are known to be physiologically different from one another (Frisch,
1987), with the Santa Gertrudis is a composite breed composed of both Bos indicus cattle
(3/8 Brahman) and Bos taurus cattle (5/8 Shorthorn) (Ferraz et al., 2000). When Santa
Gertrudis bulls are crossed with Angus cows, the resulting calves are approximately
3/16ths Bos indicus, and the remaining percentage is Bos taurus. This use of
crossbreeding Bos indicus with Bos taurus helps to mitigate some of the negative effects
that are commonly associated when using Bos indicus genetics within the herd, (Cooke,
2014; Elzo et al., 2016; Wright et al., 2018), while allowing for the preservation of the
advantageous traits of the Bos indicus (Forbes et al., 1998). Additionally, research has
emerged demonstrating that skeletal muscle between Bos indicus influenced animals and
Bos taurus animals is intrinsically different (Wright et al., 2018), with research from our
group and others finding that anabolic implant protocol and cattle breed types interact,
leading to questions regarding the optimization of implant protocols for specific breed
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types (Reichhardt et al., 2021a; Rivero et al., 2021). However, it has been found that
anabolic implants do not alter performance in a breed dependent manner between
Continental and British feedlot cattle (Boles et al., 2009). Therefore, the interactions this
trial found are most likely due to the inclusion of Bos indicus genetics, and not a result of
crossbreeding different taurine breeds. It is important to note that interpretation of the
results of this study are somewhat limited due to the small sample size utilized, however,
to the authors’ knowledge this is one of the first studies examining the changes that occur
in skeletal muscle in response to anabolic implants, and the resulting relationship with
breed type. Better understanding this relationship between cattle breed types and anabolic
implant protocols will allow for management strategies to be developed so that cattle
producers may further improve environmental and economic sustainability of their
operations.
The steers used in this trial were part of a previously published performance trial
(Reichhardt et al., 2021a). In brief, it was found that average daily over the course of the
trial was greater in AN steers when compared to SG steers. Furthermore, numerically
anabolic implants improved average daily gain by 7% in AN steers and 13% in SG steers.
The SG-CON steers numerically gained the least amount of weight throughout the course
of the trial. This translated into economic return increasing the most in AN-IMP steers,
then AN-CON and SG-IMP steers, with the least amount of economic return for the SGCON steers. Additionally, serum haptoglobin concentrations were altered by anabolic
implants in a breed dependent manner with 28 d post-implanting AN-CON steers having
the lowest circulating serum haptoglobin concentration (Reichhardt et al., 2021b).
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Mammalian muscle fiber number is largely fixed at birth; therefore, hypertrophy
of existing muscle fibers is the primary mechanism for postnatal growth (Hawke and
Garry, 2001; Li et al., 2011; Yablonka-Reuveni, 2011). Hypertrophy does eventually
require additional nuclei from satellite cells for muscle growth to occur (Hawke and
Garry, 2001; Li et al., 2011; Yablonka-Reuveni, 2011; Dayton and White, 2014). Satellite
cells are muscle precursor cells that proliferate, then differentiate and fuse with existing
muscle fibers to support post-natal hypertrophy (Li et al., 2011). Differentiation and
phenotypic maturation are necessary for satellite cells to fuse (Gonzalez et al., 2020).
Markers of differentiation in skeletal muscle include increased expression of MYOD,
MYF5, and myogenin, and decreased expression of PAX7 (Halevy et al., 2004;
Yablonka-Reuveni et al., 2008; Yablonka-Reuveni, 2011). Furthermore, research has
found that ¾ Bos taurus and ¼ Bos indicus crossbred animals possess more type IIa
fibers and less type IIx fibers than purebred animals of either breed type (Wright et al.,
2018), with type IIa fibers being known to have more satellite cells (Holterman and
Rudnicki, 2005).
To better understand the relationship between cattle breed type and anabolic implants, the
first group of genes investigated in this study was related to skeletal muscle
differentiation. The present study found that ten d post implanting, CON steers had a
greater mRNA abundance of MYF5 compared to IMP steers. When primary bovine
satellite cells are induced to differentiate and are treated with TBA, MYF5 mRNA
abundance is increased by 4 h post-treatment when compared to control treated cultures
(Reichhardt et al., 2021b). However, by 12 h post-treatment, MYF5 mRNA abundance is
drastically decreased when compared to that of control cultures (Reichhardt et al.,
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2021b). This suggests that TBA accelerates satellite cells through the myogenic lineage.
In the present study, the opposite was observed. This could have been due to differences
in the time points assessed and also the inherent differences between in vitro and in vivo
studies. Additionally, examining the PAX7:MYOD ratio can help determine the current
activity within the satellite cell pool. In the current study, it was found that SG steers had
a greater PAX7:MYOD ratio than AN steers. This indicates that SG steers had a greater
proportion of satellite cells remaining in the proliferation phase. Furthermore, CAPN6
mRNA abundance tended to be increased in SG-CON steers two d post-implanting. In
mouse satellite cells, loss of function of CAPN6 results in accelerated differentiation into
myotubes, suggesting that CAPN6 is a suppressor of satellite cell differentiation (Tonami
et al., 2013). Taken together, these findings suggest that Bos indicus influenced steers
may have decreased satellite cell differentiation when compared to Bos taurus steers,
however future work is warranted in this area to assess the relationship between cattle
breeds and their satellite cell pools.
Protein turnover is intimately related to skeletal muscle growth as growth is
defined as the difference between protein synthesis and protein breakdown (Owens et al.,
1993). Mitogen activated protein kinase is a marker of cellular proliferation and an
upstream regulator of the mTOR pathway via the MAPK/ERK pathway (Cargnello and
Roux, 2011). Two d post-implantation, SG-CON steers had a greater mRNA abundance
of MAPK than AN-CON steers. Additionally, a tendency was observed in the current trial
for CON steers to have increased abundance of MURF-1 when compared to IMP steers
regardless of breed. Muscle RING finger protein-1 triggers skeletal muscle protein
degradation by ubiquitination (Koyama et al., 2008). In cattle it has been found that E2
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promotes protein synthesis and decreases protein degradation (Kamanga-Sollo et al.,
2010), with literature consistently demonstrating that E2 increases protein synthesis rates
of fused bovine satellite cells in vitro (Kamanga-Sollo et al., 2010; Kamanga-Sollo et al.,
2017). Overall, these findings suggest that the hormones present in anabolic implants
may decrease protein breakdown regardless of cattle breed type. Additionally, CAST and
CAPN1 can be used as identifiers of meat tenderness due to their relationship with
protein degradation (Casas et al., 2006). Abundance of CAST was impacted by breed in
the current trial, with AN steers having increased abundance compared to SG steers.
Furthermore, it has been suggested that increasing Bos indicus percentage leads to an
increase in CAST activity resulting in lower tenderness values (Ferguson et al., 2000).
Calpastatin is an inhibitor of CAPN1 (Koohmaraie, 1996), with research finding
that as the percentage of Bos indicus influence increases, CAPN1 autolysis decreases
(Ramos et al., 2018; Wright et al., 2018). The current trial found that CAST protein
expression was affected by a breed×treatment interaction with SG-CON and SG-IMP
steers having greater expression than AN-CON steers two d post-implanting, while ten d
post-implanting SG steers had greater expression of CAST than AN steers. This
corroborates the finding from other research groups that increasing Bos indicus
percentage leads to an increase in CAST activity (Ferguson et al., 2000). Collectively,
these data suggest that both anabolic implants and cattle breed type may alter protein
turnover early on in the feedlot stage of production, which may eventually lead to
alterations in meat quality, specifically tenderness. Therefore, future work is necessary in
this area to identify the relationship between cattle breed type, anabolic implants, and
protein turnover.
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Succinate dehydrogenase has been identified as a predictor of meat tenderness in
beef (Morzel et al., 2008). Increasing the usage of anabolic implants and increasing the
percentage of Bos indicus influenced genetics both independently raise concerns as they
relate to meat quality (Montgomery et al., 2001; Elzo et al., 2012), especially tenderness,
however, in the current trial skeletal muscle biopsies were taken early in the feedlot phase
of production. Succinate dehydrogenase was affected by a breed×treatment interaction
within the current trial, however, the LS Means were not different from one another,
which is most likely explained due to the small sample size used in the trial.
Nevertheless, AN-IMP had numerically greater abundance of SDHA compared to ANCON steers, while SG-CON steers had a greater abundance of SDHA compared to SGIMP steers. This suggests that anabolic implants may alter SDHA in a breed dependent
manner. Succinate dehydrogenase is one of the mitochondrial enzymes of the TCA cycle
in skeletal muscle, with SDHA being greater in oxidative fibers and lowest in glycolytic
fibers (Peter et al., 1972). As previously discussed, ¾ Bos taurus and ¼ Bos indicus
crossbred animals possess more type IIa fibers and less type IIx fibers (Wright et al.,
2018). Type IIa fibers have been known to have greater SDHA activity than type IIx
fibers in cattle (Picard and Gagaoua, 2020). These preliminary findings warrant further
research to determine whether mitochondria and muscle fiber type are involved in the
interaction between cattle breed type and anabolic implants.
The oxytocin receptor and VDR have been linked to both skeletal muscle growth
and the physiological response of anabolic implants (Jager et al., 2011; Zhang et al.,
2018; Reichhardt et al., 2021a). In the present study, it was found that SG steers had
increased abundance of OXTR in the LT. To the authors’ knowledge, the effect of cattle
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breed type on circulating oxytocin has yet to be investigated. However, oxytocin has been
found to directly inhibit the proteolytic activities of the lysosomal and proteasomal
systems in rat oxidative skeletal muscle by suppressing atrogene expression through
stimulation of Akt/FoxO signaling (Costa et al., 2021). Furthermore, oxytocin has been
found to increase fusion indexes in bovine satellite cells induced to differentiate (Zhang
et al., 2018). The role that oxytocin and the OXTR are appearing to play in skeletal
muscle growth suggests that oxytocin and the OXTR may partially explain the differences
observed in skeletal muscle growth between the two cattle breed types. Additionally, it
has been found that vitamin D and its receptor are required for adult mammalian skeletal
muscle growth and maintenance (Ceglia, 2008). Previous work completed by our group
has found that circulating serum 25-HydroxyVitamin D was affected by cattle breed type
and anabolic implants, with non-implanted SG steers having lower concentrations than
non-implanted AN steers (Reichhardt et al., 2021a). In the present study, SG-CON steers
had an increased mRNA abundance of VDR ten d post-implanting than all other steers in
the current trial. Most likely, this is explained due to the fact the SG-CON steers had a
lower concentration of 25-HydroxyVitamin D, resulting in an upregulated abundance of
the VDR. Additionally, in rats it has been found that overexpression of the VDR
stimulates skeletal muscle hypertrophy (Bass et al., 2020). This suggests a critical role for
VDR in skeletal muscle growth. Additional studies are needed to clarify the role of VDR
in bovine skeletal muscle growth.

Summary
In summary, the findings of this research suggest that anabolic implants and cattle
breed type impact calpastatin expression and mRNA abundance associated with protein
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in the LT of feedlot steers. More specifically, anabolic implants and cattle breed type
interact with each other to alter mRNA abundance of SDHA and CAST, while protein
expression of CAST is impacted by this interaction with SG-CON and SG-IMP having
greater expression than AN-CON steers. Future work is warranted to improve our
understanding of interactions between cattle breed type and anabolic implants so that
proper implant protocols can be developed to better improve environmental and
economical sustainability without sacrificing meat quality.
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Table 5.1. Abundance of mRNA associated with skeletal muscle differentiation from
longissimus thoracis skeletal muscle of feedlot steers of different cattle breed types following
implanting.
Implant and Breed Treatments1
AN-IMP SG-IMP
ANSGCON
CON
5
5
5
5

SEM

Breed

P-values2
Trt
BxT

Steers (n)
PAX73
d2
53.98
56.76
45.14
21.89
33.47
0.77
0.54
0.71
d 10
10.73
15.52
18.41
30.54
7.15
0.26
0.13
0.58
MYF54
d2
14.11
3.27
10.07
13.03
5.06
0.46
0.59
0.21
d 10
10.38
9.98
20.84
38.47
10.02
0.41
0.05
0.32
MYOD5
d2
11.80
7.74
7.15
6.89
2.57
0.39
0.27
0.44
d 10
21.02
30.82
32.66
14.92
12.29
0.75
0.87
0.29
MYOG6
d2
8.75
6.57
10.01
4.45
3.38
0.23
0.88
0.54
d 10
6.26
6.39
4.32
139.6
65.52
0.32
0.33
0.32
PAX7:MYOD7
d2
0.08
0.33
0.14
0.53
0.15
0.05
0.39
0.63
d 10
0.15
0.06
0.22
0.14
0.08
0.27
0.29
0.99
1
Implant treatments administered on d 0 include: no implant + Angus (AN-CON), no implant + Santa
Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and
Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol). 2P-values indicate
the effect of Breed, Treatment (TRT), or B × T (Breed × Treatment). Skeletal muscle biopsies were
collected on d 2 and 10 post-implanting, and RNA isolation and quantitative PCR were performed as
described in the Materials and Methods. All data are presented as the least square means ± SEM. 3Paired
box transcription factor 7. 4Myogenic regulatory factor 5. 5Myoblast differentiation factor 1. 6Myogenin.
7
The paired box transcription factor 7 to myoblast differentiation factor 1 ratio.
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Table 5.2. Abundance of mRNA associated with protein turnover from longissimus thoracis
skeletal muscle of feedlot steers of different cattle breed types following implanting.
Implant and Breed Treatments1
AN-IMP
SG-IMP
ANSGCON
CON
5
5
5
5

SEM

Breed

P-values2
Trt
BxT

Steers (n)
CAPN6 3
d2
53.46
15.35
21.77
151.92
42.26
0.29
0.24
0.07
d 10
56.13
38.21
45.54
57.86
13.15
0.84
0.74
0.29
CAST 4
d2
49.79
30.25
42.17
28.00
7.83
0.05
0.52
0.72
d 10
26.85
47.46
26.03
32.99
10.63
0.22
0.48
0.53
mTOR5
d2
90.09
60.18
55.27
56.57
17.63
0.45
0.31
0.41
d 10
56.77
60.02
38.94
74.59
17.31
0.31
0.93
0.39
MAPK6
d2
22.84xy
21.71xy
16.50x
44.10y
7.87
0.10
0.28
0.05
d 10
19.95
29.22
29.12
31.08
5.55
0.34
0.35
0.53
ATROG-17
d2
60.39
61.41
84.11
78.48
13.47
0.87
0.15
0.81
d 10
64.75
89.25
81.69
96.44
18.82
0.32
0.53
0.79
MURF-18
d2
53.85
53.11
52.24
75.21
8.48
0.23
0.26
0.20
d 10
73.79
70.19
98.02
105.61
16.05
0.91
0.09
0.74
FOXO39
d2
76.48
64.28
123.20
83.28
28.97
0.35
0.23
0.59
d 10
55.37
71.68
65.61
86.27
17.21
0.26
0.41
0.88
1
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa
Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and
Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol). 2P-values indicate
the effect of Breed, Treatment (TRT), or B × T (Breed × Treatment). Skeletal muscle biopsies were
collected on d 2 and 10 post-implanting, and RNA isolation and quantitative PCR were performed as
described in the Materials and Methods. x,yDifferent letters indicate a tendency between time points (0.05
< P ≤ 0.10). All data are presented as the least square means ± SEM. 3Calpain 6. 4Calpastatin.
5
Mammalian target of rapamycin. 6Mitogen activated protein kinase. 7Atrogin-1. 8Muscle RING finger
protein 1. 9Fokhead Box O3.
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Table 5.3. Abundance of mRNA associated with skeletal muscle metabolism from longissimus
thoracis skeletal muscle of feedlot steers of different cattle breed types following implanting.
Implant and Breed Treatments1
AN-IMP
SG-IMP
ANSGCON
CON
5
5
5
5

SEM

P-values2
Breed
Trt
BxT

Steers (n)
MHC I 3
d2
266.72
230.33
199.06
164.17
50.74
0.66
0.26
0.72
d 10
308.59
273.19
249.17
316.28
82.60
0.84
0.91
0.49
MHC IIa 4
d2
99.29
75.01
65.00
58.87
16.56
0.33
0.11
0.53
d 10
114.14
132.94
127.21
102.70
29.99
0.93
0.79
0.51
MHC IIx5
d2
445.61
361.86
309.57
257.19
114.26
0.56
0.31
0.89
d 10
591.44
385.96
551.07
688.26
133.90
0.80
0.34
0.21
AKT6
d2
26.44
26.24
21.47
26.11
4.51
0.64
0.59
0.61
d 10
25.59
33.34
31.08
10.15
7.06
0.26
0.39
0.93
LDHA7
d2
87.24
100.85
94.62
80.21
23.85
0.98
0.77
0.53
d 10
148.73
107.89
113.62
104.80
32.74
0.48
0.58
0.64
GAPDH8
d2
275.32
256.61
268.35
228.0
69.95
0.67
0.79
0.87
d 10
381.15
353.67
356.92
356.45
109.60
0.90
0.92
0.91
CS9
d2
137.18
76.62
118.95
117.29
20.61
0.16
0.59
0.18
d 10
74.97
98.60
105.38
126.76
19.17
0.26
0.14
0.95
SDHA10
d2
45.37
35.95
18.74
60.79
13.36
0.94
0.23
0.05
d 10
44.37
36.06
43.57
66.17
14.93
0.65
0.36
0.34
1
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa
Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and
Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol). 2P-values indicate
the effect of Breed, Treatment (TRT), or B x T (Breed x Treatment). Skeletal muscle biopsies were
collected on d 2 and 10 post-implanting, and RNA isolation and quantitative PCR were performed as
described in the Materials and Methods. aDifferent letters indicate a difference (P < 0.05) between time
points. xDifferent letters indicate a tendency between time points (0.05 < P ≤ 0.10). All data are
presented as the least square means ± SEM. 3Myosin Heavy Chain I. 4Myosin Heavy Chain IIa. 5Myosin
Heavy Chain IIx. 6Serine threonine kinase 1. 7Lactate dehydrogenase A. 8Glyceride-3-phosphate
dehydrogenase. 9Citrate Synthase. 10Succinate dehydrogenase.
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Table 5.4. Abundance of receptor mRNA associated with skeletal muscle growth from
longissimus thoracis skeletal muscle of feedlot steers of different cattle breed types following
implanting.
Implant and Breed Treatments1
AN-IMP
SG-IMP
ANSG-CON
CON
5
5
5
5

SEM

Breed

P-values2
Trt
BxT

Steers (n)
OXTR 3
d2
56.58
19.56
69.90
99.98
50.91
0.94
0.24
0.37
d 10
0x
23.21xy
0x
88.58y
32.01
0.03
0.15
0.31
IGF-1R 4
d2
59.65
23.46
25.83
18.00
14.00
0.15
0.19
0.35
d 10
21.75
23.01
31.87
37.65
10.08
0.72
0.19
0.80
VDR 5
d2
77.05
25.26
62.18
104.46
48.13
0.92
0.47
0.29
d 10
6.93a
22.91a
4.66a
114.93b
22.54
0.01
0.04
0.03
1
Implant treatments administered on d 0 include: no implant +Angus (AN-CON), no implant + Santa
Gertrudis (SG-CON), Revalor-S + Angus (AN-IMP; 120 mg trenbolone acetate + 24 mg estradiol) and
Revalor-S + Santa Gertrudis (SG-IMP; 120 mg trenbolone acetate + 24 mg estradiol). 2P-values indicate
the effect of Breed, Treatment (TRT), or B × T (Breed × Treatment). Skeletal muscle biopsies were
collected on d 2 and 10 post-implanting, and RNA isolation and quantitative PCR were performed as
described in the Materials and Methods. a,bDifferent letters indicate a difference (P < 0.05) between time
points. x,yDifferent letters indicate a tendency between time points (0.05 < P ≤ 0.10). All data are
presented as the least square means ± SEM. 3Oxytocin Receptor. 4Insulin like growth factor-1 Receptor.
5
Vitamin D Receptor.
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Figure 5.1. Calpastatin (CAST) protein expression was determined on (A) d two and (B)
ten post-implanting by SDS-PAGE and Immunoblotting as described in the Materials and
Methods. Steers were stratified by weight and by breed; Angus (AN) or Santa Gertrudis
(SG) and assigned to one of two treatments: (1) Control, no implant (CON), or (2)
implanted with 120 mg trenbolone acetate and 24 mg estradiol (IMP). Data represent
calpastatin abundance and are presented as LS mean ± SEM.
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Figure 5.2. Calpain-1 (CAPN1) protein expression was determined on (A) d two and (B)
ten post-implanting by SDS-PAGE and Immunoblotting as described in the Materials and
Methods. Steers were stratified by weight and by breed; Angus (AN) or Santa Gertrudis
(SG) and assigned to one of two treatments: (1) Control, no implant (CON), or (2)
implanted with 120 mg trenbolone acetate and 24 mg estradiol (IMP). Data represent
calpastatin abundance and are presented as LS mean ± SEM.
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CHAPTER VI
THE RELATIONSHIP BETWEEN CATTLE BREED TYPE AND ANABOLIC
IMPLANT PROTOCOL RELATIVE TO FEEDLOT STEER PERFORMANCE;
GROWTH, TEMPERAMENT, FEEDING BEHAVIOUR, CARCASS
CHARACTERISTICS, AND ECONOMIC RETURN

Abstract
Recent research has suggested that different cattle breed types may respond
differently to anabolic implant protocols of varying intensity. Therefore, the purpose of
this research was to compare anabolic implant protocols in feedlot steers of two different
breed types. Sixty steers were stratified by weight and breed in a 2 x 3 factorial design
examining two different breeds: Angus (AN; n=38) or Santa Gertrudis influenced (SG;
n=22), and three implant strategies: no implant (CON; n=20), a moderate intensity
implant protocol (d0 implant: Revalor-G, d56 implant: Revalor-IS, d112 implant:
Revalor-S; MI; n=20), or a high intensity implant protocol (d0 implant: Revalor-IS, d56
implant: Revalor-S, d112 implant: Revalor-200; HI; n=20). Steers were randomly placed
into pens equipped with GrowSafe bunks to collect dry matter intake and feeding
behavior and fed the same ration. Weight, chute score, exit velocity, serum, rectal
temperature, hip height and 12th rib fat thickness were collected approximately every 28
d over a 196 d period. Serum urea nitrogen (SUN) was evaluated as well. Total average
daily gain was increased (P < 0.0001) in both the HI and MI steers compared to the CON
steers by 29.4% and 26%, respectively. A treatment ˟ breed interaction was observed (P
< 0.0001) for hip height, with AN-CON steers being shorter (P < 0.0007) than AN-HI,
SG-CON, SG-MI, and SG-HI steers. A breed ˟ treatment interaction was observed (P <
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0.004) for chute score and rectal temperature, with SG-HI and SG-MI steers having
increased chute scores (P < 0.001) than AN-HI, AN-MI, AN-CON, and SG-CON
through the course of the trial. Additionally, SG-HI and SG-MI steers had an increased
rectal temperature (P < 0.004) compared to AN-HI, AN-MI, AN-CON, and SG-CON
steers. A breed effect was observed (P = 0.002) for SUN with AN steers having
increased (P = 0.002) SUN concentration compared to SG sired steers, in addition to a
treatment effect (P < 0.0001), with CON steers having a higher (P < 0.0001) SUN
concentration than MI and HI steers. The MI implant protocol increased net return per
head, on average, by $97.28, regardless of breed, while the HI implant protocol increased
net return by only $80.84. Taken together, despite the cattle breed types responding
differently to the different anabolic implant protocols at times, a moderate intensity
anabolic implant protocol is optimal regardless of breed type, for steers raised in a
temperate climate.
Implications
In the U.S., anabolic implants are routinely used in beef cattle production to
increase growth and feed efficiency, ultimately increasing economic return and
improving environmental sustainability. Recent research has suggested that different
cattle breed types may respond differently to different anabolic implant protocols. The
current research found that despite the two different breed types responding differently to
commonly used implant protocols, a moderate intensity anabolic implant protocol
improved economic return in both cattle breed types investigated when the steers were
raised in a temperate climate.
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Introduction
Climate change currently poses many new challenges for most agricultural sectors
(Rojas-Downing et al., 2017). In the livestock sector, climate change impacts livestock
production through an increased thermal load for production animals, ultimately leading
to decreased yield and profitability by depressing feed intake efficiency, growth rates,
and product quality, all of which translate into large economic losses for producers
(Belhadj Slimen et al., 2016; Summer et al., 2019). Two methods that the beef cattle
industry can use to potentially improve efficiency, sustainability, and economic viability
are by crossbreeding different cattle breed types and through the use of growth
promotants (Capper and Hayes, 2012).
In considering the use of breeding to improve cattle efficiency, it is valuable to
note some of the well documented differences between the two main beef cattle breed
types, Bos taurus (BT) and Bos indicus (BI) (Coles et al., 2014). Bos taurus cattle, which
are of European descent, tend to be early maturing with superior carcass traits (Forbes et
al., 1998). In the U.S., taurine breeds, including the Angus (AN) and Hereford breeds, are
most commonly used. Bos indicus cattle tend to be better adapted to higher temperatures
and nutritional stress than BT (Forbes et al., 1998), and are more disease resistant than
their European counterparts (Glass et al., 2005). Cattle with BI influence are able to
withstand higher temperatures (Forbes et al., 1998), while consuming less water
(Winchester and Morris, 1956; Forbes et al., 1998). The US cow herd is only 8% BIinfluenced (Cundiff et al., 2012). One potential method to improve the sustainability of
the beef industry is to increase the percentage of BI-influenced animals in the U.S.
However, BI-influenced steers have two potential drawbacks. First, BI-influenced
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animals commonly have a more excitable temperament, leading to animal handling
difficulty (Voisinet et al., 1997). The second drawback of BI-influenced animals is that
they possess less desirable carcass and palatability characteristics compared to the typical
BT-influenced steer (Wright et al., 2018). Negative impacts on carcass quality of BI
animals can be minimized by crossing BI cattle with BT cattle (Elzo et al., 2012).
Anabolic implants are steroid hormones that have been routinely used in U.S. beef
cattle production since the early 1950’s, with currently over 40 approved products by the
U.S. Food and Drug Administration (Smith and Johnson, 2020). In the U.S., over 90% of
all cattle on feed will receive an anabolic implant some point during production (APHIS,
2013). Anabolic implants increase growth and efficiency of beef cattle (Duckett and
Pratt, 2014), while increasing economic return by $15-163 a head (Duckett and Pratt,
2014; Reichhardt et al., 2021a). In addition to improved growth and economic return,
anabolic implants decrease land usage by 7.8-9.1% and greenhouse gas emissions by 5.18.9% (Basarab et al., 2012; Capper and Hayes, 2012).
However, the relationship between anabolic implant strategy and breed type
remains unclear. Research has reported that different cattle breeds respond differently to
anabolic implants suggesting that anabolic implant protocols may need to be optimized
depending on the cattle breed type to maximize performance and economic return
(Reichhardt et al., 2021a; Rivero et al., 2021). Therefore, the purpose of the research
presented in this manuscript is to better understand how anabolic implant protocols of
varying intensity effect feedlot performance, carcass quality, behaviour and economic
return of BI influenced cattle compared to BT cattle raised in temperate climates.
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Materials and Methods
Animals, Experimental Design and Treatments
All live animal procedures and protocols for this experiment were approved by
the Utah State University Institutional Animal Care and Use Committee, IACUC
Protocol #10216. This experiment utilized a 2 ˟ 3 factorial design and was conducted at
the Utah State University feedlot. Sixty steers, 38 AN sired (267.6 ± 5.5 kg) and 22 SG
sired (282.1 ± 6.8 kg), that had not previously received any growth promotants, were
initially stratified by weight. All steers used in this trial were out of commercial Angus
dams. Prior to beginning the trial, each steer received an electronic and visual ear tag.
Steers were assigned to one of three implant treatments: (1) no implant (CON; n=20), (2)
a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant: Revalor-IS,
d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant:
Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200; HI; n=20). Steers were
randomly placed into one of four covered pens each equipped with two GrowSafe bunks.
Each pen housed a total of 15 steers. Steers always had free choice access to water. All
steers were fed the same diet. Diets were stepped up between 10 and 12% (DM basis)
concentrate every 10 d from a background diet consisting of 44.5% (DM basis)
concentrate to a finishing diet consisting of 81% (DM basis) concentrate (Table 6.1) over
a 35 d period.
Feedlot performance, behaviour, and sample collection
Individual as-fed feed intake was calculated by the GrowSafe system. Daily feed
intake was converted to dry matter intake (DMI) by utilizing as-fed feed intake and the
percent DM of each ration. Rations samples were collected weekly and analysed
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commercially (Cumberland Valley Analytical, Waynesboro, PA). Steers were weighed
on a certified scale (Tru-Trust GR3000, College Station, TX) and a certified ultrasound
technician measured ribeye fat thickness (REFT) using a portable ExaGo ultrasound
(Universal Imaging, Bedford, NY, USA) on d 0 and every 28 d after until harvest.
Weights, average daily gain (ADG), rectal temperature, chute score, and exit velocity
were recorded on d 0 and every 28 d till harvest. Hip heights were recorded on d 0, 56,
84, 112, 140, and day of harvest. Individual ADG was calculated by subtracting the initial
body weight for the period from the final body weight for the period and dividing by the
number of d for that period. Gain to feed (G:F) for individual steers was calculated by
dividing ADG by DMI for each period. Rectal temperature was taken using a digital
thermometer fitted with a rectal probe (AmerisourceBergen, Conshohocken, PA, USA).
Chute scores were taken by the same two individuals, blind to the individual animal
treatments, following published guidelines (Cooke, 2014; Federation, 2018). Chute
scores were assigned according to behaviour while entering and in the squeeze chute
following a five point scale. In brief, a score of 1 = docile, 2 = restless, 3 = nervous, 4 =
flighty, and 5 = aggressive. Exit velocity was determined by using an electronic timing
system (FarmTek Equipment, Dyersville, IA, USA) with transmitters placed at 1 m and 4
m in front of the chute for a total distance of 3 m. Blood was collected via jugular
puncture and harvested as serum on d 0, 6, 28, 56, 62, 84, 112, 118, 140, and d of harvest
using 10.0 mL, 16 ˟ 100 mm BD Vacutainer Serum Blood Collection Tubes. Blood
samples were allowed to coagulate, kept on ice, and transported approximately 12 km to
the laboratory. Blood samples were centrifuged at 1,000 ˟ g for 15 min at 4°C.
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Supernatants were then collected, aliquoted, and serum samples were stored at -20°C
until further analysis.
Feeding behaviour data
Feeding behaviour data were analysed following previously published methods by
our lab group (Reichhardt et al., 2021a; Reichhardt et al., 2021b) and others (McGee et
al., 2014). Data were based off the two main categorical traits calculated by the
GrowSafe bunks; (1) bunk visit, which is the single reading of an EID tag when entering
a bunk, whether feed is consumed or not, and (2) feed bouts, which is the reading of a
single animal EID tag when entering a bunk, and a minimum of 10 g of feed is
consumed. Based off bunk visits, the average duration of the bunk visit, the average
amount of feed consumed per bunk visit, and the amount of time an animal spent with its
head down per bunk visit were analysed. Regarding feed bout data, the following was
also calculated: the duration of the feed bout, the average amount of feed consumed per
feed bout, and the average time an animal’s head was down while it consumed feed
during a feed bout.
Serum urea nitrogen assay
Serum urea nitrogen (SUN) concentrations were determined using a commercially
available colorimetric assay in triplicate (Invitrogen, Urea Nitrogen BUN Colorimetric
Detection Kit; ThermoFisher Scientific) following manufacturer’s protocol. The plate
was read on a BioTek all-in-one microplate reader using Gen5 3.0 all-in-one microplate
reader software (BioTek Instruments, Winooski, VT). Intra-assay CV: 1.62%. Inter-assay
CV: 1.93%.
Carcass Characteristics
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The steers were harvested at a commercial harvest facility (Hyrum, UT) once an
average amount of 9.5 mm of 12th REFT was measured via ultrasound. This resulted
with the steers being harvested on two separate days, d 168 and d 196. Dressing
percentage, hot carcass weight (HCW), marbling score, ribeye area (REA), REFT, and
cold camera yield grade were recorded at the plant by trained USDA inspectors. Dressing
percentage was calculated by dividing HCW by final live weight and multiplying by 100.
A marbling to backfat ratio (M:BF) was calculated by using previously described
equations (Mohrhauser et al., 2015).
Economic Analysis
The economic performance of the six treatments within this study were compared
by creating separate budgets for each treatment as in previously published work
(Reichhardt et al., 2021a). Within each budget, the expected net return per head was
calculated for comparison across the six treatments. Feed costs and implant costs were
the only variable costs entered into each budget. All other costs of production not
effected by treatment were held constant and assumed equal to zero. This simplifies the
analysis and allows for the appropriate identification of the key drivers in differences in
economic performance. The expected net return per head was calculated as
1)

〖NR〗i=〖DP〗_i (〖DW〗_i )/100-SP(IW)/100-〖FC〗_i

where 〖NR〗_i is the net return ($/head) of treatment i, 〖DP〗_i is the dressed price
($/cwt.) of treatment i, 〖DW〗_i is the dressed weight (lbs.) of treatment i, SP is the
stocker price ($/cwt.), IW is the initial weight (lbs.), and 〖FC〗_i is the feed cost for
treatment i.
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The dressed price was based on grid pricing with the grid taken from the
Agricultural Marketing Service’s National Weekly Direct Slaughter Cattle- Premiums
and Discounts report (dated August 9, 2021). The grid base price was taken as a five-year
average of the 5-market average dressed price (Center, 2021). The appropriate premiums
and discounts were added to each treatment’s dressed priced based on the treatment’s
quality grade and yield grade averages. The grid valued Prime quality grade at $19.54
above Choice while Select and Standard were discounted $17.92/cwt and $31.50
respectively. Yield grade 1 and 2 were valued at $3.69 and $1.58/cwt above yield grade 3
while yield grade 4 and 5 were discounted by $11.23 and $16.85/cwt respectively. A
five-year average of the Colorado combined auction prices for feeder steers 550-650 lbs
was used for the stocker price (Center, 2020). Similar to previous work (Reichhardt et al.,
2021a), the stocker price for the SG treatments was discounted $3.50/cwt to coincide
with findings in the literature (Feuz et al., 2008; Hawkes et al., 2008; Troxel, 2011) that
support discounts for BI influenced feeder cattle. The initial weight used in the budgets
for each treatment was taken as the average initial weight of the steers across all
treatments in our study and was equal to 600 lbs. The dressed weight was calculated as
the sum of the initial weight and the product of days on feed (DOF), treatment ADG, and
the average treatment dressing percentage. The costs for individual feed components
within a treatment were estimated using five-year historical averages for the feed prices
($/lb) multiplied by the total pounds of intake (as fed) and the corresponding percentage
of the feed components within the feed ration. The budget assumptions for the individual
treatments are summarized in Table 6.2.
Statistical Analysis
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A 2 ˟ 3 factorial design was utilized for this trial, where steers of two different
breed types (AN or SG) were initially stratified by weight and assigned to one of three
treatments (CON, MI, HI). Statistical analysis was performed using the MIXED
procedure of SAS (version 9.4; SAS Inst. Inc., Cary, NC, USA). All data are presented as
the least square means ± standard error of the mean (SEM). Weight, feeding behaviour,
temperature, SUN, and hip height were analysed as repeated measures for differences
between breed, treatment, breed ˟ treatment, day, day ˟ breed, day ˟ treatment, and
treatment ˟ day ˟ breed. Average daily gain (ADG), DMI, G:F and carcass characteristics
were analysed for differences between breed, treatment, and breed ˟ treatment. Individual
steer and pen were included as random variables in all analyses. When treatment
differences were found to be significant (P < 0.05), least square means were separated
using Tukey-Kramer adjustments. When interactions were found to be significant, the
main effects of that variable were not discussed individually. Significance was declared
at P ≤ 0.05 and tendencies are discussed between 0.05 < P ≤ 0.10.

Results
Live Animal Performance
Live animal performance was evaluated via measuring DMI, gain to feed (G:F),
ADG, weights, 12th REFT , and hip height. Weight, 12th REFT, and hip height were
analysed with repeated measures and are presented in Figure 6.1. Dry matter intake, G:F,
and ADG were averaged throughout the entire finishing period and are presented in Table
3. On d 0 of the trial, there was no differences (P > 0.09) in weight relative to treatment,
breed, or breed ˟ treatment (Figure 6.1A). However, during the trial, a breed ˟ treatment
interaction arose with AN-CON steers weighing less (P < 0.004) than SG-HI, SG-MI,
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AN-HI, and AN-MI steers in respect to total weight gain. No breed ˟ treatment was
observed (P > 0.09) for DMI, however both breed (P = 0.007) and treatment (P <
0.0001) influenced DMI (Table 6.3). Santa Gertrudis-sired steers increased (P = 0.007)
DMI by 4.4% compared to AN steers. Implanted steers had an increased (P < 0.0001)
DMI compared to CON steers, with MI steers having an 8% greater (P = 0.0002) DMI
than CON steers, and HI steers having an 11.6% increase (P < 0.0001) in DMI compared
to CON steers (Table 6.3). A breed ˟ treatment interaction was not observed (P = 0.43)
for G:F, nor did breed have an effect (P = 0.57) on G:F over the course of the trial (Table
6.3). However, treatment did impact G:F (P = 0.007), with MI steers having improved (P
= 0.005) G:F by almost 20%. A breed ˟ treatment interaction was observed (P = 0.04) for
12th REFT over the course of the trial, however there were no differences (P > 0.10)
between the six treatment groups analysed (Figure 6.1B). Total gain and ADG were also
examined (Table 6.3). There were no breed ˟ treatment interactions observed (P > 0.26)
for gain or ADG, however treatment did influence gain and ADG. Total gain was
increased (P < 0.001) 26.6% in the HI steers compared to CON steers, and by 25% in the
MI steers compared to CON (Table 6.3). Total ADG was increased (P < 0.0001) by
29.4% in the HI steers compared to CON steers, while it was increased by 26% in the MI
steers compared to CON steers. A treatment ˟ breed interaction was observed (P <
0.0001) for hip height (Figure 6.1C). Angus-CON steers were shorter (P < 0.0007) than
AN-HI, SG-CON, SG-MI, and SG-HI steers. Control-SG steers were taller (P < 0.002)
than AN-HI and AN-MI steers, while AN-MI steers were shorter (P < 0.05) than SG-MI
steers and SG-HI steers. Additionally, there was a day effect, with steers getting taller (P
< 0.001) over the course of the trial.
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Chute score, exit velocity, and rectal temperature
When chute score, exit velocity, and rectal temperature were analysed (Figure
6.2), a breed ˟ treatment interaction was observed (P < 0.004) for chute score and rectal
temperature, while no breed ˟ treatment interaction was observed (P = 0.11) for exit
velocity. Santa Gertrudis-HI and SG-MI steers had increased chute scores (P < 0.001)
compared to AN-HI, AN-MI, AN-CON, and SG-CON throughout the course of the trial
(Figure 6.2A). There was also a day effect (P < 0.001) for chute scores, with steers
typically having lower chute scores as the trial progressed (Figure 6.2A). Rectal
temperatures followed a similar pattern to that of chute scores, with SG-HI and SG-MI
steers having an increased rectal temperature (P < 0.004) compared to AN-HI, AN-MI,
AN-CON, and SG-CON steers (Figure 6.2B). Additionally, a day effect was once again
observed (P < 0.0001) with steers typically having a lower rectal temperature as the trial
progressed (Figure 6.2B). Despite breed ˟ treatment interactions being observed for both
chute score and rectal temperatures, no interaction (P = 0.18) was observed for exit
velocity (Figure 6.2C). However, a treatment effect was observed (P = 0.02) with HI
steers having a slower (P = 0.02) exit velocity than CON steers (Figure 6.2C). Again,
there was an effect of day on exit velocity, with steers typically having slower exit
velocities (P = 0.0013) as the trial progressed.
Feeding behaviour
When feeding behaviours were investigated, it was found that there were no (P >
0.37) breed, treatment, or breed ˟ treatment interactions overserved for bunk visits, feed
bouts, or the duration of bunk visits and feed bouts (Figure 6.3). Day did influence both
bunk visit and feed bout with fewer (P < 0.0001) occurring as the trial went on (Figure
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6.3A). A similar event was observed with the duration of feed bouts and bunk visits, with
the duration of the bunk visits and feed bouts being shorter (P < 0.0001) as the trial went
on (Figure 6.3B). There were no treatment ˟ breed interactions observed (P > 0.18) for
the average amount consumed per bunk visit or feed bout (Figure 6.4). Treatment did
influence the amount of feed that was consumed per bunk visit, with both MI and HI
steers consuming more (P < 0.0002) per visit than CON steers (Figure 6.4A). This was
also observed with the average amount consumed per feed bout, with implanted steers
consuming more (P < 0.0005) than CON steers per feed bout (Figure 6.4B). A breed ˟
treatment interaction was observed (P < 0.0001) for both the average time spent with
head down per bunk visit and feed bout (Figure 6.5). Santa Gertrudis-HI steers spent
more time (P < 0.0001) with their heads down per bunk visit than AN-HI, AN-CON,
AN-MI, and SG-MI steers (Figure 6.5A). Control SG steers spent more time with their
heads down (P < 0.0001) than AN-CON, AN-MI, and AN-HI steers. Meanwhile, SG-MI
steers spent more time with their heads down (P = 0.03) than AN-HI steers. A similar
interaction was observed for the amount of time spent with heads down per feed bout
(Figure 6.5B). Santa Gertrudis-HI steers spent more time with their heads down (P<
0.0001) than AN-CON, AN-MI, AN-HI, and SG-MI steers. Control SG steers spent more
time with their heads down (P < 0.0001) per feed bout than AN-CON, AN-MI, AN-HI,
and SG-MI steers. Again, the SG-MI spent more time with their heads down per feed
bout (P = 0.03) than the AN-HI steers. Additionally, a day effect was observed (P <
0.0001) as the trial went on, with steers spending less time with their heads down per
bunk visit and feed bout.
Serum urea nitrogen
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Serum urea nitrogen was measured on d 0, 6, 28, 56, 62, 84, 112, 118, 140, and d
of harvest (Table 6.4) and analysed as a repeated measure over time. No treatment ˟
breed interactions were observed (P = 0.11) for SUN. A breed effect was observed (P =
0.0002) with AN steers having increased (P = 0.0002) SUN concentration compared to
SG sired steers. A treatment effect was also observed (P = 0.0006), with CON steers
having increased (P = 0.0006) SUN concentration compared to MI and HI steers. A day
effect (P < 0.0001) was also observed, with SUN concentrations varying throughout the
course of the trial, with the largest increase (P < 0.0001) in SUN retention occurring in
the first 28 d following the start of the trial (Table 6.4).
Carcass characteristics
No breed ˟ treatment interactions (P > 0.35) were observed when carcass
characteristics were investigated (Table 6.5). Hot carcass weight was altered by treatment
with MI and HI steers having larger (P < 0.0002) carcasses than CON steers, with the
carcasses being 12.8% and 14.8% heavier, respectively. Ribeye area was also increased
(P < 0.006) by implanting with MI steers having a 10.6% larger (P= 0.03) REA than
CON steers, and HI steers having a 12.6% larger (P =0.008) REA than CON steers.
Marbling score was influenced by breed (P = 0.001), with AN steers having improved (P
= 0.001) marbling compared to SG-sired steers. The M:BF ratio was altered by both
treatment (P < 0.01) and breed (P = 0.004). Control steers had a higher ratio (P < 0.01)
compared to implanted steers in both treatment groups. Additionally, AN sired steers had
an improved (P = 0.004) ratio when compared to SG-sired steers. Dressing percentage,
cold camera yield grade, and REFT were not altered by either breed (P > 0.39) or
treatment (P > 0.46) (Table 6.5).
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Economic Analysis
The gross return, total feed and implant costs, and net return for each treatment
are calculated as in equation 1) and summarized in Table 6.6. Using the results in Table
6.2, the net returns can be directly compared across implant strategies and breeds. Our
results suggest that SG genetics would be expected to decrease the net return per head.
The difference between the average net return of the three SG treatments (-$15.84) and
the average of the three AN treatments ($35.12) is -$50.96/hd. and represents the
expected decrease to net return for SG genetics as compared to AN. The estimated
average increase to net return when using an anabolic implant (whether MI or HI) is
$89.06.
The current study also compared the relative impact to net return or MI anabolic implant
protocol as compared to a HI protocol. As seen in Table 6.6, the largest expected net
return within a breed (AN or SG) is expected when given a MI implant treatment. We
expect the MI implant protocol to increase net return per head on average by $97.28
(regardless of breed) while the high intensity implant protocol increases net return by
only $80.84.

Discussion
A growing concern for U.S. beef producers is the changing climate and drought
conditions that alter performance and economic viability (Capper and Hayes, 2012;
Rojas-Downing et al., 2017). One potential method for improving the environmental
sustainability of the beef industry is by increasing the percentage of BI influenced
animals, as they have a higher heat index and are able to consume less water (Forbes et
al., 1998). Additionally, anabolic implants are routinely used in U.S. beef cattle
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production to increase growth and feed efficiency, economic return, and environmental
sustainability (Capper and Hayes, 2012; Duckett and Pratt, 2014). It has been reported
that on average, anabolic implants increase ADG by 18%, feed efficiency by 6%, and
feed intake by 6% (Duckett and Pratt, 2014). However, research is emerging suggesting
that anabolic implants improve performance differently depending on cattle type and
breed (Reichhardt et al., 2021a; Rivero et al., 2021). Therefore, the purpose of this project
was to determine optimal anabolic implant protocols for BI influenced feedlot steers and
for BT steers, each raised in a temperate climate. This was accomplished by utilizing SG
sired steers, which are a composite breed of 3/8 Brahman and 5/8 Shorthorn (Ferraz et al.,
2000), and commercial AN steers. All the steers used in the study were out of
commercial AN cows. The resulting steer calves were then developed in a feedlot where
live animal performance, cattle behaviour data, and carcass data were collected.
It is well accepted that anabolic implants increase ADG, DMI, and feed efficiency
of feedlot steers (Duckett and Pratt, 2014; Smith and Johnson, 2020). In the current study,
a MI anabolic implant protocol increased DMI by 8% and ADG by 26% compared to
non-implanted control steers. Meanwhile, a HI anabolic protocol increased DMI by
11.5% and ADG by 29% compared to non-implanted steers. This increase in performance
is consistent with findings reported in reviews published elsewhere (Duckett et al., 1996;
Duckett and Pratt, 2014; Smith and Johnson, 2020) demonstrating that anabolic implants
are a useful tool to improve G:F and ADG of feedlot steers.
Research completed in heifers has found that as the percentage of Bos indicus
increases, whither height increases (Hearnshaw et al., 1994). The research presented here
found a breed ˟ treatment interaction such that AN-CON steers were shorter than all of
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the SG sired steers and AN-HI steers. Collectively, this indicates that more than breed
alone drives animal height. In crossbred calves, it has been found that when anabolic
implants high in TBA and low in E2 are administered four times, skeletal development is
altered in steers and heifers, with implanted animals having larger pelvic areas (Hardt et
al., 1995). Research conducted in bulls using a milder implant strategy found that
although not statistically significant, implanted bulls were numerically 4 cm taller (Jones
et al., 1991). A combination of breed and genetics can influence mature frame size in
beef cattle (Comerford et al., 1988), with this research indicating management techniques
such as anabolic implants also contributing to frame size in feedlot steers.
For cattle producers, temperament is an important trait as more temperamental
cattle can increase the risk of injury to both the cattle and the producer (Grandin, 1994),
while leading to decreased growth rates, ADG, and carcass quality (Voisinet et al., 1997).
Evaluating temperament in cattle can be assessed by chute scores, exit velocity, cortisol
(Cooke, 2014), and more recently, rectal temperature (Williams et al., 2019). It is well
accepted that BI cattle have a more excitable temperament when compared to BT cattle
(Cooke, 2014). When evaluating the temperament of heifers, it has been found that
Brahman Angus cross heifers have greater exit velocities than straightbred Angus heifers,
and Brahman sired heifers have greater chute scores than non-Brahman sired heifers
(Riley et al., 2010). The present study found that when SG steers were implanted, the
steers had higher chute scores and rectal temperatures, while in AN steers chute scores
and rectal temperatures were not different between treatment groups. This is interesting,
as anabolic implants have been shown to lower circulating cortisol in crossbred beef
steers (Hayden et al., 1992). However, in earlier research it has been found that there is
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no difference in serum haptoglobin concentrations 28 d after implanting in Santa
Gertrudis sired steers compared to control Santa Gertrudis steers (Reichhardt et al.,
2021a), suggesting that anabolic implants may operate through different physiological
mechanisms in BI influenced cattle when compared to BT cattle. Additionally, in the data
presented here, the steers temperament improved as the trial proceeded. Research has
shown that cattle of both breed types become adapted to human handling, and become
less temperamental as time goes on (Cooke, 2014), which was supported by the findings
of this trial.
Feeding behaviour has been shown to be linked to feedlot performance
(Schwartzkopf-Genswein et al., 2002; McGee et al., 2014), and previous research has
also demonstrated that steers that receive a single E2 only implant have altered feeding
behaviour compared to control steers (Reichhardt et al., 2021b). In the present trial, both
MI and HI anabolic implant protocols influenced feeding behaviour. Implanted steers
consumed more feed per feed bout, which is reasonable as the implanted steers had a
greater DMI and greater ADG. In Red Angus heifers, the duration of feed bouts and
ADG were intimately linked, such that heifers with longer feed bouts having increased
ADG (McGee et al., 2014). Previous research has shown that feedlot steers implanted
with E2 only spend less time with their heads down per bunk visit (Reichhardt et al.,
2021b). Additionally, in a previously completed trial, non-implanted SG sired steers were
shown to have shorter bunk visits than implanted and non-implanted AN sired steers and
implanted SG steers (Reichhardt et al., 2021a). However, in the current trial the SG-CON
steers spent more time with their heads down than the AN steers in all the treatments, as
well as SG-HI spending more time with their heads down than SG-MI steers. Other
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research in grazing heifers has shown that angus heifers have shorter and fewer grazing
periods than Angus Brahman heifers (Forbes et al., 1998). Cumulatively, it is appearing
that both cattle breed type and anabolic implants regulate feeding behaviour in beef
feedlot steers.
A marker of lean tissue anabolism is SUN, as it inversely indicates increased N
retention (Smith and Johnson, 2020). The hormones that are typically used in anabolic
implants have consistently resulted in increased protein accumulation in vivo and in vitro
(Johnson et al., 1996; Thornton et al., 2016; Kamanga-Sollo et al., 2017), while varying
anabolic implant strategies have been shown to alter SUN of feedlot cattle (Smith et al.,
2018). Both HI and MI anabolic implants increased N retention by d 84 post-implanting
in the current study. Previous research has found that re-implanted feedlot steers had
decreased plasma urea nitrogen by d 70 post-implanting (Niedermayer et al., 2018).
Earlier completed research found that there is a breed ˟ implant interaction when SG sired
steers are implanted compared to AN steers (Reichhardt et al., 2021a), however the
current trial did not find a breed ˟ implant interaction. Despite this, breed influenced
SUN, with SG sired steers having increased N retention when compared to AN sired
steers. In a study comparing N retention between Hereford and Brahman steers, it was
found that Brahman steers also had greater N retention (Hunter and Siebert, 1985). Taken
together, these findings suggest that BI influenced cattle may have a greater potential for
lean tissue anabolism linked to greater ability to retain N, additionally both anabolic
implant protocols decreased SUN on d 84 of the trial.
A concern when introducing BI influenced genetics into the beef herd is the
resulting effects on carcass quality. In the U.S., beef producers are typically paid on the
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grid system, resulting in yield grade and quality grade being extremely important
(Schroeder et al., 2009). The AN sired steers in this study had improved marbling scores,
when compared to SG sired steers, this was expected as typically there is less fat on BI
influenced carcasses (Wheeler et al., 1994), however there was no difference between
yield grades. Despite there being no difference between yield grades, the M:BF ratio was
different between breeds with AN sired steers having an improved ratio compared to SG
sired steers. This improved ratio indicates that the AN steers were more efficient at
depositing intramuscular fat than SG sired steers, which relates to the improved marbling
that was observed in the AN steers.
Both moderate and high intensity anabolic implant protocols improved HCW by
12.8% and 14.8%, respectively. When a single, mild anabolic implant was administered
to Angus steers, HCW increased by 8% (Reichhardt et al., 2021b). The current trial used
both a MI and HI anabolic implant protocol, which explains the increase in HCW that
was observed, as research has found that increasing the hormone content of anabolic
implants linearly increases both HCW and REA in feedlot steers (Smerchek and Smith,
2020). When a single TBA anabolic implant is administered to Angus steers, REA is
increased by 10.7% (Reichhardt et al., 2021b). The current trial found that a MI and HI
anabolic implant protocol also increased REA by 10.6% and 12.6%, respectively. This
increase in HCW and REA is most likely due to increased skeletal muscle growth and
protein accretion due to increased hormone concentrations in the current trial, with breed
not impacting HCW or REA.
The estimated average increase to net return when using an anabolic implant
(whether MI or HI) is $89.06. In comparison, previous research by our group
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demonstrated a relatively similar expected decrease of $46/hd when introducing SG
genetics and a $46/hd increase when using anabolic implants (Reichhardt et al., 2021a).
Though our estimate of change in net return from implant use is comparatively larger
than the estimate of previous research (Reichhardt et al., 2021a), it is still well within a
range of similar estimates within the literature which has estimated the benefit of
anabolic implants in the range of $15-$163 per head (Donovan et al., 1983; Duckett and
Pratt, 2014). Earlier research also compared the relative impact to net return of anabolic
implant use within AN as compared to SG steers (Reichhardt et al., 2021a). They
estimated a larger increase to expected net return per head within SG sired steers as
compared to AN— approximately $72/hd versus $20/hd respectively. Within the current
study, we found a similar expected increase of $77.92 to net return when using anabolic
implants within SG sired steers. However, the increase to net return within AN steers is
estimated at $100.20. This is most likely explained as the previous trial only utilized a
single, mild anabolic implant, while the current trial utilized a MI and HI anabolic
implant protocol.
The current study also compared the relative impact to net return or moderate
intensity anabolic implant protocol as compared to a high intensity protocol. As seen in
Table 5, the largest expected net return within a breed (AN or SG) is expected when
given a moderate intensity implant treatment. We expect the moderate intensity implant
protocol to increase net return per head on average by $97.28 (regardless of breed) while
the high intensity implant protocol increases net return by only $80.84. The marginal
effect of the MI implant protocol on net return is, therefore, approximately $16 per head
more than the HI implant treatment. This suggests from an economic perspective that the
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moderate intensity implant strategy would be sufficient, and producers should not expect
any added economic benefit (increased returns) from using a high intensity implant
strategy.
In summary, a MI implant protocol had the best economic return when utilized in both
SG sired steers and AN sired steers that were raised in a temperate climate, despite the
breeds possibly having different physiological responses to the implants. This study
found that were several breed ˟ treatment interactions including, ADG, hip height, 12th
REFT, chute score, rectal temperature, and some feeding behaviours. This indicates that
anabolic implants alter performance of feedlot steers in a breed type dependent manner.
Therefore, in the future it could be beneficial for beef producers to match their anabolic
implant protocol to the cattle type that they raise to further improve environmental and
economic sustainability. Future research is warranted to determine the different
physiological and molecular mechanisms that anabolic implants operate through in these
different breed types so we can maximize economic return to producers, while still
improving environmental sustainability.
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Table 6.1. Composition and nutritional
analysis of background and finishing diets fed to
beef steers throughout trial.1

Feed (% DM)
Corn Silage
Cracked Barley
Alfalfa
Finishing Mineral2
Analysis (% DM)
Moisture
Crude Protein
Net Energy(m)3
Net Energy(g)3
1

Background
Diet, (%)

Finishing
Diet, (%)

31.9
43.3
23.6
1.2

10.1
80.0
8.7
1.0

36.4
12.5
2.02
1.18

19.2
13.0
2.20
1.33

Background diet was fed d 0-50 of trial, steers then
received a series of step-up diets incrementally
increasing percent concentrate (DM Basis) until the
finishing ration was reached. Finishing ration was fed d
85-harvest.
2
Composition of Finishing Mineral (DM Basis):
16.73% Ca, 11.09% Cl, 0.23% Mg, 0.31% P, 0.52% K,
6.73% Na, 0.32% S, 10.46 mg/kg Co, 941 mg/kg Cu,
2,614 mg/kg Fe, 5,018 mg/kg Mn, 10.46 mg/kg Se,
6,273 mg/kg Zn, and 921 mg/kg Monensin
3
Net Energy is presented as Mcal/kg
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Table 6.2. Budget assumptions by treatment of beef steers of different breed types
receiving different anabolic implant protocols.
AN-CON

SG-CON

AN-MI

SG-MI

AN-HI

SG-HI

Feeder Price ($/kg)

$3.46

$3.38

$3.46

$3.38

$3.46

$3.38

Starting Weight (kg)

272.7

272.7

272.7

272.7

272.7

272.7

Days on Feed

190.5

190.5

190.5

190.5

190.5

190.5

Dressing Percentage

59.57%

60.06%

61.23%

60.03%

61.14%

60.62%

Average Daily Gain
(kg/day)

1.24

1.29

1.53

1.65

1.53

1.60

Ending Weight (kg)

509.1

507.7

551.8

573.6

574.1

565.4

Kg produced

236.08

234.7

278.8

300.5

301.0

292.4

Total Intake (kg as
fed)

450.9

500.9

507.3

520

526.8

521.4

Yield Grade1

2.75

3.14

2.95

3.04

2.98

2.99

Quality Grade2

2.46

2.86

2.58

3.29

2.91

3.38

Average Total
Revenue ($/hd)

$1,174

$1,120

$1,290

$1,224

$1,294

$1,213

Fed Dressed Price
($/kg)

$3.88

$3.67

$3.82

$3.56

$3.69

$3.54

1

Yield Grade averages reported within this table are from cold camera measurements

2

Quality Grade ranked 1-4 with prime=1, choice=2, select=3, and standard=4

250

Table 6.3. Feedlot performance of steers of different cattle breed types receiving different anabolic implant protocols.
Implant and Breed Treatments1

Steers (n)

P-Values2

AN-CON

SG-CON

AN-MI

SG-MI

AN-HI

SG-HI

13

7

12

8

13

7

a

ab

ab

ab

ab

b

SEM

Breed

Trt

BxT

0.36

0.28

0. 04

0.59

Overall Dry Matter Intake (kg)

8.63

Overall Gain:Feed

0.14

0.14

0.17

0.18

0.17

0.16

0.006

0.98

<0.0001

0.27

Overall Average Daily Gain
(kg)

1.24a

1.29a

1.53b

1.65b

1.53b

1.60b

0.09

0.39

<0.0001

0.35

Total Gain (kg)

240.0a

246.8ac

292.2bc

316.8b

317.1b

299.0b

20.8

0.68

<0.0001

0.26

1

a

9.46

a

9.69

b

9.83

10.02
b

b

10.12

b

Steers were assigned to one of three implant treatments: (1) no implant (CON; n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant:
Revalor-IS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200;
HI; n=20) and of two different breed types Angus (AN) or Santa Gertrudis influenced (SG). 2P-values indicate the effect of Breed, Treatment (TRT), or B x T (Breed x
Treatment).aValues within a row with different letters are different (P < 0.05) from one another. xDifferent letters tend (0.05 ≤ P ≤ 0.10) to be different from one another.
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Table 6.4. Serum urea nitrogen concentration (mg/dL) of steers of different cattle breed types receiving different anabolic implant
protocols.
Implant and Breed Treatments1

P-Values2

AN-CON

SG-CON

AN-MI

SG-MI

AN-HI

SG-HI

SEM

Breed

Trt

BxT

13

7

12

8

13

7

Day 0

19.18

17.14

21.76

17.65

22.96

20.63

1.98

0.05

0.11

0.81

Day 6

15.39

16.57

17.40

15.68

16.52

17.52

1.85

0.90

0.78

0.56

Day 28

7.71 xy

8.89x

7.16 xy

5.81 xy

6.07 xy

5.55y

0.91

0.72

0.006

0.26

Day 56

15.75

14.27

12.84

13.51

14.10

13.35

1.25

0.57

0.24

0.61

Day 62

10.88

10.98

9.71

9.98

9.84

10.61

1.11

0.62

0.50

0.93

Day 84

6.99a

7.00 a

4.24 b

4.87 ab

4.55b

4.33 b

0.83

0.78

0.001

0.79

Day 112

14.14

13.84

11.29

9.52

14.95

11.36

1.71

0.09

0.03

0.47

Day 118

13.57

12.66

12.95

9.33

10.28

10.19

1.18

0.08

0.03

0.21

Day 140

11.72

11.98

11.55

9.46

10.63

8.80

1.37

0.20

0.17

0.52

Day 168

15.73

14.39

13.85

11.30

16.03

13.42

1.62

0.07

0.20

0.88

Day 196

17.65

14.16

15.17

12.46

16.39

12.91

2.02

0.03

0.49

0.96

Steers (n)
Serum Urea Nitrogen (mg/dL)

Breed3

P=0.0002

Treatment3

P=0.0006
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Breed x Treatment3
Day3

P=0.38
P<0.0001

Breed x Day3

P=0.14

Treatment x Day3

P=0.08

Breed x Treatment x Day3

P=0.98

1

Steers were assigned to one of three implant treatments: (1) no implant (CON; n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant:
Revalor-IS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200; HI;
n=20) and of two different breed types Angus (AN) or Santa Gertrudis influenced (SG). 2P-values indicate the effect of Breed, Treatment (TRT), or B x T (Breed x
Treatment).aValues within a row with different letters are different (P < 0.05) from one another. xDifferent letters tend (0.05 ≤ P ≤ 0.10) to be different from one another. 3PValues are from when serum urea nitrogen concentratiosn were analyzed with repeated measures
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Table 6.5. Carcass data of steers of different cattle breed types receiving different anabolic implant protocols.
Implant and Breed Treatments1

P-Values2

AN-CON

SG-CON

AN-MI

SG-MI

AN-HI

SG-HI

13

7

12

8

13

7

59.6

60.1

61.2

60.0

61.1

Hot Carcass Weight (kg)

296.04a

321.87ac

342.52bc

354.26bc

Marbling Score3

398.96a

343.54ab

374.78ab

Ribeye Area (cm2)

73.43ab

69.17a

Ribeye Fat Thickness

8.71

Cold Camera Yield Grade
Marbling:Backfat Ratio4

Steers (n)
Dressing Percentage

1

SEM

Breed

Trt

BxT

60.6

10

0.56

0.43

0.61

357.86b

351.47b

12.7

0.26

0.0002

0.35

328.81ab

372.31ab

323.71b

19.9

0.001

0.37

0.96

80.61ab

77.19ab

81.81b

78.78ab

3.4

0.14

0.006

0.98

9.94

11.39

10.45

11.18

10.41

1.2

0.85

0.24

0.51

2.75

3.14

2.95

3.04

2.98

2.99

0.26

0.39

0.97

0.69

1.14a

-0.22b

-0.14b

-0.64b

-0.12b

-0.72b

0.37

0.003

0.01

0.37

Steers were assigned to one of three implant treatments: (1) no implant (CON; n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant:
Revalor-IS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200; HI;
n=20) and of two different breed types Angus (AN) or Santa Gertrudis influenced (SG). 2P-values indicate the effect of Breed, Treatment (TRT), or B x T (Breed x
Treatment).aValues within a row with different letters are different (P < 0.05) from one another. xDifferent letters tend (0.05 ≤ P ≤ 0.10) to be different from one another.
3
300 to 399 = slight, 400 to 499 = small, 500 to 599 = modest. 4Marbling to backfat ratio was determined using the calculations previously described by (Mohrhauser et al.,
2015). [(observation marbling score- marbling score x̄)/marbling SD]- [(observation backfat- backfat x̄)/backfat SD]
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Table 6.6. Gross return, feed costs, and profit by treatment of beef steers of different breed
types receiving different anabolic implant protocols.
AN-CON

SG-CON

AN-MI

SG-MI

AN-HI

SG-HI

$232.47

$221.80

$376.83

$330.96

$381.58

$319.21

Silage

$29.63

$32.32

$32.74

$32.64

$33.94

$33.98

Alfalfa

$60.40

$65.36

$66.49

$65.90

$68.85

$68.65

Barley

$164.06

$180.69

$185.26

$190.53

$192.46

$195.89

Mineral

$10.06

$11.21

$11.41

$11.81

$11.87

$12.14

Implant

$0.00

$0.00

$7.96

$7.96

$10.40

$10.40

Total Feed and
Implant Costs

$264.15

$289.58

$303.85

$308.84

$317.52

$321.06

Net Return2

-$31.68

-$67.79

$72.98

$22.12

$64.06

-$1.85

Gross Return1
Costs

1

Gross Return was calculated as the difference between sales revenue and the cost of the feeder steer

2

Net Return was calculated as the difference between Gross Return and Total Feed Costs
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Figure 6.1. Weights (A), and 12th ribeye fat (B) were determined on d 0, 28, 56, 84, 112, 140, 168, and day of harvest as described in
the Materials and Methods. Hip height (C) was determined on d 0, 56, 84, 112, 140, and day of harvest as described in the Materials
and Methods. Steers were stratified by weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of three anabolic
implant protocols (1) no implant (CON; n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant: RevalorIS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112
implant: Revalor-200; HI; n=20). Data are presented as LS means ± SEM. Differences (P < 0.05) between different cattle breed types
and anabolic implant protocol are presented as different letters (a,b,c).
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Figure 6.2. Animal temperament was evaluated based on chute score (A), rectal temperature (°C; B), and on exit velocity (m/s;C) on d
0, 28, 56, 84, 112, 140, 168, and day of harvest as described in the Materials and Methods. Steers were stratified by weight and by breed;
Angus (AN) or Santa Gertrudis (SG) and assigned to one of three anabolic implant protocols (1) no implant (CON; n=20), (2) a moderate
intensity implant protocol (d0 implant: Revalor-G, d56 implant: Revalor-IS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity
implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200; HI; n=20). Data are presented as LS
means ± SEM. Differences (P < 0.05) between different cattle breed types and anabolic implant protocol are presented as different letters
(a,b,c).
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Figure 6.3. (A) Feed events, feed bout and bunk visit and (B) duration of feed bout and bunk visit were measured as described in the
Materials and Methods. Feed events were influenced (P ≤ 0.05) by time when analysed as a repeated measure. Different letters, a,b,c,
indicate a difference (P ≤ 0.05) between time points . The P-value for these analyses are displayed on the figure. All data are reported
as LSMEANS ± SEM.
.
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Figure 6.4. The average amount of feed consumed per bunk visit (A) and the average amount of feed consumed per feed bout (B) were
determined on d 0, 28, 56, 84, 112, 140, 168, and day of harvest as described in the Materials and Methods. Steers were stratified by
weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of three anabolic implant protocols (1) no implant (CON;
n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant: Revalor-IS, d112 implant: Revalor-S; MI; n=20),
or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112 implant: Revalor-200; HI; n=20). Data
are presented as LS means ± SEM. Differences (P < 0.05) between different cattle breed types and anabolic implant protocol are
presented as different letters (a,b,c).
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Figure 6.5. The average amount of time spent with the head down per bunk visit (A) and the average amount of time spent with the
head down per feed bout (B) were determined on d 0, 28, 56, 84, 112, 140, 168, and day of harvest as described in the Materials and
Methods. Steers were stratified by weight and by breed; Angus (AN) or Santa Gertrudis (SG) and assigned to one of three anabolic
implant protocols (1) no implant (CON; n=20), (2) a moderate intensity implant protocol (d0 implant: Revalor-G, d56 implant: RevalorIS, d112 implant: Revalor-S; MI; n=20), or (3) a high intensity implant protocol (d0 implant: Revalor-IS, d56 implant: Revalor-S, d112
implant: Revalor-200; HI; n=20). Data are presented as LS means ± SEM. Differences (P < 0.05) between different cattle breed types
and anabolic implant protocol are presented as different letters (a,b,c).

262

CHAPTER VII
CONCLUSIONS

The United States is a leader in beef cattle production, with the largest annual
beef production, the third largest cattle herd, and the largest fed cattle industry in the
world [1]. Due to this, beef production is widely distributed and exists in all 50 states
with an array of climates, environmental conditions, management strategies, and cattle
breed types [2-5]. The cattle industry is very unique, as it is divided into distinct
segments including seedstock production, cow-calf production, stocker and
backgrounding, the feedlot segment, and the packing segment [6]. Currently, there is a
need to further improve beef cattle production in the United States, while adapting to
changes in the environment to ensure that enough food is available for the growing
population in both an environmentally and economically sustainable manner. Two
potential methods to help further improve environmental and economic sustainability of
the beef industry are through the use of heterosis by crossbreeding Bos taurus and Bos
indicus, and through the use of growth promotants [7]. These two methods led to the
overarching hypothesis of this dissertation that through the use of anabolic implants and
utilizing different cattle breed types, feed efficiency and skeletal muscle can be improved
to further improve environmental and economic sustainability for beef producers. As
such, the objective of this body of work was to improve our understanding of anabolic
implants, and the resulting relationship between anabolic implants and cattle breed type.
Chapters II and III explore the relationship between anabolic implants varying in
hormone type and concentration and the resulting effects on feedlot performance, feeding
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behavior, carcass characteristics, and mRNA abundance of genes associated with skeletal
muscle growth of Angus feedlot steers. In the United States, anabolic implants are
commonly given to beef cattle to increase skeletal muscle growth and improve feed
efficiency [8, 9]. However, despite their widespread usage and known benefits, the
mechanisms of action through which skeletal muscle growth is improved have yet to be
understood. Additionally, comparisons between hormone type and content of different
implants and the effects on growth and trace mineral stores is limited. The objective of
chapter II was to evaluate the effects of anabolic implants varying in hormone type and
concentration on growth, carcass characteristics, and trace mineral concentrations in
Angus steers. Cattle administered an estradiol only implant did not experience differences
in growth compared to non-implanted controls. However, cattle implanted with a
trenbolone acetate only implant or a combined (estradiol and trenbolone acetate) implant
experienced improvements in growth and changes in plasma and liver trace mineral
concentrations. Greatest differences in growth and trace mineral concentrations were
observed in steers administered the combination implant compared to non-implanted
controls. These data suggest hormone type and concentration influence implant-induced
growth and changes in plasma and liver trace mineral concentrations. The purpose of
Chapter III was to improve understanding of how anabolic implants increase skeletal
muscle growth of beef steers. The main findings of this research suggest that steroid
hormones, estradiol and trenbolone acetate, operate through different molecular
mechanisms to increase skeletal muscle growth of beef steers. Overall, it appears that
estradiol alters skeletal muscle growth via nutrient partitioning related to metabolism.
Trenbolone acetate improves skeletal muscle growth by activating pathways involved in
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skeletal muscle growth. Meanwhile, when these steroid hormones are administered
together, both mechanisms of action are observed. This research provides important
insight into the molecular mechanism through which different anabolic implants function
to improve growth of skeletal muscle. Additional work is still warranted to determine
proteomic and metabolomic changes that occur post-implanting in feedlot steers.
To further investigate the relationship between cattle breed type and anabolic
implants, Chapters IV-VI investigate feedlot performance, behavior, carcass
characteristics, economic return, and mRNA abundance associated with skeletal muscle
growth. Two methods that the beef cattle industry can use to potentially improve
efficiency, sustainability, and economic viability are growth promotants and
crossbreeding cattle of different breed types [7]. Research suggests that the two main
cattle breed types, Bos indicus and Bos taurus, respond differently to different anabolic
implant strategies. The objective of Chapter IV was to determine how Bos indicusinfluenced steers respond to anabolic implants and perform in a feedlot setting compared
to Bos taurus steers several breed × treatment interactions were observed in this study,
providing very interesting initial evidence that cattle breed type and anabolic implants
interact with each other to cause changes in production. Future work is needed to
optimize different implant protocols for different breeds and types of cattle. On average,
a mild anabolic implant increased return to producers by $46 a head, while using Bos
indicus genetics decreased economic return to feedlot producers by $46 a head. These
results indicate that producers that wish to utilize Bos indicus genetics, can increase
economic return and improve performance by implanting their cattle, while using Bos
indicus genetics can help improve yield grade if the producers are paid on a grid-based

265
system. The objective of Chapter V was to characterize changes that occur in the skeletal
muscle following implanting in Bos indicus-influenced animals and Bos taurus animals.
This research measured mRNA abundance of 24 genes associated with skeletal muscle
growth, and protein expression of calpain-1 and calpastatin. The findings of this research
suggest that anabolic implants and cattle breed type interact to cause changes in mRNA
abundance in the longissimus thoracis that are related to protein turnover of skeletal
muscle. Furthermore, calpastatin protein abundance was also altered by this
breed×treatment interaction. This research demonstrates that anabolic implants cause
molecular changes in skeletal muscle of feedlot steers, with some of these changes being
breed dependent. The purpose of Chapter VI is to optimize anabolic implant protocols of
Bos indicus influence cattle compared to Bos taurus cattle, each raised in temperate
climates. A moderate intensity implant protocol had the best economic return when
utilized in both Santa Gertrudis-sired steers and Angus-sired steers that were raised in a
temperate climate, despite the breeds possibly having different physiological responses to
the implants. The high intensity Angus steers did have the greatest growth; however, their
economic return was less when compared to the moderate intensity Angus steers. This
can most likely be explained by the increase in dry matter intake and lower carcass
quality score. Future research is warranted to determine the different physiological and
molecular mechanisms that anabolic implants operate through in these different breed
types so we can maximize economic return to producers, while still improving
environmental sustainability.
As with any study, the research presented in this dissertation had several
limitations that need to be acknowledged. In chapters III and V, skeletal muscle biopsies
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were only collected from the longissimus thoracis. Research has shown that muscles
from different locations are intrinsically different from one another [10]. Therefore, there
is a potential that if muscle from different locations were sampled, different responses to
anabolic implants may be observed. However, it is important to keep in mind that despite
this limitation, the longissimus is one of the most economically valuable muscles in the
carcass and is the primary muscle used to determine carcass quality, making it an
important muscle to understand. Second, these studies only evaluated a limited number of
genes known to be involved in skeletal muscle growth and metabolism and did not
investigate the whole skeletal muscle transcriptome. Despite this potential limitation, this
allowed for a very targeted approach to help further understand the mechanisms through
which anabolic implants increase skeletal muscle growth. In Chapter VI, chute scores
were collected to assist in evaluating animal temperament. Chute scores are subjective,
which is a potential limitation, however they are commonly used to evaluate animal
temperament [11]. To offset these subjective measurements, exit velocity and rectal
temperature were also evaluated. Furthermore, chute scores were given by two people
blind to the treatments. Furthermore, in Chapters IV and V only five steers were utilized
per treatment. It is therefore important to note interpretation of the results of this study
are somewhat limited due to the small sample size utilized. However, to the authors’
knowledge this is one of the first studies examining the changes that occur in skeletal
muscle in response to anabolic implants, and the resulting relationship with breed type.
Better understanding this relationship between cattle breed types and anabolic implant
protocols will allow for management strategies to be developed so that cattle producers
may further improve environmental and economic sustainability of their operations.
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In summary, this research provides novel insight into improving understanding of
anabolic implants and is one of the first projects to investigate the relationship between
anabolic implants and cattle breed type. Future studies should include a greater number of
animals to help with interpretation of the results. Additionally, the research could be
beneficial to include animals of greater Bos indicus influence, as the animal utilized in
Chapters IV-VI were only 3/16 Brahman. Follow-up studies investigating the proteome
and metabolome would be beneficial to assist in furthering the understanding of anabolic
implants and cattle breed type so management strategies may be developed to assist with
further improving environmental and economic sustainability of beef cattle production.
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